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Kurzzusammenfassung 
Adulte mesenchymale Stammzellen (MSCs) werden bereits für die Therapie 
verschiedener Krankheiten klinisch eingesetzt. Der erste Teil der vorliegenden Arbeit 
beschäftigt sich mit der Aufklärung von Schlüsselmechanismen, die an der 
Transmigration von MSCs über die Endothelbarriere und der Invasion in ein Ziel-
gewebe beteiligt sind. Beide Prozesse sind die Grundvoraussetzung für eine 
erfolgreiche Stammzelltherapie, da MSCs stets das Blutgefäßsystem verlassen 
müssen, um in umgebendes Gewebe einzuwandern. Versuche mit verschiedenen 
Modelsystemen sowie in vivo Experimente ergaben, dass MSCs schnell Kontakt zur 
Endothelbarriere aufnehmen und anschließend die Blutbahn über folgende Schritte 
verlassen: (1) durch eine Integration in das Endothel, (2) durch die Transmigration 
über die Endothelbarriere, vermittelt durch die Ausbildung von Zellfortsätzen, (3) 
durch Penetration der Basalmembran und anschließende Invasion in das 
umgebende Gewebe.  
Zudem konnte gezeigt werden, dass die Transmigration humaner MSCs durch die 
Interaktion der Oberflächenmoleküle VLA-4 und VCAM-1 vermittelt wird und in einer 
regionalen Ansammlung von β1-Integrinen resultiert. Desweiteren schütten MSCs 
aktive Matrix-Metalloproteinase (MMP)-2, nicht aber MMP-9 aus, um in Herzmuskel-
gewebe einzudringen.  
Die vorliegende Arbeit zeigt, dass sowohl der zeitliche Verlauf als auch die morpho-
logischen Aspekte der Transmigration vom Phänotyp der Endothelzellen abhängig 
sind. Dies deutet auf Unterschiede in der Effizienz der Transmigration innerhalb des 
Gefäßsystems – abhängig vom Gefäßtyp – hin. Außerdem beschleunigt die Zugabe 
von Zytokinen, besonders VEGF und EPO, zu Beginn der Transmigration den Ablauf 
des Prozesses. Auch ergaben Versuche, dass MSCs, sobald sie Kontakt zu Endo-
thelzellen aufnehmen, vermehrt Stickstoffmonoxid (NO) und reaktive Sauerstoff-
Spezies (ROS) freisetzen. Veränderungen des NO- oder ROS-Haushaltes 
resultierten in Abweichungen der transmigratorischen Fähigkeit der MSCs.  
Der letzte Teil der vorliegenden Arbeit beschäftigt sich mit zwei möglichen Ansätzen, 
die therapeutische Effizienz von MSCs zu erhöhen. Einerseits zeigte sich, dass eine 
genetische Modifikation der Stammzellen durch adenovirale Überexpression des 
Chemokin-Rezeptors CXCR4 keine Verbesserung ihrer transmigratorischen Aktivität 
zur Folge hat. Andererseits verbesserte eine gezielte Vorbehandlung des Endothels 
durch eine neuartige und nicht-invasive Technik, die Ultraschall-vermittelte Mikro-
bläschen-Stimulierung (UMS), sowohl die Anlockung als auch die Transmigration und 
Invasion von MSCs in gesundes und ischämisches Herzmuskelgewebe. Diese 
regionale Verbesserung wurde vermutlich durch die Ultraschall-vermittelte Frei-
setzung von Stickstoffmonoxid und Zytokinen, sowie die lokale Aktivierung von 
Matrix-Metalloproteinasen erzielt. Daher stellt die Ultraschall-vermittelte 
Mikrobläschen-Stimulierung eine zukunftsweisende Möglichkeit dar, die 
therapeutische Effizienz von MSCs lokal und nicht-invasiv zu erhöhen.  
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Abstract 
Stem cell therapy using human adult mesenchymal stem cells (MSCs) has emerged 
as a novel strategy for the treatment of a variety of damaged tissues. For a 
successful systemic stem cell therapy MSCs have to exit the blood circulation by 
transmigrating across the endothelium and invading into the target tissue. Elevating 
our knowledge on these core processes might help to optimize stem cell based 
therapies. The first part of the present study provides insights into key mechanisms 
involved in the transmigration and invasion of MSCs. Different model systems as well 
as in vivo studies revealed that MSCs quickly come into contact with the endothelium 
and subsequently exit the blood circulation by (1) integrating into the endothelium, (2) 
transmigrating across the endothelial barrier via the insertion of plasmic podia, (3) 
penetrating the basement membrane and subsequently invading the surrounding 
tissue.  
Additionally, it was proven that transmigration of human MSCs not only requires the 
interaction of very late antigen-4 (VLA-4, α4β1 integrin) and its most important ligand 
vascular cell adhesion molecule-1 (VCAM-1), but also triggers a clustering of β1 
integrins. Furthermore, upon invading into cardiac tissue MSCs secrete active matrix 
metalloproteinase (MMP)-2, but not MMP-9.  
This study also demonstrates that both the time course and the morphological 
aspects of MSC transmigration differ depending on the endothelial phenotype, thus 
indicating, that a variable capacity for transendothelial migration exists within the 
vasculature. Furthermore, addition of cytokines, mainly vascular endothelial growth 
factor (VEGF) and erythropoietin (EPO), accelerate the transmigration of MSCs at 
early stages. Moreover, nitric oxide (NO) and reactive oxygen species (ROS) are 
released by MSCs upon contact with endothelial cells; manipulating the NO and ROS 
system by donors and inhibitors resulted in alterations of the transmigratory capacity 
of MSCs.  
The second part of the study deals with two possible strategies to enhance the 
transmigration of MSCs and thereby their therapeutic effectiveness. First, the results 
demonstrate that genetic modification of MSCs using adenoviral overexpression of 
the chemokine receptor CXCR4 does not lead to an increase in the transmigration 
efficiency. Second, focussed pretreatment of the endothelium by a novel and non-
invasive technique using ultrasound-mediated microbubble stimulation (UMS) 
induces a targeted improvement of MSC attraction, transmigration and invasion into 
non-ischemic as well as into ischemic myocardium. This effect was most likely due to 
the release of nitric oxide, cytokines and the regional activation of proteases. Thus, 
UMS represents a forward-looking possibility to increase the efficiency of MSC 
engraftment by modulating the process of transmigration in a targeted and non-
invasive manner.  
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1. Introduction 
Bone marrow-derived mesenchymal stem cells (MSCs) are adult stem cells that 
reside within the bone marrow compartment (Schmidt et al., 2006b). MSCs can be 
isolated and expanded in culture and are described as multipotent because of their 
ability, even as clonally isolated cells, to differentiate into a variety of different cells 
(Tuan et al., 2002; Pittenger et al., 2004). Stem cell therapy using human adult bone 
marrow derived MSCs has emerged as a novel strategy for the treatment of a variety 
of damaged tissues as they possess a multi-lineage differentiation potential (Jiang et 
al., 2002). The use of adult stem cells to regenerate damaged tissue not only 
circumvents the ethical and technical issues associated with the use of embryonic 
stem cells, but also allows the transplantation of autologous as well as allogeneic 
cells. As allogeneic MSCs inhibit T cell proliferation and maturation (Krampera et al., 
2003; Le Blanc et al., 2003; Tse et al., 2003b) they are not recognized by responder 
T cells and therefore not rejected by a recipient host. Thus, allogenic MSCs can be 
prepared in advance for any patient at the needed time (Pittenger et al., 1999) and 
can be administered without immunosuppression (Krause et al., 2007).  
 
1.1 Sources, multipotency and markers of mesenchymal stem cells 
MSCs, first identified by Friedenstein and co-workers in 1976 (Friedenstein et al., 
1976), have a fibroblastic morphology, possess a broad ex vivo expansive potential 
and can maintain an undifferentiated, stable phenotype over many generations 
(Pittenger et al., 1999). Currently, bone marrow aspirate is considered to be the most 
accessible and enriched source of MSCs. Nevertheless, MSCs have also been 
isolated from several other sources, including adipose tissue (Zuk et al., 2002; Lee et 
al., 2004b), scalp tissue (Shih et al., 2005), dermal tissue (Toma et al., 2001) and 
peripheral blood (Fernandez et al., 1997). In addition to adult tissues, MSCs were 
also identified in various fetal tissues, such as in the placenta (In 't Anker et al., 
2004), in umbilical veins and umbilical cord blood (Erices et al., 2000). Although 
MSCs represent a very small fraction of cells – only about 0.001 to 0.01% of the cells 
isolated from a density gradient of a bone marrow aspirate belong to this population 
(Pittenger et al., 1999) – they are easy and fast expandable ex vivo. Due to the 
plastic-adherence of MSCs, non-adherent contaminating hematopoietic cells can be 
easily removed after isolation. Human MSC populations can be distinguished from 
Introduction 
 
2 
hematopoietic stem cells and leukocytes by distinct cell surface markers. Considering 
their mesodermal origin, MSCs are known to be negative for the leukocyte common 
antigen CD45, for the lipopolysaccharide receptor CD14 and for CD34, a marker of 
human hematopoietic stem and progenitor cells. The collective presence of a 
combination of other markers, such as CD105 (endoglin or transforming growth factor 
TGF β1/3-receptor) and CD106 (vascular cell adhesion molecule-1, VCAM-1), albeit 
not specific to MSCs, defines the MSC cell population (Pittenger et al., 1999).  
As depicted in Figure 1, MSCs are capable of differentiating into various tissues of 
mesenchymal origin such as bone (Friedenstein et al., 1987; Haynesworth et al., 
1992; Kuznetsov et al., 1997; Meinel et al., 2004a; Meinel et al., 2004b), skeletal 
muscle cells and cardiomyocytes (Wang et al., 2000; Goodell et al., 2001; Toma et 
al., 2002; De Bari et al., 2003), cartilage (Friedenstein et al., 1987; Li et al., 2005b) or 
vascular endothelial cells (Reyes et al., 2002; Koike et al., 2004), but can also give 
rise to non-mesenchymal cells like neural cells (Azizi et al., 1998; Kopen et al., 1999).  
 
1.2 Therapeutic usage of MSCs 
The ability of MSCs to differentiate into various cells in vivo has understandably 
aroused great interest for the therapeutic treatment of a variety of diseases. Indeed, 
clinical benefit has been observed following the intravenous administration of 
heterogeneous populations of MSCs in patients with osteogenesis imperfecta 
(Horwitz et al., 1999) or severe acute graft-versus-host disease (Le Blanc et al., 
2004). Moreover, due to the very limited ability of myocardial tissue to regenerate 
after a myocardial infarction, treatment with stem cells also seems to be a promising 
therapeutic approach in cardiology. Adult cardiomyocytes have essentially no 
regenerative capacity and although a cardiac stem cell has been described (Anversa 
et al., 2002), its physiological role in repair after infarction appears minimal (Pittenger 
and Martin, 2004). Therefore, only an implantation of exogenous cells may allow 
replacement of damaged cardiac cells. Indeed, cellular transplantation, termed 
cellular cardiomyoplasty, has been investigated as a potential therapy for myocardial 
infarction in order to replace cardiomyocytes lost after ischemia (Bittner et al., 1999; 
Jackson et al., 2001; Orlic et al., 2001a; Orlic et al., 2001b; Nygren et al., 2004). The 
first use of bone marrow cells for cardiomyoplasty was reported in 1999 by Tomita 
and co-workers at the University of Toronto (Tomita et al., 1999). For a successful 
cardiomyoplasty, MSCs are a promising stem cell type, because they differentiate 
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into a cardiomyocyte-like phenotype when implanted in healthy myocardium 
(Pittenger et al., 2000; Toma et al., 2002). Furthermore, MSCs supply growth factors 
and cytokines, which help to repair the damaged tissue via paracrine effects 
(Pittenger and Martin, 2004; Mirotsou et al., 2007). Thus, in several ongoing clinical 
trials, patients are treated with MSCs after a myocardial infarction (for review see 
(Laflamme et al., 2005; Ohnishi et al., 2007)). However, for a successful clinical 
application different strategies for transporting MSCs to their target destinations have 
to be evaluated regarding their applicability and efficiency.  
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Figure 1: MSC multi-lineage differentiation potential 
MSCs are able to undergo extensive proliferation prior to differentiation into a range of 
mesenchymal tissue and cell types, including bone, cartilage, muscle, stroma, tendon 
and adipose tissue. In addition, there is evidence that MSCs possess the ability to 
differentiate into non-mesenchymal tissues including skin and nervous tissues. 
Scheme adapted from Caplan and Bruder, 2001 (Caplan et al., 2001).  
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Various routes of administration have been tested for delivering MSCs. For example, 
stem cells were applied during a heart catheter session (Wang et al., 2001; Assmus 
et al., 2002; Chen et al., 2004; Kang et al., 2004; Wollert et al., 2004; Katritsis et al., 
2005; Chen et al., 2006) or via an intramyocardial (Wang et al., 2000; Kawamoto et 
al., 2003; Li et al., 2005a; Yoon et al., 2005), intraventricular or intravenous injection 
(Barbash et al., 2003).  
However, as lately demonstrated by Breitbach and co-workers (Breitbach et al., 
2007), a direct intramyocardial transplantation of bone marrow cells into the infarcted 
heart carries a considerable risk since MSCs formed encapsulated structures in the 
infarcted myocardium containing ossifications. Apparently, systemic delivery of MSCs 
circumvents theses problems associated with site-specific delivery, such as risks of 
calcification and tissue damage (Fox et al., 2007), because none of these 
complications have been reported after systemic administration (Saito et al., 2002; 
Barbash et al., 2003; Price et al., 2006). Furthermore, systemic cell delivery allows 
the administration of multiple doses (Fox et al., 2007). Indeed, MSCs have the ability 
to home to sites of myocardial injury when administered intravenously after acute 
infarction (Saito et al., 2002; Price et al., 2006). Therefore, for therapeutic purposes 
systemic infusion of MSCs is not only the most practicable way of administration, but 
also holds less risk due to its minimal-invasive character. However, during a systemic 
application MSCs must be attracted to the target tissue, come into contact with the 
endothelial barrier and subsequently open and transmigrate across the endothelium 
to exit the blood circulation and to invade their target tissue. To date, most of the 
underlying morphological and molecular mechanisms involved in transmigration and 
invasion of MSCs remain unelucidated. However, improving our knowledge on these 
core processes might help elevate the efficiency of stem cell therapy. 
 
1.3 Open questions regarding transmigration and invasion of MSCs 
1.3.1 Adhesion molecules involved 
In order to elucidate key steps of transendothelial migration and invasion of MSCs, 
the diapedesis of leukocytes can serve as a model system. Leukocyte diapedesis is 
well characterized and divided into four steps: (1) margination, (2) rolling, (3) 
adherence and finally (4) transmigration (Seely et al., 2003). This multi-step process 
involves several types of adhesion molecules, proteases and cytokines (De Becker et 
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al., 2007). Most of the leukocyte adhesion molecules like β2 integrin linked molecules 
are not expressed on the surface of MSCs (Pittenger and Martin, 2004; Ruster et al., 
2006; Docheva et al., 2007). However, very late antigen-4 (VLA-4, α4β1 integrin) and 
its most important ligand, vascular cell adhesion molecule-1 (VCAM-1), are 
expressed in MSCs (Minguell et al., 2001; Ruster et al., 2006; Segers et al., 2006). A 
recent study reported that anti-VCAM-1 antibodies, but not anti-ICAM-1 (intercellular 
adhesion molecule-1) antibodies, reduce the adhesion of rat MSCs to microvascular 
endothelial cells (Segers et al., 2006). In addition, it has been shown that β1 integrins 
are crucial for the rolling and adhesion of human MSCs to endothelial cells (Ruster et 
al., 2006). Thus far, adhesion molecules involved in the transmigration of MSCs – the 
final step of exiting the blood circulation – remain to be identified.  
 
1.3.2 Role of proteases for the invasion of MSCs 
The second key barrier within vascular walls is the basement membrane. It is 
composed of a complex network of several extracellular matrix proteins, such as 
laminins (Sorokin et al., 1994), collagen type IV (Timpl, 1996) and gelatine (Nagase 
et al., 1999). The vascular basement membrane serves as a significant structural 
support for endothelial cells, but also provides a distinct and effective barrier to 
macromolecules and infiltrating cells, such as leukocytes. Leukocytes navigate 
toward their target sites by adhering to extracellular matrix glycoproteins and 
secreting degradative enzymes (Vaday et al., 2001). This proteolytic cleavage of the 
basement membrane is a commonly proposed mode of leukocyte penetration of 
basement membrane barriers (Wang et al., 2006). Such degradation of the basement 
membrane via proteolytic enzymes is also a prerequisite for the invasion of MSCs. 
Matrix metalloproteinases (MMPs) are candidate proteolytic enzymes which could be 
involved in this process. MMPs depend on binding a Zn2+ ion for their catalytic 
activity. They are synthesized as pre-pro-enzymes and most are secreted as inactive 
pro-enzymes or zymogens that are activated by cleavage of the pro-domain 
(Sternlicht et al., 2001). Based on substrate specificity and structure they are divided 
into several subgroups: gelatinases, collagenases, stromelysins, matrilysins and 
membrane-type MMPs. The gelatinases, MMP-2 and MMP-9, have the same basic 
structure as the other MMPs, but their catalytic domain contains three repeats of the 
fibronectin type II domain. These repeats interact with major constituents of the 
basement membrane, gelatine, laminin and collagen type IV (Nagase and Woessner, 
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1999). Gelatinases are not only involved in cancer cell migration, but also in 
leukocyte homing (Leppert et al., 1995; Faveeuw et al., 2001). Furthermore, De 
Becker et al. recently demonstrated a functional involvement of MMP-2 in MSC 
homing through bone marrow endothelium (De Becker et al., 2007). However, 
involvement of MMPs in transmigration and invasion of MSCs outside the bone 
marrow has not been verified, yet. 
 
1.3.3 Role of endothelial phenotype and cytokines 
For successful and efficient systemic delivery of MSCs it might be important to 
identify target vessels, which enable the most effective transmigration of MSCs. It is 
known that in various regions of the vascular tree, the endothelium is functionally 
different and its barrier function varies accordingly (Dejana et al., 1995). For example, 
variances in the amount of intercellular tight junctions exist at different points along 
the vascular tree and thereby cause differences in the endothelial permeability. For 
instance, intercellular junctions are well-organized and numerous in large arteries or 
in the blood vessels of the brain where the control of permeability must be restricted, 
whereas they are very primitive and almost disappear in the postcapillary venules 
where cell extravasation needs to be particularly efficient (Simionescu et al., 1991). 
For the extravasation of leukocytes it is discussed that endothelial cells not only play 
an important role in regulating leukocyte attachment, but also actively modulate their 
extravasation. For example, differences comparing the modalities of leukocyte 
extravasation exist for different types of vessels such as lymphatic versus large 
vessels (Dejana et al., 1996). Similar differences depending on the endothelial 
phenotype could also play a key role for the transmigration of MSCs.  
During extravasation leukocytes constantly orientate themselves in response to 
specific signals in their surroundings. Cytokines and chemokines are key biological 
mediators that provide such signals for cell navigation (Vaday et al., 2001). Lately, 
Schmidt et al. (Schmidt et al., 2006a) validated that cytokines, in particular basic 
fibroblastic growth factor (bFGF), increase the migratory activity of MSCs. Because 
cytokines such as bFGF (Kuwabara et al., 1995; Stavri et al., 1995), vascular 
endothelial growth factor (VEGF) (Sasaki et al., 2001), interleukin-6 (IL-6) (Imaizumi 
et al., 2007), interleukin-1 beta (IL-1β) (Mitchell et al., 2007) and tumor necrosis 
factor alpha (TNF-α) (Pasqui et al., 2006) are released after a myocardial infarction 
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they may play an important role in recruiting MSCs to infarcted myocardium and in 
facilitating or increasing transmigration.  
Recently, Segers and co-workers demonstrated an increase of cardiac infiltration of 
MSCs after activation with TNF-α or IL-1β before cell interaction (Segers et al., 
2006). In addition, rolling and adhesion of MSCs was found to be increased after pre-
stimulation of endothelial cells with TNF-α (Ruster et al., 2006). Therefore, the 
question arises whether cytokines not only improve the migratory capacity as well as 
rolling and adhesion, but also the transmigration of MSCs. Till date, no study has 
clarified the involvement of cytokines in the transmigration of MSCs.  
 
1.3.4 Involvement of nitric oxide and reactive oxygen species 
Nitric oxide (NO), the classic vasorelaxing factor discovered by Furchgott in 1980 
(Furchgott et al., 1980), is a short-lived ubiquitous second messenger that has been 
linked to events in the MSC lifecycle like proliferation, differentiation or apoptosis 
(Klinz et al., 2005). NO is produced by nitric oxide synthases (NOS), namely the 
neuronal nNOS, the inducible iNOS and the endothelial nitric oxide synthase eNOS 
(Alderton et al., 2001). In the vascular system a continuous production of NO by 
eNOS helps to maintain the endothelium in an anti-atherogenic state, in part by 
preventing the activation of transcription factors that determine the expression of 
proatherogenic adhesion molecules required for the attachment and sequestration of 
monocytes through the endothelial cell monolayer (Fleming et al., 2003). It is known 
that NO can modulate the permeability of endothelial cell monolayers to mononuclear 
cells (Isenberg, 2003; Isenberg et al., 2005). Klinz et al. showed that the NO-
producing enzyme eNOS is not only expressed by endothelial cells, but also by 
MSCs (Klinz et al., 2005). In a recent study implantation of MSCs overexpressing 
eNOS improved right ventricular impairments caused by pulmonary hypertension 
(Kanki-Horimoto et al., 2006). Whether this is at least partly the result of an increase 
in MSC engraftment has not been assessed, though. Moreover, Kaminski and co-
workers recently demonstrated that the firm adhesion of c-kit+ bone marrow stem 
cells to the endothelium was entirely abrogated in eNOS-kockout mice (Kaminski et 
al., 2007). Thus, the presence of eNOS appears to be crucial for the firm adhesion of 
c-kit+ cells (Kaminski et al., 2007). However, only little information is available about 
the involvement of NO during the contact of MSCs and the endothelial barrier, while 
NO released by MSCs might also play a key role during the transmigration of MSCs.  
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Beside NO, reactive oxygen species (ROS) function as important intracellular and 
intercellular second messengers to modulate many downstream signaling molecules 
in endothelium and vascular smooth muscle (Paravicini et al., 2006). ROS also have 
distinct physiological and pathophysiological impacts on vascular cells. Herein, ROS 
contribute to vascular dysfunction and remodeling through oxidative damage, for 
example by stimulating cell migration, activating adhesion molecules and 
inflammatory reaction (Yung et al., 2006) as well as modifying the extracellular matrix 
(Paravicini and Touyz, 2006). In addition, Fischer and colleagues revealed that H2O2 
induces an increased endothelial permeability (Fischer et al., 2005). Therefore, it 
might be interesting to examine whether MSCs release ROS to modulate the 
permeability of the endothelial barrier.  
 
1.4 Approaches to enhance the transmigration of MSCs 
Therapeutic success of stem cell therapy essentially depends on an efficient cell 
delivery to the required site. Based on experimental and clinical data best functional 
recovery of infarcted myocardial tissue was obtained in the peri-infarction myocardial 
borderzone tissue (Schachinger et al., 2004; Hofmann et al., 2005; Ghanem et al., 
2007). Therefore, the peri-infarction borderzone, but not the myocardial scar itself 
seems to be the adequate target tissue for regenerative stem cell therapy. Moreover, 
transplantation efficacy improved significantly after a direct application of MSCs into 
the left-ventricular cavity (Barbash et al., 2003). This improvement was due to less 
entrapment of the stem cells in the pulmonary circulation as it has been described for 
the intravenous transfusion of MSCs (Barbash et al., 2003). However, even after 
intracoronary cardiomyoplasty the actual number of MSCs delivered to the 
myocardium is very low, whereas cell uptake in liver and spleen is very high (Barbash 
et al., 2003). Targeted cell delivery, for example to the borderzone of myocardium is 
possible via intramyocardial cell injection, but this strategy is limited because of its 
invasive character resulting in tissue damage, the difficulty of delivering multiple 
doses and risks for calcification (Breitbach et al., 2007). Due to a markedly lower 
expression of chemoattractant factors, recruitment and transmigration of a 
reasonable number of stem cells into non-ischemic myocardium is a rare event. 
Therefore, since stem cell therapy should be aimed at vital myocardium, for example 
to the peri-infarction borderzone, improvements in non-invasive transplantation 
efficacy is of major interest. 
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1.4.1 Genetic modification of MSCs 
One way to augment the efficiency of cardiomyoplasty is to genetically modify MSCs 
by transgene expression before transplantation. Such a targeted modification of 
MSCs could trigger an enhancement of stem cell transplantation. Successful genetic 
modification of MSCs via retroviral transduction has been reported (Mangi et al., 
2003; Bhakta et al., 2006; Gnecchi et al., 2006). Mangi and co-workers discovered 
that intramyocardial injection of MSCs overexpressing the prosurvival gene Akt 
remarkably prevented ventricular remodeling and improved cardiac function after 
myocardial infarction compared with the administration of control MSCs (Mangi et al., 
2003). Therefore, genetic modification of MSCs might help to elevate the efficiency of 
stem cell therapy.  
The chemokine stromal-derived-factor-1 (SDF-1) and its G-protein-coupled receptor 
CXCR4 play an important role in the homing and engraftment of hematopoietic stem 
cells in the bone marrow. For example, an overexpression of CXCR4 in mobilized 
peripheral blood hematopoietic stem cells improves their marrow engraftment 
(Brenner et al., 2004). Lately, Schmidt et al. evidenced that the CXCR4-ligand SDF-1 
significantly enhances the migratory activity of MSCs (Schmidt et al., 2006a). 
Furthermore, a study using MSCs transduced with a retroviral vector containing 
CXCR4 showed a significantly increased migration toward SDF-1 (Bhakta et al., 
2006). To summarize, a genetic modification of the CXCR4-expression in MSCs 
could be an approach to improve the transmigratory capacity of MSCs.  
 
1.4.2 Ultrasound-mediated microbubble stimulation 
A second approach to possibly improve targeted cell delivery makes use of a novel 
non-invasive strategy: the focussed ultrasound-mediated microbubble stimulation 
(UMS) (Imada et al., 2005; Zen et al., 2006). The focussed effect of this technique is 
based on intravascular oscillation and possibly implosion of gas-filled lipid-coated 
microbubbles after their activation via targeted ultrasound (Imada et al., 2005; Zen et 
al., 2006; Caskey et al., 2007). The ultrasound-mediated oscillation of microbubbles 
results in a transient alteration of the endothelium. UMS was reported to cause at 
high emission power an acute inflammatory action on the cell surface by the transient 
formation of small holes (less than 5 µm) in the cell surface that revert to normal 
appearance (Taniyama et al., 2002b). Those local small transient pores were induced 
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immediately after regional insonication and allowed targeted gene and cell delivery 
over the endothelial barrier. This technique has been used recently for targeted 
delivery of unfractionated bone marrow-derived mononuclear cells into chronic 
ischemic skeletal muscle (Imada et al., 2005) and myocardium (Zen et al., 2006). In 
skeletal muscle ultrasound-mediated microbubble oscillation activated platelet-
derived proinflammatory factors, which induced in vitro expression of the adhesion 
molecules P-selectin and ICAM-1 1 hour after UMS (Imada et al., 2005). These UMS-
mediated effects resulted in an increased attachment of transplanted bone marrow-
derived mononuclear cells on the endothelium (Imada et al., 2005). Zen et al. 
reported that stimulation via UMS induced the expression of the adhesion molecules 
VCAM-1 and ICAM-1 in capillaries. Furthermore, the UMS-mediated supply of bone 
marrow-derived mononuclear cells in the myocardium of a hamster cardiomyopathy 
model increased the myocardial content of VEGF and improved cardiac function 12 
weeks after UMS application (Zen et al., 2006). Additionally, low-frequency contrast 
microbubble-enhanced ultrasound was reported to increase the vascular permeability 
(Stieger et al., 2007). To summarize, UMS alters the functionality of the endothelial 
barrier over a longer period of time after the insonication by up-regulating the 
secretion of cytokines, inducing the expression of adhesion molecules, enhancing the 
attachment of bone marrow-derived mononuclear cells on the endothelium and 
increasing the vascular permeability (Taniyama et al., 2002b; Imada et al., 2005; Zen 
et al., 2006; Stieger et al., 2007). Therefore, UMS might be a powerful and non-
invasive tool to locally improve the transmigration of MSCs.  
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1.5 Aims and experimental design of this study 
For a successful systemic therapy, mesenchymal stem cells must come into contact 
with the endothelium and subsequently open and transmigrate across the endothelial 
barrier to exit the blood circulation and to invade their target tissue. To date, most of 
the underlying mechanisms of transmigration and invasion remain unelucidated. 
Improving our knowledge on these core processes might elevate the efficiency of 
stem cell therapy. The aims of the study were (1) to characterize key mechanisms 
involved in transmigration and invasion of MSCs and (2) to identify strategies to 
enhance the efficiency of myocardial MSC engraftment. Hence, this study comprises 
two major parts, the second of which concentrates on possible applications.  
 
(1) Characterization of the transmigration and invasion of MSCs 
(a) Interaction of MSCs with the endothelial barrier 
Several model systems were established to visualize and morphologically 
characterize the interaction of MSCs with the endothelial barrier. Furthermore, in vivo 
experiments were conducted to validate that transmigration of MSCs is a 
physiologically occurring process. Although, MSCs home to infarcted myocardium 
after systemic administration (Barbash et al., 2003) and transmigrating MSCs were 
observed ex vivo (Schmidt et al., 2006b), thus far, no direct evidence about 
transmigration of MSCs in vivo exists.  
(b) Mechanisms involved in the transmigration and invasion of MSCs 
To investigate the mechanisms involved in the transendothelial migration and 
invasion of MSCs, the diapedesis of leukocytes served as a model system. 
Consequently, experiments were designed to (a) identify adhesion molecules 
involved in transmigration by investigating the effect of blocking VCAM-1 and VLA-4; 
(b) to monitor the involvement of matrix metalloproteinases during the invasion of 
MSCs into cardiac tissue; (c) to determine the role of the endothelial phenotype for 
the transmigration and finally (d) to elucidate the influence of cytokines on the 
transmigration of MSCs.  
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(c) Possible role of NO and ROS for the transmigration of MSCs 
This section deals with nitric oxide and reactive oxygen species, because it is known 
that NO as well as ROS can modulate the permeability of the endothelium (Isenberg, 
2003; Fischer et al., 2005; Isenberg et al., 2005). Therefore, the contribution of NO- 
and ROS-release during the contact of MSCs and the endothelial barrier was 
investigated.  
 
(2) Strategies to enhance the transmigration of MSCs 
(a) Possible improvement of transmigration by genetic modification of MSCs 
MSCs were genetically manipulated by infecting them with a CXCR4-expressing 
adenovirus to study whether CXCR4 overexpression of MSCs improves their 
transmigratory activity.  
(b) Influence of ultrasound-mediated microbubble stimulation 
A novel strategy, the ultrasound-mediated microbubble stimulation (UMS), was 
employed, which allows a non-invasive focussed alteration of myocardial 
endothelium. Such focussed pretreatment of endothelium by UMS could influence the 
targeted myocardial engraftment of MSCs. Therefore, the distinct effects of UMS on 
the endothelium as well as the impact of focussed UMS on the cell attraction and the 
transmigration of MSCs into non-ischemic and ischemic myocardium were 
characterized in vivo. 
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2. Material and Methods 
2.1 Cell Culture 
2.1.1 Mesenchymal stem cells (MSCs) 
2.1.1.1 Isolation of human MSCs 
MSCs were isolated from the bone marrow of hip heads of 48 patients (average age 
73 ± 7 years; 72% of patients were female, 28% male) undergoing hip prosthesis 
surgery in the Dreifaltigkeits Hospital Cologne by Professor Dr. Joachim Schmidt. 
Samples were obtained following procedures as approved by the local ethics 
committee.  
MSCs were prepared as previously described (Klinz et al., 2005; Schmidt et al., 
2006a; Schmidt et al., 2006b). Bone marrow samples were diluted with 35 ml Ca2+- 
and Mg2+-free phosphate-buffered saline (0.1 M PBS: 81 mM di-
sodiumhydrogenphosphate-di-hydrate, 19 mM sodium-di-hydrogenphosphate 
monohydrate, 150 mM sodium chloride, pH 7.4, Gibco BRL, Karlsruhe, Germany) 
and filtered through a 70-µm nylon mesh (Cell strainer, Falcon, Becton Dickinson, 
Franklin Lakes, USA). The cell suspension was laid over 15 ml Ficoll-Paque™ Plus 
(Amersham Pharmacia Biotech, Uppsala, Sweden) and centrifuged at 800 g for 30 
minutes at room temperature (Multifuge 3, Heraeus, Hanau, Germany). 
The layer containing mononuclear cells was isolated and washed with 50 ml PBS. 
After centrifugation at 1200 rpm for 10 minutes the washed cells were resuspended 
in 1 ml growth medium: Minimum Essential Medium Alpha Modification (α-MEM) 
supplemented with 2 mg/ml L-glutamine, 50 U/ml penicillin, 50 µg/ml streptomycin 
and 20% (v/v) of a selected batch of non-heat-inactivated fetal calf serum (all 
chemicals and media were obtained from Gibco). The MSC growth medium is 
referred to as 20% α-MEM throughout this work. Figure 2 schematically depicts the 
isolation procedure. Cells were maintained as monolayers in 100-mm culture dishes 
(Falcon, Becton Dickinson Labware) in 10 ml 20% α-MEM. Non-adherent cells were 
removed after 1 day at 37°C in a humidified 5% CO2 atmosphere (Binder GmbH, 
Tuttlingen, Germany).  
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Figure 2: Scheme of the isolation procedure of mononuclear cells via density 
gradient centrifugation 
Scheme adapted from Dynal Biotech GmbH, Hamburg, Germany.  
 
2.1.1.2 Culture of human MSCs 
MSCs were supplemented with fresh pre-warmed 20% α-MEM twice a week. For 
each passage confluent MSCs were washed with 10 ml PBS and detached from the 
culture dish with 2 ml pre-warmed Accutase™ (PAA Laboratories, Cölbe, Germany) 
for 3 minutes at 37°C. Accutase is a synthetic enzyme, which comprises both 
activities of collagenase and trypsin, but in a mild manner. Detached cells were 
diluted in 9 ml 20% α-MEM and centrifuged at 150 g for 5 minutes. MSCs were 
resuspended in 1 ml 20% α-MEM, counted in a “Neubauer counting chamber” and 
re-plated at a density of 2000 cells/cm2 onto 100-mm culture dishes with 10 ml 20% 
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α-MEM. The MSCs thus maintained within passages 1 to 4 were utilized for the 
experiments.  
 
2.1.2 Feeder cells 
A layer of feeder cells (fibroblasts) constitutes the basis for embryonic stem cell 
growth as it enables embryonic stem cells to attach. Furthermore, the feeder cells 
produce leukaemia inhibition factor (LIF), which prevents the differentiation of 
embryonic stem cells. Feeder cells isolated from mouse embryos were kindly 
provided by Professor Dr. Jürgen Hescheler (Institute for Neurophysiology, University 
of Cologne). 
 
2.1.2.1 Culture of feeder cells 
Feeder cells were passaged as described for MSCs in section 2.1.1.2. Because of 
their lower metabolism rate, feeder cells were passaged and supplemented with fresh 
medium only once a week. Feeder cells were cultured in D-MEM-medium high 
glucose (Dublecco`s Modified Eagle Medium, Gibco) supplemented with 2 mg/ml L-
glutamine, 25 U/ml penicillin, 25 µg/ml streptomycin, 1% (v/v) MEM non-essential 
amino acids solution, 100 µM β-mercaptoethanol and 15% (v/v) of a selected batch 
of fetal calf serum (all chemicals were obtained from Gibco). This growth medium is 
referred to as 15% D-MEM throughout this work. 
 
2.1.2.2 Inactivation of feeder cells 
Before cultivation of embryonic stem cells on a feeder cell layer, feeder cells were 
inactivated using the cell toxin mitomycin C, which inhibits mitosis acitvity, to prevent 
their proliferation. Adherent cells were treated with 10 μg/ml mitomycin C (Serva, 
Electrophoresis GmbH, Heidelberg, Germany) for 2-3 hours at 37°C. After 
inactivation cells were washed thrice with PBS and detached with Accutase. Cells 
were centrifuged for 5 minutes at 150 g and resuspended in 15% D-MEM. After 
counting, 106 feeder cells were seeded onto 60-mm culture dishes (Falcon).  
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2.1.3 Embryonic stem cells 
Mouse blastocyst-derived embryonic stem cells of the D3 cell line were kindly 
provided by Professor Dr. Jürgen Hescheler (Institute for Neurophysiology, University 
of Cologne). 
 
2.1.3.1 Culture of embryonic stem cells 
Cells were maintained and cultured on feeder layers as described by Doetschman et 
al. (Doetschman et al., 1985). Adherent cells were passaged thrice a week to prevent 
induction of differentiation of the pluripotent embryonic stem cells. For passaging 
cells were washed with PBS and detached using Accutase. The suspension was 
centrifuged for 5 minutes at 150 g and cells were resuspended in 15% D-MEM. After 
counting, 5x104 cells were plated onto 60-mm culture dishes containing an 
inactivated feeder layer. Medium was changed the day after the passage. 
 
2.1.3.2 Preparation of hanging drops 
To stimulate the formation of embryoid bodies (EBs) embryonic stem cells were 
grown in hanging drops (Fassler et al., 1996). Therefore, cells were detached as 
described in section 2.1.3.1, centrifuged and counted. A hanging drop should contain 
1000 cells in a total volume of 20 µl. After dilution of the cell suspension in an 
appropriate manner in 15% D-MEM 50-60 drops were placed onto the inside of the 
lid of non-adhesive bacteriological dishes (Greiner, Frickenhausen, Germany). The 
lid was inverted and the dish was filled with 10 ml PBS to prevent drying out of 
hanging drops. Within 2 days the single cells formed EBs.  
 
2.1.3.3 Culturing of aggregates in suspension 
Two days after preparing hanging drops, EBs were rinsed with 10 ml 15% D-MEM 
and cultured in suspension (10 ml 15% D-MEM) in non-adhesive bacteriological 
dishes for 3 days. During this cultivation period cells proliferated without 
differentiating. 
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2.1.3.4 Gelatine coating and plating of embryoid bodies 
Differentiation of EBs was induced by plating them on gelatine-coated cover slips. 
Cover slips (12 mm diameter) were placed in each well of a 24-multi well plate 
(Falcon), covered with gelatine (0.1% in PBS; gelatine from porcine skin, Sigma-
Aldrich, Steinheim, Germany) and incubated overnight at 37°C. Before plating EBs, 
the gelatine solution was removed, cover slips were air-dried for 2 minutes and each 
well was filled with 1 ml 15% D-MEM. One to three embryoid bodies were isolated 
out of suspension and placed onto a gelatine-coated cover slip. EBs were 
supplemented with fresh medium every 3-4 days. Figure 3 schematically depicts the 
preparation of embryoid bodies.  
 
2.1.4 Endothelial cells 
2.1.4.1 Isolation of murine microvascular endothelial cells via Magnet 
associated cell sorting (MACS) and culture 
Magnet associated cell sorting (MACS)-sorted microvascular endothelial cells were 
isolated as previously described (Schmidt et al., 2004a; Schmidt et al., 2004b; Muller-
Ehmsen et al., 2006).  
After a period of 5+7 days EBs were dissociated by treatment with Accutase. For 
immunomagnetic selection a single cell solution of 106 cells in 1 ml 15% D-MEM was 
stained with the endothelial-specific marker PECAM-1 (rat anti-mouse-PECAM-
1/CD31, 1:800, mAb, Pharmingen, San Diego, USA) for 30 minutes under growth 
conditions. Cells were washed twice with 2 ml MACS buffer (0.5% BSA and 2 mM 
EDTA in 0.1 M PBS). Cells were incubated with secondary antibody goat anti-rat IgG-
conjugated micro beads (1:4 in MACS buffer, Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany) for 15 minutes at 4°C. After washing in MACS buffer, up to 108 
cells were resuspended in 500 µl MACS-buffer. The mini-MACS system with MS 
separation columns (Miltenyi Biotec GmbH) was equilibrated using 500 µl MACS 
buffer and loaded with the cell suspension. After washing thrice with MACS buffer the 
MS separation column was removed from the magnetic holding device. The 
endothelial cell fraction was removed into a reaction cup (Eppendorf, Wesseling, 
Germany). Cells were centrifuged (5 minutes, 800 rpm) and resuspended in 1 ml 
15% D-MEM. The isolated endothelial cell fraction was cultured on gelatine-coated 
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dishes. After 2 to 3 weeks, the murine microvascular MACS-sorted endothelial cells 
were passaged the first time, afterwards twice a week. The purity of cells was tested 
by Dr. Annette Schmidt, German Sport University Cologne, with dil-Ac-LDL (Paesel + 
Lorei GmbH & Co, Hanau, Germany) and different endothelial specific markers (e.g. 
PECAM-1, VE-Cadherin, flk-1, flt-1, VEGF, Lectin and eNOS) and was amounted to 
89% (Schmidt, 2003). Murine microvascular MACS-sorted endothelial cells are 
referred to as MACS cells throughout this work.  
Figure 3: Scheme of the preparation of embryoid bodies 
Scheme adapted from Schmidt, 2003 (Schmidt, 2003).  
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2.1.4.2 Culture of human umbilical vein, coronary artery and aortic 
endothelial cells 
Human umbilical vein endothelial cells (HUVEC), human coronary artery endothelial 
cells (HCAEC) and human aortic endothelial cells (HuAoEC) were obtained from 
PromoCell (Heidelberg, Germany). HUVEC were cultured in ECG-medium 
(PromoCell), HCAEC and HuAoEC in ECG-MV-medium (PromoCell) (Schmidt et al., 
2004a). All three types of cells were incubated until confluence at 37°C, 95% 
humidity and 5% CO2. The cells were detached upon treatment with Accutase, 
centrifuged and resuspended in medium. For every passage, cells were distributed to 
25-cm2 cell culture flasks (200.000 cells/flask) and were supplemented with fresh 
medium twice a week. The cells were utilized within passages 3 to 4.  
 
2.2 Quality control of MSCs 
The quality of MSCs was ensured by microscopic observations for their characteristic 
spindle-shaped morphology, flow cytometry, colony forming unit-fibroblast assays 
and differentiation assays.  
 
2.2.1 Flow cytometry (FACS) 
For flow cytometric analysis, MSCs were detached with Accutase, centrifuged at 
1300 rpm for 3 minutes, washed with PBS and stained in 100 µl PBS with CD106-
Fluorescein isothiocyanate (FITC) (1:20, Becton Dickinson), CD105-Phycoerythrin 
(PE) (1:50, Ancell, Bayport, USA), CD45-energy-coupled dye (ECD) (1:20, Beckman 
Coulter, Krefeld, Germany), CD34- Phycoerythrin-Cyanine 5 (PC5) (1:20, Beckman 
Coulter) and CD14-PC5 (1:20, Beckman Coulter) at room temperature in dark for 15 
minutes. The excess dye was removed by washing with PBS and cells were 
resuspended in 200 µl PBS. FACS analyses were performed by means of a 
Beckman Coulter Epics XL/MCL with Expo 32 software (Beckman Coulter) (Klinz et 
al., 2005; Schmidt et al., 2006a). According to published data, human MSCs were 
defined to be CD14, CD34 and CD45 triple-negative and CD105, CD106 double-
positive (Pittenger et al., 1999).  
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2.2.2 Colony forming unit-fibroblast (CFU-F) assay 
To determine the proliferative potential of cultured MSCs, CFU-F assays were 
performed as described before (Shur et al., 2004). Immediately after isolation 
(passage P0) 100.000 MSCs were seeded onto a 60-mm culture dish. Cells were 
cultured for 14 days without changing the media. MSC colonies were washed with 
PBS and stained with cresyl-violett (Merck, Darmstadt, Germany) for 10 minutes. 
After repeated washing steps, blue colonies were macroscopically counted.  
 
2.2.3 Differentiation assays 
The differentiative potential of MSCs was evaluated by growing the cells under 
conditions favorable for adipogenic, osteogenic and chondrogenic differentiation 
(Pittenger et al., 1999; Arnhold et al., 2006). 
 
2.2.3.1 Adipogenic differentiation 
For adipogenic differentiation 1000 MSCs/cm2 were seeded onto 4-well plates (Nunc 
GmbH, Wiesbaden, Germany) and cultured under adipogenic-specific culture 
conditions in growth medium α-MEM supplemented with 2 mM L-glutamine, 0.5% 
antibiotic-antimycotic solution (Fungizone, Gibco), 1 µM dexamethasone (Sigma-
Aldrich), 5 µg/ml insulin (ITS Liquid Media supplement 100x, Sigma-Aldrich) and 15% 
(v/v) of a selected batch of non heat-inactivated fetal calf serum (Gibco). Additionally 
60 µM indomethacin (Sigma-Aldrich) was added shortly before use. Cells growing in 
20% α-MEM served as control. Cells were cultured at 37°C in a humidified 5% CO2 
atmosphere for 2 weeks and were supplemented with fresh pre-warmed medium 
thrice a week. 
Adipose differentiation was analyzed by Oil Red O-staining. To prepare the working 
solution a stock solution of 0.17% Oil Red O (Merck) in 60% isopropanol (Merck) was 
diluted 3+2 with distilled water. After shaking for 5 minutes the working solution was 
filtered. Unfixed cells were incubated with fresh Oil Red O working solution for 15 
minutes at room temperature. Cells were washed thrice with distilled water and 
counterstained for 4 minutes using Mayer`s hematoxylin stain. Cells were mounted 
with Kaiser`s glycerol gelatine (Merck). Staining resulted in red lipid drops and blue 
nuclei. Staining was analyzed using a Zeiss Axiophot microscope (Oberkochem, 
Germany).  
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2.2.3.2 Osteogenic differentiation 
For Osteogenic differentiation 1000 MSCs/cm2 were seeded onto 32-mm culture 
dishes (Falcon) and cultured under osteogenic-specific culture conditions in growth 
medium α-MEM supplemented with 2 mM L-glutamine, 0.5% antibiotic-antimycotic 
solution, 60 µM ascorbic acid (Sigma-Aldrich), 10 mM β-glycerophosphate (Sigma-
Aldrich), 0.1 µM dexamethasone and 15% (v/v) of a selected batch of non heat-
inactivated fetal calf serum. Cells growing in 20% α-MEM served as control. Cells 
were cultured at 37°C in a humidified 5% CO2 atmosphere for 2 weeks and were 
supplemented with fresh pre-warmed medium thrice a week. 
Osteogenic differentiation was analyzed by von Kossa staining to visualize deposits 
of calcium. Cells were fixed for 5 minutes in a solution containing equal volumes of 
methanol and acetone and washed in distilled water for 5 minutes. Samples were 
incubated with 5% aqueous silver nitrate solution (Sigma-Aldrich) in the dark and 
washed thrice with distilled water. After incubating with 5% sodium carbonate (Merck) 
in formaldehyde, cells were rinsed several times in distilled water. Nuclei were 
counterstained for 10 minutes using a 0.1% nuclear fast red solution (2-methyl-4-
chlorobenzenediazonium tetrachlorozincate, Roche Diagnostics, Mannheim, 
Germany) containing 5% ammonium sulfate (Sigma-Aldrich). After washing, cells 
were dehydrated through graded EtOH (Hoffmann, Germany) and xylol (Alfred 
Quadflieg, Germany) and mounted in Entellan (Merck). Staining resulted in black 
calcifications and red nuclei. Staining was analyzed using a Zeiss axiophot.  
 
2.2.3.3 Chondrogenic differentiation 
To promote chondrogenic differentiation 500.000 MSCs were centrifuged for 5 
minutes at 800 g to form a pelleted micromass which was cultured under 
chondrogenic-specific culture conditions in growth medium D-MEM supplemented 
with 2 mM L-glutamine, 0.5% antibiotic-antimycotic solution, 10 ng/ml transforming 
growth factor-β1 (Sigma-Aldrich), 50 µM ascorbic acid, 0.5 µg/ml insulin (Sigma-
Aldrich) and 1% (v/v) of a selected batch of non heat-inactivated fetal calf serum 
(Gibco). Cells growing in 20% α-MEM served as control. Micromasses were cultured 
at 37°C in a humidified 5% CO2 atmosphere and were supplemented with fresh pre-
warmed medium thrice a week. After 3 weeks the probes were rapidly frozen in liquid 
nitrogen and stored at -80°C.  
Material and Methods 
 
22 
2.2.3.3.1 RNA isolation 
To analyze the chondrogenic differentiation potential of MSCs total RNA of samples 
under differentiation conditions or control conditions was extracted using peq-Gold 
TriFast™ Reagent (Peqlab, Erlangen, Germany). This reagent allows single step 
RNA isolation. Frozen micromasses were lysed in 1 ml TriFast and homogenized by 
applying ultrasound (Vibracell, Bioblock, Illkirch, France) for 20 seconds followed by 
incubation for 5 minutes at room temperature. After addition of 200 µl chloroform 
samples were agitated and incubated for 5 minutes. Centrifugation for 5 minutes at 
12000 g and room temperature separated the solution into an upper aqueous phase 
containing the RNA and an organic phase. After transfer of the aqueous phase RNA 
was recovered by precipitation with 500 µl isopropyl alcohol. After agitation samples 
were incubated for 10 minutes at room temperature and centrifuged at 12000 g for 10 
minutes at 4°C. The supernatant was removed, precipitated RNA was washed twice 
with 70% EtOH and air dried for 30 minutes. RNA was dissolved in 10 µl DEPC-
treated H2O (0.1% DEPC in 100 ml distilled H2O, agitated overnight and autoclaved, 
Sigma-Aldrich) and its concentration was measured photometrically at 260 nm; 
A260nm of 1 corresponds to a concentration of 40 ng/µl RNA. Afterwards RNA was 
treated with DNAse for 15 minutes at room temperature to eliminate DNA 
contaminations. The reaction was performed in the following mixture: 
2 µg RNA 
2 U DNAse (Invitrogen GmbH, Karlsruhe, Germany) 
2 µl DNAse-buffer (10x, Invitrogen) 
ad 20 µl DEPC-H2O 
The DNAse digest was terminated by addition of 2 µl 25 mM EDTA (Invitrogen). 
Samples were heated for 10 minutes to 65°C followed by 2 minutes incubation on 
ice.  
 
2.2.3.3.2 Semi-quantitative RT-PCR 
2 µg of total RNA was reverse transcribed using M-MLV reverse transcriptase. The 
reverse transcription (RT) reaction was performed in the following mixture: 
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2 µg RNA (from DNAse digest) 
10 µl First-Strand-buffer (5x, Invitrogen) 
2.5 µl dNTP-Mix (10 mM, Invitrogen) 
1 µl Oligo dT (0.5 µg/µl, Invitrogen) 
2 µl DTT (100 mM, Invitrogen) 
1 µl M-MLV RT (Invitrogen) 
ad 50 µl DEPC-H2O 
RT-reaction was performed for 60 minutes at 37°C followed by 5 minutes at 90°C. 
Afterwards, a hotstart PCR was performed (94°C for 10 minutes, followed by 40 
cycles of 94°C for 1 minute, 59°C for 45 seconds and 72°C for 90 seconds, followed 
by 72°C for 10 minutes) using 2 µg of cDNA as template and specific primers (MWG-
Biotech, Ebersberg, Germany) for collagen II to amplify a 388 bp fragment of 
collagen II mRNA. As reference for the quantification the mRNA of the housekeeping 
gene β-actin was employed (amplified fragment size 698 bp). The reaction was 
performed in the following mixture: 
4 µl cDNA (from the RT-mixture) 
5 µl PCR-buffer (10x, Genecraft, Lüdinghausen, Germany) 
1.5 µl dNTP-Mix (10 mM) 
1 µl of each antisense and sense specific primer (25 pmol/µl, MWG-Biotech) 
2.5 U BioTherm DNA polymerase (Genecraft) 
ad 50 µl DEPC-H2O 
The following pimers were used: 
 
Primer  Sequence (5´-3) GeneBank Position Fragment 
ß- Actin- F sense 
ACC TTC AAC ACC CCA GCC ATG 
TAC G 
449- 473 
ß- Actin- R antisense 
CTG ATC CAC ATC TGC TGG AAG 
GTG G 
NM_001101 
1122-1146 
698 bp 
Collagen II- F sense GAA CAT CAC CTA CCA CTG CAA G 4163-4184 
Collagen II- R antisense GCA GAG TCC TAG AGT GAC TGA G 
BC116449.1 
4550-4529 
388 bp 
 
PCR products were analyzed by agarose gel electrophoresis. 15 µl PCR-products 
and 3 µl 6x DNA-sample buffer (Fermentas, St. Leon-Rot, Germany) were 
transferred onto a 2% agarose gel (Biozym, Oldendorf, Germany) with 1x TAE-buffer 
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(90 mM Tris pH 7.4, 2 mM EDTA pH 8, 90 mM acetic acid) and separated in an 
electrical field (5 V/cm). To visualize the DNA, agarose-solution contained 1 µg/ml 
ethidium bromide (Sigma-Aldrich). After electrophoresis gels were analyzed with UV 
light (302 nm, MWG-Biotech). 
 
2.3 Vital staining of cells 
2.3.1 PKH26 and PKH67 staining 
MSCs and ECs were vital stained using a MINI-67 or MINI-26 staining kit (Sigma-
Aldrich) according to the manufacturer’s instructions. A uniform single cell 
suspension was incubated with 2 µl/ml PKH67 dye (green fluorescence) or PKH26 
dye (red fluorescence) in Diluent C for 5 minutes in the dark. After terminating the 
reaction by washing with medium, cells were centrifuged for 5 minutes at 150 g, 
resuspended in medium and counted.  
 
2.3.2 CellTracker staining 
Prior to co-cultivation, adherent endothelial cells and MSCs were stained with 
CellTracker™ Green CMFDA or Red CMTPX (Molecular Probes, Eugene, USA). The 
medium was removed and cells were washed with PBS. A pre-warmed staining 
solution, containing 0.5 µM CellTracker in serum-free medium was added and cells 
were incubated for 30 minutes under growth conditions. The excess staining solution 
was removed by washing the cells with PBS following incubation for 30 minutes in 
fresh, pre-warmed serum-free medium.  
 
2.4 Monolayer co-cultivation experiments 
For co-cultivation experiments, endothelial cells were seeded onto 12-mm glass 
cover slips at a density sufficient to become a confluent monolayer overnight. The 
confluence of the endothelial monolayers was randomly checked by immunostaining 
with anti-VE-cadherin (see section 2.8).  
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2.4.1 Co-cultivation 
For co-cultivation, MSCs stained with CellTracker Red were detached and seeded on 
endothelial monolayers stained with CellTracker Green at a density of 10.000 MSCs 
per cm2. MSCs seeded on cover slips without an endothelial monolayer served as 
control. Co-cultivations were conducted for 15, 30, 60, 120, 180 and 240 minutes and 
were performed independently of the endothelial phenotype in 20% α-MEM. Cells 
were fixed with 4% paraformaldehyde (PFA, Merck) in 0.1 M PBS for 20 minutes, 
washed 3 times with PBS and embedded in Entellan. During fixation the NH2-groups 
of cellular and membrane proteins were connected by aldehyde bindings. The 
duration of fixation procedure depended on tissue size. Experiments were carried out 
on 4 to 6 samples and analyzed as described in section 2.16.2.  
 
2.4.2 Cytokines and additive substances 
Cytokines/chemokines were used in the following concentrations: 20 ng/ml bFGF 
(Cell Concepts, Umkirch, Germany), 20 ng/ml VEGF (PAN Biotech, Nürnberg, 
Germany), 0.5 U/ml EPO (Roche), 10 ng/ml IL-6 (Boehringer, Mannheim, Germany) 
and 50 ng/ml SDF-1β (Acris Antibodies, Hiddenhausen, Germany). 
Additive substances were used in the following concentrations: 0.05 mM H2O2 
(Merck), 10 mM N-Acetylcysteine (Sigma-Aldrich), DETA (Diethylenetriamine) 
NONOate 10 µM (Alexis Biochemicals, Lörrach, Germany), 100 µM L-NAME (N-
Nitro-L-Arginine Methyl Ester, Sigma-Aldrich). 
 
2.4.3 Blocking experiment 
For blocking experiments, the monoclonal blocking antibodies against CD49d 
(integrin alpha4 chain of VLA-4 complex), CD106 (VCAM-1) and isotypic control IgG1 
(Beckman Coulter) were used at 20 times the saturating dilution as determined by the 
manufacturer to conduct immunohistochemistry experiments. HUVEC monolayers 
were pre-incubated with anti-VCAM-1, IgG1 or in absence of antibodies for 30 
minutes under growth conditions. Co-cultivation was performed for 120 minutes in the 
presence of anti-VLA-4, IgG1 or as a control in the absence of antibodies and 
analyzed as described in section 2.16.2.  
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2.5 Three-dimensional model systems for transmigration 
2.5.1 Collagen invasion assay 
For collagen invasion assays collagen gels were prepared (Bauer et al., 2007). A 
solution containing equal volumes of 1 M sodium hydroxide and 1 M HEPES buffer 
was equally mixed with 10x Minimum Essential Medium Eagle (Sigma-Aldrich). 2 ml 
of this solution was mixed with 4 ml of Collagen R solution from rat tail (Serva) and 4 
ml of Collagen G from calf skin (Biochrom AG, Berlin, Germany). 500 µL of the 
resulting solution was applied for each 12-mm well and incubated at 37°C for 24 
hours in order for it to solidify into a thin collagen gel matrix. HUVEC were seeded on 
the gel, grown to confluence, stained with CellTracker Green CMFDA and co-
cultivated with MSCs (CellTracker Red CMTPX, see section 2.3.2) for 2 to 24 hours. 
Collagen constructs were fixed with 4% PFA for 1 hour, washed with PBS and were 
either transferred onto a glass slide and embedded in AquaPolyMount (Polysciences, 
Warrington, USA) or cryo-embedded in Tissue-Tek® (Sakura Fintek, Zoeterwoude, 
Netherlands) and sliced in 7 µm (Leica CM1900, Wetzlar, Germany). Specimens 
were analyzed by confocal microscopy (section 2.16.1).  
 
2.5.2 Endothelial spheroid model 
Endothelial spheroids of random size were generated using MACS cells as described 
previously (Korff et al., 1998). Briefly, MACS cells were detached, suspended in 
culture medium containing 20% carboxymethyl cellulose (Sigma-Aldrich), seeded into 
non-adhesive bacteriological dishes (Greiner) and cultured overnight at 37°C. 
Spheroids were harvested by centrifugation for 1 minute at 200 g, stained with 
CellTracker Green CMFDA and co-cultivated with MSCs (CellTracker Red CMTPX, 
see section 2.3.2) in 20% α-MEM containing 20% carboxymethyl cellulose for 2, 4 
and 6 hours. After fixation with 4% PFA the spheroids were transferred onto a glass 
slide, embedded in AquaPolyMount and analyzed by confocal microscopy (section 
2.16.1).  
 
2.5.3 Perfusion of isolated mouse hearts 
Wild-type mice (C57BL/6, both genders, aged 3-18 months) were obtained from the 
animal care facility of the Institute for Physiology, University of Cologne. They were 
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housed and fed according to federal guidelines, and all procedures were approved by 
local authorities. Mice were killed by cervical dislocation and the hearts were quickly 
removed. The aorta was cannulated for the initiation of an antegrade perfusion. 
Either PKH67/26 vital stained MSCs (section 2.3.1) or MSCs after adenoviral 
transfection (section 2.6) were used. A uniform single cell suspension of 5x105 MSCs 
in 50 ml 20% α-MEM aerated with 100% O2 at 37°C was perfused into the heart for 
60 or 90 minutes with constant flow velocity and at a pressure of 60 cm H2O.  
The isolated heart samples were prepared for microtome sectioning by fixing the 
tissue immediately with 4% PFA for 4 to 6 hours at 4°C. The fixed heart samples 
were washed thrice in PBS followed by incubation of the tissue in 18% sucrose 
solution for 6 to 8 hours to prevent further tissue damage during the freezing process. 
The heart samples were frozen at -80°C in Tissue-Tek and 7 µm slices were 
prepared by cryo-slicing. 
The endothelium was stained with a selective endothelial marker Rhodamine-
Griffonia (Bandeiraea) simplicifolia Lectin I (10 µg/ml in 10 mM HEPES, 0.15 M NaCl, 
pH 7.5, Vector Laboratories, Buringame, USA) (Laitinen, 1987; Porter et al., 1990) for 
30 minutes, washed with PBS and embedded in AquaPolyMount. Experiments were 
carried out on 4 samples and analyzed as described in section 2.16.3.  
 
2.6 Adenoviral infection of MSCs 
For overexpression of CXCR4 stem cells were infected with a CXCR4-expressing 
adenovirus (Ad.CXCR4.GFP). The recombinant adenovirus was constructed and 
kindly provided by Dr. Birgit Boelck, German Sport University Cologne, and Professor 
Roger Hajjar, Department of Gene and Cell Medicine, The Mount Sinai School of 
Medicine, New York. The generation of a recombinant (E1 deficient) adenovirus 
(serotype 5) carrying the reporter gene green fluorescent protein (GFP) and the 
human CXCR4 (kindly provided by Dr. Alison Schecter, The Mount Sinai School of 
Medicine, New York) was performed with the overall strategy developed by He et al. 
(He et al., 1998). Briefly, human CXCR4 cDNA was cloned into the shuttle vector 
pAdTrack-CMV under the control of the cytomegalovirus promoter (see Figure 4). 
The resulting construct was cleaved with the restriction endonuclease PmeI to 
linearize it. This was then cotransformed with the supercoiled backbone adenoviral 
vector pAdEasy-1 into Escherichia coli strain BJ5183. Recombinants were selected 
with kanamycin and screened by restriction endonuclease digestion. The 
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recombinant adenoviral construct was cleaved with PacI to expose its inverted 
terminal repeats and transfected into the packing cell line, subconfluent HEK-293 
cells, by using a modified calcium phosphate coprecipitation method (Lieber et al., 
1993). The process of viral production could be directly and conveniently followed in 
HEK-293 cells by visualization of the GFP reporter, which was incorporated into the 
viral backbone. After 8-10 days, the virus was harvested and then amplified by 
infecting increasing numbers of packing cells each time, with a final round using a 
total of 50 145-cm2 dishes. After 2-3 days, the resultant virus (Ad.CXCR4.GFP) was 
purified by CsCl banding, with the final yield at 3.5 x 1012 particles/ml. A reporter virus 
producing GFP alone, but also under the control of the cytomegalovirus promoter 
was generated (Ad.GFP) at 1.58 x 1012 particles/ml and served as control. Viral titers 
were determined to be 3.5 x 1010 plaque-forming units (pfu)/ml for Ad.CXCR4.GFP 
and 4.72 x 109 pfu/ml for Ad.GFP (He et al., 1998). 
For infection MSCs were washed with PBS and incubated with Ad.CXCR4 at a 
multiplicity of infection (MOI) between 20-80 in 20% α-MEM at 37°C in a humidified 
5% CO2 atmosphere. The MOI is the number of viral particles per cell that is desired 
during the infection reaction. The excess viruses were removed by washing with 20% 
α-MEM after 24 hours. Experiments using CXCR4-infected MSCs were performed 48 
hours after infection. To study the efficiency of adenoviral infection MSCs were 
assessed by fluorescent microscopy at increasing concentrations (MOI). Reactivity to 
SDF-1β was studied by performing migration assays (2.9). Western blots were 
conducted to evaluate the amount of overexpession on protein level (2.12).  
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Figure 4: Scheme of the adenoviral shuttle vector pAdTrack-CMV 
Cytomegalovirus (CMV) long-terminal repeats served as promoters. The vector 
contained green fluorescent protein (GFP) under the control of a separate CMV 
promoter and the subcloned CXCR4-cDNA. Scheme adapted from 
http://www.coloncancer.org/adeasy/pAdTrack-CMV%20vector%20map.htm 
 
2.7 In vivo experiments 
The in vivo experiments were designed by Dr. Alexander Ghanem, Department of 
Medicine/Cardiology, University of Bonn, and were performed in the laboratories of 
Dr. Klaus Tiemann, Department of Medicine/Cardiology, University of Bonn. Surgical 
interventions were conducted by the technical assistant Pascal Pachenda and 
ultrasound techniques by Dr. Ghanem.  
 
2.7.1 Experimental protocol 
All experimental protocols were approved by the animal care committee at the 
University of Bonn and by the local government authorities and conformed to the 
guidelines of the American Heart Association for use of animals in research. All 
animals were housed at constant room temperature of 24°C and 12 hours light-dark 
cycle and maintained on an ad libitum diet (Altromin 1324, Altromin, Lage, Germany) 
with free access to water. Female WISTAR rats (200-250 g; Charles River, Kisslegg, 
Germany) were used for all experiments. All procedures were performed in inhalative 
anaesthesia with isoflorane (3% for induction and 1.0-1.5% for maintenance) in 50% 
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nitrous oxide and 50% oxygen. For continuous ECG-recording a 2 lead ECG was 
connected using an established ECG-analysis system (PowerLab™ System, AD 
Instruments, Milford, USA). Chest-walls were carefully shaved and remaining fur was 
removed by means of depilation crème. Intrathoracic instrumentation was performed 
in all animals eleven days ahead of the transfusion experiments to avoid influence of 
post-traumatic cytokine expression (Nossuli et al., 2000). The effect of focussed 
ultrasound-mediated microbubble stimulation (UMS) was investigated in native, non-
ischemic and ischemic myocardium in vivo resulting in 4 groups (n=24). Figure 5 
summarizes the experimental protocol. Groups C and D received 1 hour of 
anterolateral myocardial ischemia (Nossuli et al., 2000). Therefore, rats were 
intubated and ventilated with a tidal volume of 200 µl and respiratory rate of 80/min 
(Hugo-Sachs, Type Small Animal Ventilator KTR4, Harvard Apparatus). After left 
thoracotomy in the fourth intercostal space, the pericardial sac was opened and a 6-0 
monofilament polypropylene suture was passed under the left anterior descending 
coronary artery (LAD) 2 mm distal of the atrioventricular grove avoiding affection of 
septal branches. After forming a loose snare around the LAD, each end of the suture 
was then exteriorized through each side of the chest wall and placed 
subcutaneously. Four days before cell transplantation left anterior descending 
coronary artery was ligated for 60 minutes. Anterolateral myocardial ischemia and 
reperfusion were controlled by means of electro- (ST-segment analysis) and 
echocardiography (wall motion abnormality, wall thinning) as described previously 
(Kim et al., 2007).  
For application of microbubbles a femoral vein was cannulated with a Polyethylene 
(PE)-50 tube (0.4 mm inner diameter) for continuous echocontrast application. 
SonoVue™ (Bracco Inc., Milano, Italy) was infused during constant agitation at 
approximately 130 µl/minute (Lohmaier et al., 2004). Flow rate was adapted to 
achieve good left-ventricular opacification without shadowing, steady state conditions 
were achieved approximately 2 minutes after infusion start. Centrifuged ultrasound 
gel was placed on top of the depilated chest wall to ensure optimal acoustic coupling 
with the ultrasound system.  
For cell application the aorta was additionally cannulated for cell delivery via right 
common carotid artery by means of a PE-40 tube (Templin et al., 2006). Positioning 
of the catheter in the aortic root approximately 2 mm distal of the aortic valve was 
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Figure 5:  Scheme of experimental protocol of in vivo experiments 
Impact of focussed ultrasound-mediated microbubble stimulation (UMS) on 
myocardial stem cell attraction and transendothelial migratory capacity was evaluated 
in native (groups A, B) and ischemic (groups C, D) myocardium. Groups C and D 
received 1 hour of anterolateral myocardial ischemia (I) followed by reperfusion (R) 4 
days before MSC transfusion. Groups B and D were treated with UMS. Cell 
application was conducted in vivo via percutaneous PE-catheter placement in the 
aortic root.  
 
2.7.2 Focussed ultrasound-mediated microbubble stimulation (UMS) 
For UMS a hybrid ultrasound device (Philips Research North America, Briarcliff, 
USA) provided a) b-mode high-resolution ultrasound imaging of anatomical structures 
(15 MHz) electronically and mechanically coupled with b) low-frequency / high-energy 
focussed ultrasound application (see Figure 6a). The simultaneous use of both 
technologies allowed positioning of the focus point within the b-mode window. For 
aiming at cardiac structures, e. g. the vital borderzone of myocardial infarction, the 
focus point of the system was positioned in regions of interest guided by the high 
frequency transducer. Borders of the UMS zone (approximately 3x10 mm) were 
identified in b-mode, coordinates were stored and insonication was programmed 
within these borders (see Figure 6b). Focus was set on the anterior left-ventricular 
wall in native myocardium (group B). In ischemic hearts (group D) UMS was aimed at 
the anteroseptal peri-infarction borderzone. The ultrasound system was attached to a 
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a)
S
E
b)
stepper-motor driven tripod which allowed movements in three dimensions within a 
stereotactic grid. The movements of the tripod system and the application of UMS 
were synchronized with a time trigger to ensure a) delivery of identical ultrasound-
pulses to dedicated target zones phase of the cardiac cycle resulting in optimum 
interindividual reproducibility as well as b) to ensure a distinct replenishment time for 
fresh contrast microbubbles in the left ventricle following UMS. Each therapeutic 
pulse (frequency of pulse 0.2 Hz) resulted in the oscillation and the destruction of 
myocardial microbubbles and was followed by a programmed movement of the 
scanhead. In total every heart received the sequence of 30 pulses twice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Focussed ultrasound-mediated microbubble stimulation (UMS) 
a) Hybrid ultrasound device allows simultaneous high-resolution imaging (for aiming) 
and focussed ultrasound at high-emission power (for UMS).  
b) Sequential UMS-pulses were synchronized with an automated stepper motor and 
allowed application to a standardized volume. Arrows indicate UMS-pulse-movement-
sequences on the left-ventricular anterior wall in native myocardium from start (S) to 
end (E). In case of anterolateral ischemia UMS was targeted on anteroseptal 
borderzone tissue (light grey). Myocardial scar is depicted dark grey. 
Photographs were kindly provided by Dr. Alexander Ghanem, Department of 
Medicine/Cardiology, University of Bonn.  
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2.7.3 Transplantation of MSCs via aortic root catheter 
MSCs were PKH67 vital-stained, washed and counted in a ‘Neubauer counting 
chamber’. For each experiment 1.5x105 MSCs were resuspended and homogenized 
in 1 ml of 20% α-MEM. The homogenized cell suspensions were administered slowly 
(1 ml during constant agitation over 90 seconds) via a catheter placed in the aortic 
root within 5-10 minutes after UMS. To rule out microembolisms resulting in further 
acute myocardial ischemia left-ventricular function was investigated during 
cardiomyoplasty with two-dimensional echocardiography for new wall motion 
abnormalities. Rats were kept in inhalative anaesthesia before organs were 
harvested after 30, 60 and 120 minutes and fixated as described above (section 
2.5.3).  
 
2.8 Immunohistochemistry 
Fixed co-cultures were washed thrice with 0.05 M Tris-buffered saline (TBS: 50 mM 
Tris, 150 mM NaCl, pH 7.6) and were permeabilized using TBS containing 0.5 M 
ammonium chloride (Sigma-Aldrich) and 0.25% Triton-X-100 (Serva). The detergent 
Triton-X-100 permeabilizes the cell membrane while ammonium chloride reacts with 
free aldehyde groups to prevent unspecific binding of the antibody. Non-specific 
binding sites were blocked using 5% bovine serum albumin (BSA, PAA) in TBS (1 
hour, room temperature). Primary antibodies CD29 mouse IGg1 integrin β1 chain of 
VLA-4 (Becton Dickinson) and VE-cadherin (F-8) mouse IgG1 (Santa Cruz 
Biotechnology, Santa Cruz, USA) were diluted in 1:500 and 1:400 ratios in 0.8% BSA 
and incubated overnight at 4°C. Specimens were washed three times with TBS. Cy5- 
and Cy2-conjugated goat anti-mouse IgG (1:400 in TBS, Jackson Immuno Research 
Laboratories, Suffolk, UK) served as secondary antibodies and were incubated for 1 
hour at room temperature. Non-specific staining was assessed by omission of the 
primary antibody and examination of the samples in the presence of the secondary 
antibody alone. The coverslips were washed three times with TBS. Afterwards cells 
were dehydrated for 2 minutes in each of the following alcohols: 70% EtOH, 96% 
EtOH, 100% EtOH and Xylol. The coverlips were mounted onto glass slides using 
Entellan.  
To examine the integrity of the basement membrane immunohistochemical staining 
for laminin was carried out. Frozen sections were blocked with 5% BSA. Anti-laminin 
Material and Methods 
 
34 
Insert
Insert
Well
Membrane 
(with pores
and cells)
Membrane
Pore in the membrane
Cells
Well of a multi-well
plate Insert
rabbit IgG (Sigma-Aldrich) was diluted 1:200. Cy5-conjugated goat anti-rabbit IgG 
(1:400; Jackson Immuno Research Laboratories, Suffolk, UK) served as secondary 
antibodies.  
 
2.9 Migration assay 
To evaluate the migratory capacity of MSCs a modified Boyden chamber assay was 
conducted by using a 24-well HTS Fluoro Blok TM insert system (Falcon) as shown 
in Figure 7. Each insert consists of a polyethylene membrane with 8.0 μm pores 
which blocks >99% of the light transmission in a wavelength region from 490-700 nm. 
10.000 MSCs in 20% α-MEM were seeded into each insert. For testing the migratory 
reactivity to SDF-1β 50 ng/ml SDF-1β was added. After 6 hours incubation at 37°C in 
a humidified 5% CO2 atmosphere, cells were fixed with 4% PFA for 20 minutes, 
washed 3 times with PBS. Filters were excised and mounted with DAPI mounting 
medium (4´,6-diamidino-2-phenyl-indole, Vectashield, Vector Laboratories, 
absorption 360 nm, emission 460 nm). The total number of migrated cells was 
counted using a LSM 510 Meta microscope (Zeiss). Assays were performed in 4 
setups.  
Figure 7: Scheme of a modified Boyden Chamber migration assay 
Scheme adapted from Schmidt, 2003 (Schmidt, 2003). 
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2.10 DAF and APF fluorometry 
To detect changes in NO and ROS levels upon contact of MSCs with endothelial 
cells (ECs), adherent MACS were co-cultivated with PKH26 stained MSCs for 30 
minutes. NO and ROS levels were measured on MSCs and ECs which were in 
contact with each other as well as on MSCs and ECs cultivated solitarily.  
For NO measurements 4-Amino-5-methylamino-2`,7`-difluorofluorescein diacetate 
(DAF-FM DA, Alexis) was used. DAF is converted via an NO-specific mechanism to 
an intensely fluorescent triazole derivative (Kojima et al., 1998). Cells were 
equilibrated in tyrode (1.8 mM CaCl2, 1.1 MgCl2, 5.4 mM KCl, 140 mM NaCl, 4.2 mM 
NaH2PO4, 10 mM glucose, 23 mM NaHCO3 and 1 mM L-arginine) for 2 minutes and 
subsequently incubated with DAF (1:1000 in tyrode) for 2 minutes at 37°C. For 
negative controls the nitric oxide synthase (NOS) inhibitor L-NAME (100 µM) was 
used.  
For the measurement of reactive oxygen species 3'-(p-aminophenyl) fluorescein 
(APF, Alexis) was used. APF is an aromatic amino-fluorescein derivative that has 
little intrinsic fluorescence. It immediately reacts with ROS such as hydroxyl radical, 
peroxynitrite and hypochlorite ion and certain peroxidase intermediates, but is inert to 
NO, H2O2, superoxide and other oxidants. Upon oxidation, APF is converted to the 
highly fluorescent molecule fluorescein, allowing the simple direct detection of highly 
reactive biological radicals. Cells were incubated with APF (1:1000 in PBS) for 30 
minutes at 37°C. For negative control 10 mM of the free radical scavenger N-
acetylcysteine was used.  
The intensity of DAF and APF fluorescence was measured every 50 seconds for 15 
minutes using a LSM 510 Meta microscope.  
 
2.11 TUNEL assay 
For quantification of apoptotic cells terminal uridine deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) assay using In Situ Cell Death Detection Kit AP 
(Roche) was performed. 7 µm thick sections were prepared on Poly-L-Lysin coated 
slides (Menzel, Braunschweig, Germany) and incubated with Proteinkinase K (diluted 
1:1000 in 5 mM TBS pH 7.4) for 30 minutes at 37°C in a humidified 5% CO2 
atmosphere. Sections were washed twice with PBS. Positive controls were treated 
with 1 µg/ml DNAse (Qiagen, Hilden, Germany) in 25 mM Tris pH 7.6 for 10 minutes 
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at 37°C. Sections were incubated with FCS (1:25 diluted in PBS) for 30 minutes at 
room temperature and afterwards with 50 µl TUNEL-reagent per slide for 10 minutes 
at room temperature. Negative controls were incubated in the absence of the terminal 
desoxynucleotidyl-transferase. Sections were washed twice with PBS and 50 µl 
Converter-AP (2:1 diluted with 0.1 M Tris containing 1% milk powder) was added and 
incubated for 30 minutes at 37°C. One tablet of nuclear fast red (Roche) was 
suspended in 2 ml 0.1 M Tris pH 8.2 and filtered. After washing 50 µl fast red solution 
was added to each section and incubated for 30 minutes at room temperature in the 
dark. Sections were washed twice with distilled water and finally counterstained with 
Mayer`s hematoxylin stain. Sections were embedded in AquaPolyMount. Apoptotic 
signals appeared in pink. Sections were examined using a Zeiss Axiophot 
microscope.  
 
2.12 Immuno blot (SDS-Page) 
2.12.1 Preparation of cell and tissue lysates 
For cell lysates cells were washed with PBS (4°C) and detached from the culture dish 
with 500 µl of RIPA lysis buffer (25mM Tris/HCl pH 8, 150mM NaCl, 0.1% SDS, 0.1% 
Natriumdesoxycholat, 1% Nonidet P-40 (IGEPAL), 10% Glycerol, 2 mM EDTA) 
containing protease inhibitor complete (Roche) using a cell scraper. Cells were 
incubated on ice for 30 minutes and lysed by repetitive freezing and thawing cycles. 
After centrifugation at 10000 g, 4°C (table centrifuge 5417R, Eppendorf), cell debris 
was separated from cell lysate. Cell lysates were stored at -80°C until usage.  
For tissue lysates frozen heart tissue was homogenized in liquid nitrogen. The frozen 
state of the tissue facilitated to smash bigger tissue pieces to small ones using a 
crucible. Subsequently the small tissue fragments were crushed with a wolfram 
carbide bead (5 mm) in a Teflon container by using a micro-dismembranator (1600 
beats/minute) for 1 minute. During this procedure the tissue pieces were crushed to 
powder. Pulverized tissue was resuspended in 1 ml of cell lysis buffer (RayBiotech, 
Norcross, USA) containing protease inhibitor and homogenized. Probes were 
centrifuged 10 minutes at 10000 rpm (4°C, Eppendorf).  
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2.12.2 Measurement of protein content 
The protein content of the supernatant was measured by the method of Lowry (Lowry 
et al., 1951) using the DC protein ASSAY (BIO-RAD, München, Germany). According 
to the manufacturer’s instructions 5 µl of each lysate was transferred twice into a 96-
well plate. 25 µl of reagent A and 200 µl of reagent B were added. Additionally, to 
calculate the protein content a calibration dilution line with bovine serum albumin 
(BSA) was added. After 15 minutes absorption was measured at 650 nm using a 
Molecular Devices kinetic microplate reader (Sunnyvale, USA) and the mean value of 
protein content was calculated as µg/µl.  
 
2.12.3 Separation of proteins via SDS-Polyacrylamid-gelelectrophoresis (PAGE) 
For SDS-PAGE 40 µg of tissue or cell lysates were used. The required volume of 5x 
SDS-loading buffer (300 mM Tris pH 6.8, 5% SDS, 50% glycerol, 25% 
mercaptoethanol, 0.02% bromphenolblue) was added. Samples were denatured for 5 
minutes at 95°C. After quick centrifugation proteins were submitted to commercial 
SDS-PAGE (Criterion™ XT Precast Gel, 4-12% Tris-HCl gel, BIO-RAD) inside the 
Criterion™ electrophoresis chamber (BIO-RAD). After addition of running buffer (1x 
XT MOPS Running Buffer, BIO-RAD) proteins were separated at 200 V, 90 mA and 
200 W per SDS-gel. Precision Plus (BIO-RAD) served as molecular weight standard.  
 
2.12.4 Western blot 
The transfer of electrophoretically separated proteins on a PVDF (polyvinylidene 
fluoride)-membrane (BioTrace™ PVDF Transfer Membrane, BIO-RAD) was carried 
out in a semi-dry-procedure using a Biometra blotter (Göttingen, Germany). The 
SDS-gel, filter papers and sponges were equilibrated in transfer buffer (25 mM Tris, 
150 mM glycine, 10% methanol) for 5 minutes. The PVDF-membrane was activated 
in methanol and equilibrated in transfer buffer. Afterwards the following transfer unity 
was built up between the two electrodes: 
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For blotting an electrical current of 160 mA per gel was applied for 1 hour. The quality 
of protein transfer was checked by staining the membrane for 10-20 minutes in 
Ponceau S-solution (0.1% Ponceau S, 1% glacial acetic acid). After washing the 
membrane in distilled water, bands became visible.  
 
2.12.5 Immunological Detection 
After the transfer of proteins, non-specific binding sites were blocked for 1 hour at 
room temperature in TBST (50 mM Tris, 50 mM NaCl, 0.05% Tween 20, pH 7.5) 
containing 1% non-fat dry milk (BIO-RAD). After washing in TBST the membrane was 
incubated overnight at 4°C with the primary antibody in TBST. After washing 6 times 
for 5 minutes with TBST at room temperature the membrane was incubated with the 
HRP (horseradish peroxidase)-conjugated secondary antibody in TBST for 1 hour at 
room temperature. The membrane was then washed 6 times for 5 minutes. Specific 
immunoreactive proteins were detected by chemiluminescent reaction. After a short 
incubation in chemiluminescence substrate (SuperSignal™ West Dura, Pierce, 
Rockford, USA) the membrane was wrapped inside a foil followed by exposure of the 
membrane to x-ray film (BioMac Light Film, Kodak) for 1 second to 2 hours. Signals 
were detected using film developer and fixer (Adefo, Dietzenbach, Germany). 
Quantifications were performed by densitometry with ImageJ 1.38 
(http://rsb.info.nih.gov/ij). The ratio of the protein of interest to actin was calculated.  
Primary antibodies:  
Rabbit anti-laminin (1:1.000; Sigma-Aldrich) 
Rabbit anti-CXCR4 (1:2500; Chemicon, Millipore GmbH, Schwalbach, Germany) 
Mouse anti-actin (1:4.000; Chemicon) 
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Secondary antibodies:  
ImmunoPure® Peroxidase conjugated Goat anti-rabibt (1:4000; Pierce) 
ImmunoPure® Peroxidase conjugated Goat anti-mouse (1:1500; Pierce) 
 
2.13 Cytokine Antibody Array 
Non-ischemic rat hearts (n=4) were removed within 5-10 minutes after UMS. Hearts 
without UMS insonication (n=4) served as control. After isolation the anterior and 
posterior walls were separated and the tissues were immediately frozen in liquid 
nitrogen. Tissue lysates were prepared in Cell Lysis Buffer (RayBiotech) as described 
in section 2.12.1. Rat Cytokine Antibody Arrays (RayBiotech) were performed with 
100 µg of lysates according to the manufacturer’s instructions. All chemicals and 
buffers were obtained from RayBio. All incubation steps were performed under gentle 
rotation. Briefly, membranes were incubated with Blocking Buffer for 20 minutes. 100 
µg tissue lysate was diluted in Blocking Buffer to obtain a final volume of 1 ml. 
Membranes were incubated with samples for 2 hours at room temperature. 
Membranes were washed 3 times with Wash Buffer I and 2 times with Wash Buffer II 
and were incubated with Biotin-conjugated Anti-Cytokines at 4°C overnight. 
Membranes were washed as described and incubated with HRP-conjugated 
streptavidin for 2 hours at room temperature. Membranes were washed, incubated 
with Detection Buffer for 2 minutes and exposed to x-ray film. Signals were detected 
using film developer and fixer. The intensity of signals was quantified by densitometry 
with ImageJ 1.38. The amount of cytokines in anterior walls was normalized to the 
level of cytokines detected in the posterior wall.  
 
2.14 Enzyme-linked immunosorbent assay (ELISA) 
The amounts of matrix metalloproteinase (MMP)-2 and MMP-9 secreted by MSCs 
were determined using enzyme-linked immunosorbent assays (ELISA) (Quantikine, 
R&D Systems, Minneapolis, USA). Conditioned medium was collected after growing 
MSCs in α-MEM without FCS in the presence or absence of gelatine coating for 2, 4, 
6, 24, 48 and 96 hours. Supernatants plus protease inhibitors were centrifuged to 
remove particulates and stored at -20°C. ELISA was performed according to the 
manufacturer’s instructions. All chemicals and buffers were obtained from R&D 
Systems. Briefly, 100 µl Assay Diluent was added to each microplate well as well as 
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50 to 100 µl of MMP-standard or sample and incubated for 2 hours at room 
temperature. The microplate was washed 4 times with Wash Buffer and 200 µl of 
MMP-2 or MMP-9 Conjugate was added. After 2 hours of incubation the microplate 
was washed and 200 µl of Substrate Solution was added to each well. The assay 
was incubated for 30 minutes in the dark and subsequently 50 µl Stop Solution was 
added. Optical density was determined at 650 nm and 450 nm with the Molecular 
Devices kinetic microplate reader. The readings at 650 nm were subtracted from the 
readings at 450 nm to correct for optical imperfections of the plate. The results were 
related to the total protein concentration of the cells (section 2.12.2). 
 
2.15 In situ zymography 
To localize active MMPs during transmigration isolated mouse heart perfusions were 
performed with PKH26 (Sigma-Aldrich) labeled MSCs for 120 minutes as described 
above (2.5.3).  
To evaluate active MMPs after UMS application non-ischemic rat hearts (n=4) were 
removed within 5-10 minutes after UMS. After isolation the tissue was immediately 
frozen in liquid nitrogen. MMP activity was identified in anteroseptal and 
posterolateral myocardium of 7 µm heart slides using a modified method of Agrawal 
et al. and Oh et al. (Oh et al., 1999; Agrawal et al., 2006). Slides were placed on 10 
µg/ml DQ-gelatin (EnzCheck; Invitrogen) in 50 mM Tris-HCl, pH 7.4, plus 1 mM 
CaCl2 in the presence or absence of 0.5 mM 1,10-phenanthroline (Sigma-Aldrich) 
and incubated for 24 hours in a humid chamber at 37°C. Slides were washed and 
embedded in AquaPolyMount. Digestion of DQ-gelatin resulted in unquenching of 
fluorochrome, which was detected with excitation at 488 nm and emission at 512-542 
nm.  
 
2.16 Microscopy 
2.16.1 Confocal laser scanning microscopy 
Confocal microscopy was performed using a LSM 510 Meta microscope (Zeiss). 
Images at a resolution of 512x512 or 1024x1024 pixels were acquired in the multi-
track mode. CellTracker Green, digested DQ-gelatin, GFP, PKH67, DAF, APF and 
Cy2 were excited at 488 nm (AI laser), CellTracker Red and PKH26 at 543 nm (HeNe 
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laser) and Cy5 at 633nm (HeNe laser). After the main dichroic beam splitter (HFT 
488/543) the fluorescence signal was divided by a secondary dichroic beam splitter 
(NFT 543) and detected in the separate channels using the appropriate filters: BP 
505-530 (for CellTracker Green, DQ-gelatin, GFP, PKH67, DAF, APF and Cy2) LP 
560 (for CellTracker Red and PKH26), and LP 650 (for Cy5). In this set-up, no cross-
talk between the green and red channels was observed.  
 
2.16.2 Calculation of MSC integration 
For calculating the percentage of MSCs integrated into endothelial monolayer, slides 
were microscopically analyzed. Confocal images of 20 randomly selected MSCs per 
slide were classified as (1) MSC adherent on the endothelial monolayer, but still 
possessing their initial round shape, (2) start of flattening phase, or (3) MSC 
completely flattened and integrated into the monolayer. Additionally, the formation of 
plasmic podia of the MSCs was evaluated as (1) no plasmic podia, (2) short (< 25 
µm) or (3) long plasmic podia (≥ 25 µm). 
 
2.16.3 Quantification of transmigration 
All cell interactions were graded after three-dimensional visualization of confocal z-
stacks. Therefore eight representative short-axis slides of each left-ventricular level 
were analysed. For UMS experiments slides were placed within the UMS grid. 
Overall a minimum of 20 fluorescently labeled cells were randomly selected in each 
heart and evaluated with regards to adhesive properties. MSCs were counted as 
within the process of transendothelial migration if both of the following criteria 
applied: (1) a distinct plasmic podium connected to the MSC cell body was localized 
outside the endothelial cell layer and if (2) the staining of the endothelial barrier was 
regionally interrupted at the site of the penetrating plasmic podia (Schmidt et al., 
2006b). Results are expressed as percentage of the analysed cells. For absolute cell 
count in UMS experiments, all labeled MSCs observed in the standardized slides 
were counted and normalized to 100.000 transplanted MSCs. Transmigration was 
additionally evaluated in anteroseptal and posterolateral myocardium as well as in 
peri-infarction borderzone of ischemic myocardium.  
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2.16.4 Electron microscopy 
Embedding and microscopy was performed at the Institute I for Anatomy, University 
of Cologne (Professor Dr. Klaus Addicks). Ultrathin sections were prepared by the 
technical assistant Mojgan Ghilav. For electron microscopy of co-culture MACS cells 
were cultured on gelatine-coated foil (Plano, Wetzlar, Germany) to confluence. MSCs 
were gold labeled with 10 nm colloid gold (Sigma-Aldrich) for 7 days as described 
before (Christensen et al., 1992). In each change of medium 20% α-MEM was 
supplemented with 25 µl colloid gold solution per ml medium. Accuracy of gold 
labeling was checked via a Silver enhancement kit (Sigma-Aldrich). On addition of 
the kit, precipitation of metallic silver occurs, which enlarges colloidal gold labels 
normally visible only at the electron microscope level, yielding high-contrast signals 
visible by light microscopy. Therefore, MSCs were fixed with 4% PFA, rinsed with 
distilled H2O, incubated with a solution containing equal volumes of solution A (silver 
salt) and solution B (initiator) for 10 minutes at room temperature in the dark. After 
washing cells, were incubated with aqueous 2.5% sodium thiosulfate for 2 minutes, 
rinsed, dehydrated and embedded in Entellan. Gold particles were examined using a 
Zeiss Axiophot microscope.  
Co-culture samples were fixed in 2% glutaraldehyde and 0.2% picric acid (Merck) in 
0.1 M cacodylate buffer pH 7.4 for 45 minutes at room temperature.  
For electron microscopy of hearts the tissue was immediately fixed with 2% 
glutaraldehyde and 2% PFA in 0.1 M cacodylate buffer pH 7.4 for 6 hours at room 
temperature. The following steps were performed on ice or at 4°C. After washing 
three times in cacodylate buffer for 7 minutes, samples were treated with 1% OsO4 in 
cacodylate buffer for 30 minutes, washed three times in cacodylate buffer for 7 
minutes, treated with 50% EtOH for 7 minutes and 70% EtOH for 7 minutes. 
Afterwards samples were incubated with 1.5% uranyl acetate (Plano) in 70% EtOH 
for 1 hour. Incubation with uranyl acetate contrasted the nuclei. After dehydration in a 
series of graded ethanol (90% EtOH for 7 minutes, thrice in 100% EtOH for 7 
minutes, 7 minutes in a solution containing equal volumes of 100% EtOH and 
propylenoxide and 7 minutes in propylenoxide) specimens were embedded in Epon-
araldite (Sigma-Aldrich) (Schmidt et al., 2006b). The Epon solution contained (w/v): 
11.56 g epoxy-embedding medium, 7.13 g expoxy-embedding medium hardener 
DDSA, 6.28 g epoxy-embedding medium hardener MNA and 0.38 g epoxy-
embedding medium accelerator. First samples were incubated in Epon/1.2-
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epoxypropan in a 1:1 ratio for 30 minutes, second in a 3:1 ratio for 30 minutes and 
finally overnight at 60°C in pure Epon. For final polymerization samples were placed 
in rubber forms containing fresh Epon and incubated for 3 days at 60°C and 1 day at 
room temperature.  
After trimming (TM60, Reichert, Bensheim, Germany) thin sections (500-1000 nm) of 
embedded tissue were cut with a glass knife on an ultramicrotome (Reichert) and 
stained with methylene-azure-blue II solution (1:1 of 1% methylene blue in 1% borax 
and 1% azure-II in H2O). After localization of adequate position of the sample, ultra 
thin sections (70-80 nm) were processed on the same microtome with a diamond 
knife and placed on copper grids (Plano). For contrasting samples were incubated for 
20 minutes with aqueous 1.5% uranyl acetate at room temperature in the dark. After 
washing several times with H2O samples were contrasted in leadcitrate (800 µl H2O, 
155 µl 1.3 M tri-sodiumcitrate-2-hydrate-solution, 100 µl 1 M lead(II)-nitrate-solution, 
200 µl 1 M NaOH) for 5 minutes. After washing, grids were dried. Ultra thin sections 
were examined using a Zeiss 902A transmission electron microscope with TEM 
Imaging Platform iTEM software (Soft Imaging Systems, Münster, Germany). 
Pictures were taken using the cooled digital camera Megaview II (Soft Imaging 
Systems).  
 
2.17 Statistical analysis 
All experiments were carried out 4 to 6 times. All data are represented in mean ± 
standard deviation. The mean value and the standard deviation were calculated 
using Microsoft Excel. Statistical significance of differences was determined using the 
two-tailed unpaired Student`s t-test (2-sided) or One-way Analysis of Variance 
(ANOVA) with post-test Bonferroni using GraphPad InStat v. 3.01 (GraphPad 
Software, San Diego, USA). A p-value of less than 0.05 was considered statistically 
significant.
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3. Results 
3.1 Characterization of human mesenchymal stem cells 
Before experiments the quality of cultivated MSCs was routinely ensured by 
microscopic observations, flow cytometry, colony forming unit-fibroblast assays and 
differentiation assays. Figure 8 shows a light microscopic picture of a confluent 
monolayer of MSCs with their characteristic spindle-shaped morphology (Pittenger et 
al., 1999). Flow cytometric analyses were performed to characterize the expression 
of MSC surface antigens. Figure 9 summarizes the results of a representative FACS 
analysis of MSCs in passage 2 derived from a male 67 years old patient. In this 
example, 84.0% of the analyzed cells were negative for the leukocyte common 
antigen CD45. 77.7% of these CD45-negative cells were additionally double-negative 
for the hematopoietic markers CD14 (lipopolysaccharide receptor) and CD34 (marker 
of human hematopoietic stem and progenitor cells). 98.9% of the CD45-/CD34-/CD14- 
triple negative population of cells were double positive for CD105 (endoglin or TGF 
β1/3-receptor, highly expressed on vascular endothelial cells) and CD106 (VCAM-1). 
According to Pittenger et al. (Pittenger et al., 1999), this population of cells (CD45-
/CD34-/CD14-/CD105+/CD106+) was defined as human MSCs. Thus, in the presented 
example 64.5% (0.84·0.777·0.989) of all cells were CD45-/CD34-/CD14- and 
CD105+/CD106+. A purity of MSCs yielding a comparable range was considered to 
be a homogeneous phenotypic population (Pittenger et al., 1999; Klinz et al., 2005; 
Schmidt et al., 2006a).  
 
 
 
 
 
 
 
 
Figure 8: Light microscopic picture of a confluent monolayer of MSCs 
In culture MSCs displayed a characteristic fibroblast-like and spindle-shaped 
morphology. Magnification: 100x.  
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Figure 9: Flow cytometric analysis of expressed surface antigens of MSCs 
Representative FACS analysis of MSCs in passage 2 derived from a male 67 years 
old patient. 84.0% of all cells were CD45-. 77.7% of this CD45--population were 
additionally CD14 and CD34 double-negative. 98.9% of all CD45-/CD34-/CD14- cells 
were double positive for CD105+/CD106+.  
 
MSCs did not differentiate spontaneously during culture expansion. Thus, to evaluate 
their multilineage differentiation potential MSCs were cultured under conditions 
favourable for adipogenic, osteogenic and chondrogenic differentiation. After 2 to 3 
weeks in the lineage specific culture conditions, the expanded MSCs differentiated. 
As Figure 10a illustrates, induction of an adipogenic phenotype of MSCs grown 
under conditions favourable for adipogenic differentiation was apparent by the 
accumulation of lipid-rich vacuoles within the cells. Differentiation to the osteogenic 
lineage accompanied by an increase in calcium depositions is shown in Figure 10b. 
Chondrogenesis was validated by semi-quantitative analysis of collagen II mRNA 
expression. Figure 10c summarizes that only MSCs grown under conditions 
favourable for chondrogenic differentiation expressed collagen II, but not MSCs 
grown under control conditions.  
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Figure 10: MSCs differentiate to mesenchymal lineages 
a) Adipogenesis of MSCs grown under conditions favourable for adipogenic 
differentiation (left panel) was indicated by the accumulation of neutral lipid droplets in 
vacuoles which stain with Oil Red O. MSCs under control conditions did not 
accumulate lipids (right panel). Nuclei were counterstained by Mayer`s hematoxylin. 
Magnification: 100x.  
b) Osteogenesis of MSCs grown under conditions favourable for osteogenic 
differentiation (left panel) was indicated by formation of calcium depots stained with 
von Kossa staining. MSCs under control conditions did not accumulate calcium (right 
panel). Nuclei were counterstained by nuclear fast red. Magnification: 40x.  
[continued on next page] 
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Legend to Figure 10, continued: 
c) Chondrogenesis was demonstrated by semi-quantitative RT-PCR analysis. Only 
MSCs grown under conditions favourable for chondrogenic differentiation expressed 
collagen II (388 bp). Expression of actin (698 bp) served as internal standard.  
M: 50bp DNA ladder (Fermentas), C: MSCs grown under control conditions, Diff: 
MSCs grown under conditions favourable for chondrogenic differentiation, H2O: water 
control.  
 
3.2 Characterization of transmigration and invasion: different model 
systems 
3.2.1 Co-cultivation 
To examine the morphology and time course of the interaction of MSCs with the 
endothelial barrier, an in vitro co-cultivation approach was established. 
Representative pictures of red-labeled MSCs co-cultivated with green-labeled MACS 
endothelial monolayers illustrate that MSCs flattened and integrated into the 
endothelial monolayer (Figure 11a). In addition, further morphological changes of the 
MSC cell shape including the formation of long plasmic podia occurred. The first 
contact and adhesion of MSCs was observed within 15 minutes as shown in Figure 
11b. Here, MSCs still possessed a spherical shape. Later, MSCs integrated into the 
monolayer and endothelial cells started to grow on top of the MSCs to seal the 
monolayer. VE-cadherin staining revealed the integrity of the endothelial monolayer 
prior to co-cultivation experiments (Figure 12).  
In a different approach, ultrastructural analysis by electron microscopy of co-
cultivation supplements demonstrated as well that MSCs integrated into the 
endothelial cell monolayer in vitro (Figure 13). Here, MSCs still exhibited a spherical 
shape after 30 minutes, while a thin plasmic edge of endothelium was visible 
underneath the stem cell. The 240 minutes sample confirmed that the MSCs 
flattened and integrated into the endothelial monolayer.  
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Figure 11: MSCs integrate into endothelial monolayer in vitro 
MSCs co-cultivated with MACS endothelial monolayer (EC) for 15 to 240 minutes 
(MSCs: CellTracker Red, EC: CellTracker Green).  
a) MSCs quickly interacted with endothelial cells, flattened and integrated into the 
monolayer. Morphological changes of MSC cell shape occurred via formation of 
podia. Scale bar: 10 µm. 
b) Orthogonal projections illustrate that MSCs quickly attached within 15 minutes (left 
panel) and integrated into the monolayer (center panel, after 180 minutes). In some 
cases, endothelial cells (arrow) grew on top of MSCs (right panel, after 240 minutes). 
Horizontal bar: section of the XZ plane through a confocal image stack; vertical bar: 
section of the YZ plane through a confocal image stack.  
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Figure 12: Integrity of endothelial monolayer 
The integrity of the endothelial monolayer was checked via immunohistochemical VE-
cadherin distribution. Cy2 served as secondary antibody. Representative pictures of a 
HUVEC monolayer with tight cell-to-cell-contacts. Scale bar: 10 µm. 
 
 
Figure 13: Electron micrographs of in vitro co-cultivation 
Ultrastructure of MSCs co-cultivated with endothelial MACS cell monolayer. After 30 
minutes, MSCs exhibited a spherical shape. A thin plasmic edge of endothelial cells 
(EC) was visible underneath the MSC (arrow). After 240 minutes, MSCs flattened and 
integrated into the endothelial monolayer. Magnification: 4400x/7000x. 
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3.2.2 Three-dimensional model systems for transmigration 
To visualize not only the transmigration and opening of the endothelial barrier, but 
also the invasion of MSCs into the surrounding tissue, three different three-
dimensional approaches have been established. Taken together, the three-
dimensional model systems enabled the visualization of both the transmigration and 
the invasion process of MSCs. Both processes were accompanied by the formation 
of plasmic podia.  
 
3.2.2.1 Collagen invasion assay 
First, growing endothelial monolayers on collagen gels allowed observing MSCs 
penetrating the endothelial monolayer and invading the matrix in vitro (Figure 14). 
After 2 hours, MSCs came into contact with the HUVEC monolayer, but retained a 
spherical shape. After 4 hours the MSCs had integrated into the monolayer and 
started to penetrate it by means of plasmic podia. After 6 to 24 hours MSCs 
transmigrated across the endothelial monolayer, invaded the collagen gel and 
remained underneath the endothelial cells. 
 
3.2.2.2 Endothelial spheroids 
Second, multi-cellular endothelial spheroids were generated and co-cultivated with 
MSCs (Figure 15). After 2 hours MSCs possessed a spherical shape and were in 
contact with the surface monolayer of the spheroid. After 4 hours MSCs started to 
invade the inner mass of the spheroids. The invasion was accompanied by the 
formation of plasmic podia.  
 
3.2.2.3 Isolated mouse heart perfusions 
Third, MSCs stained with the green-fluorescent dye PKH67 were perfused through 
isolated mouse hearts. The endothelium was stained using Rhodamine-Griffonia 
simplicifolia Lectin I. Figure 16a illustrates two MSCs in one vessel in close contact 
with the endothelium after 60 minutes of perfusion. Confocal microscopy facilitated a 
three-dimensional visualization of MSCs at an early phase of penetrating the 
endothelium and invading the cardiac tissue after 90 minutes (Figure 16b). Overall, 
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after 90 minutes perfusion 38 ± 11% of the MSCs which had been retained in the 
heart transmigrated across the endothelium and started to invade the heart muscle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Collagen gel invasion assay 
Co-cultivation of HUVECs (CellTracker Green) grown on top of a collagen matrix (Col) 
with MSCs (CellTracker Red). After 2 hours MSCs possessed a spherical shape. After 
4 hours MSCs integrated into the monolayer and penetrated the barrier via plasmic 
podia. After 6 and 24 hours MSCs moved underneath the endothelial monolayer and 
invaded the collagen gel. 2 and 24 hours: XZ planes of confocal image stacks; 4 and 
6 hours: cryo slices of the collagen matrix. Scale bar: 10 µm.  
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Figure 15: Co-cultivation of endothelial spheroids with MSCs 
Spheroids were stained with CellTracker Green and were co-cultivated with MSCs 
(CellTracker Red). After 2 hours MSCs came into contact with the surface of the 
spheroids. After 4 and 6 hours MSCs had invaded the spheroids via plasmic podia 
(arrows). Scale bar: 10 µm. 
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Figure 16: Isolated mouse heart perfusions visualize transmigration and invasion 
of MSCs ex vivo 
Isolated mouse hearts were perfused with MSCs (PKH67-labeled, green); the 
endothelium was stained with Rhodamine-Griffonia simplicifolia Lectin I (red).  
a) A vessel containing two MSCs which closely interacted and started to penetrate the 
capillary endothelial barrier (arrow) after 60 minutes of perfusion. Scale bar: 10 µm. 
b) 3D-reconstruction of a confocal z-stack in an early phase of transmigration and 
invasion after 90 minutes of perfusion. The arrows point at plasmic podia of the MSC 
which penetrated the capillary endothelial barrier.  
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3.3 Observation of transmigrating MSCs in vivo 
To evaluate whether the described transmigration and invasion phenomena also 
occur under physiological conditions, in vivo experiments were performed. Therefore, 
rat hearts were perfused with green fluorescent labeled (PHK67) MSCs via a catheter 
in the aortic root. Analyses of the hearts inferred that MSCs indeed transmigrate 
across the endothelium in vivo and that this transmigration shows the same 
morphological properties as observed in the in vitro and ex vivo experiments (section 
3.2). Figure 17 illustrates a green-labeled MSC which transmigrated across the red-
labeled endothelial barrier in vivo. Plasmic podia of the MSC penetrated the capillary 
endothelial barrier as it was observed in the previously described model systems 
(section 3.2). Initial experiments revealed endothelial adhesion of MSCs, but no signs 
of transmigration after 30 and 60 minutes (0% at both time points). Slow application 
of constantly homogenized 500.000 MSCs into the aortic root resulted in wall motion 
abnormalities and severe decrease of global systolic function, most likely as result of 
microembolisms and myocardial ischemia. Therefore, the in vivo protocol was 
modified to cardiomyoplasty of 150.000 MSCs. To achieve a comparable percentage 
of transmigrating MSCs as in isolated ex vivo mouse heart perfusions in vivo rat 
hearts were harvested 120 minutes after cardiomyoplasty.  
 
 
 
 
 
 
 
 
 
 
 
Figure 17: MSCs transmigrate and invade in vivo 
MSCs (PKH67-labeled, green) transmigrate in vivo across the endothelial border 
(stained with Rhodamine-Griffonia Simplicifolia Lectin I, red) in rat hearts. Note the 
plasmic podia (each marked with an arrow) of the MSCs which penetrated the 
capillary endothelial barrier. Scale bar: 10 µm 
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3.4 VCAM-1/VLA-4-interaction and β1 integrin clustering are crucial for 
transendothelial migration 
In order to determine the role of VCAM-1 and VLA-4 for the transendothelial 
migration of human MSCs, blocking experiments were conducted. The use of 
blocking antibodies specific for CD106 (VCAM-1) and CD49d (integrin alpha4 chain 
of VLA-4 complex) resulted in a significant reduction of MSC integration into HUVEC 
monolayers compared to control experiments without antibodies or isotypic control 
IgG1 antibodies (percentage of integrated MSCs in the HUVEC monolayer: control: 
71 ± 16%; anti VCAM-1: 25 ± 5%; anti VLA-4: 40 ± 7%; isotypic control: 59 ± 19%). 
Simultaneous blockade of VCAM-1 and VLA-4 did not lead to any further reduction of 
MSC integration (25 ± 5%, Figure 18).  
In addition, from immunohistochemical staining of β1 integrin could be inferred that 
the interaction of MSCs with endothelial cells induced a distinct clustering of β1 
integrins in MSCs (see Figure 19), which was not observed in MSCs cultivated 
without an endothelial monolayer.  
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Transmigration requires VCAM-1/VLA-4 
The usage of VCAM-1 and VLA-4 blocking antibodies during co-cultivation resulted in 
a significant reduction of MSC integration into HUVEC monolayers compared to 
control experiments. Combined blockade did not lead to a further decrease in MSC 
integration.  
* significant difference compared to control (p < 0.05).  
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Figure 19: Transmigration triggers clustering of β1 integrins 
Co-cultivated MSC on a MACS monolayer (EC) exhibited clusters of β1 integrins after 
30 and 60 minutes which were not visible in MSCs cultivated without endothelial cells. 
MSCs: CellTracker Red, MACS: CellTracker Green, β1 integrin: Cy5 (white). Scale 
bar: 10 µm 
 
3.5 MSCs secrete active MMPs at sites of invasion 
ELISA for active gelatinases MMP-2 and MMP-9 using culture supernatant of MSCs 
revealed that in vitro MSCs secreted a high amount of active MMP-2 between 24 and 
96 hours and that this secretion could be increased by pre-coating the culture dishes 
with gelatine (Figure 20; MMP-2 concentration after 96 hours: with gelatine 119.09 
ng/ml·mg; without gelatine 83.59 ng/ml·mg). No detectable amount of active MMP-9 
was secreted.  
To define sites of gelatinase activity, in situ zymographies were performed on 
sections of mouse hearts that had been previously perfused with MSCs using a 
fluorescein-conjugated gelatine as substrate (Figure 21). This was combined with 
red-fluorescent labeling (PKH26) of MSCs to identify sites of MSC invasion. High 
gelatinase activity was restricted to heart vessels that contained invading MSCs (left 
panel). As a control cleavage of fluorescein-conjugated gelatine was prevented by 
the general MMP inhibitor 1,10-phenanthroline (right panel).  
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Figure 20: MSCs secrete MMP-2 
ELISA with culture supernatants of MSCs grown in the presence or absence of 
gelatine pre-coating of culture dishes demonstrated that MSCs secreted active MMP-
2, which was increased by gelatine coating of the culture dishes. 
 
 
Figure 21: Active gelatinases are secreted at sites of MSC invasion 
In situ zymography of murine cardiac tissue perfused with MSCs (PKH26, red) clearly 
showed the presence of active gelatinases (green fluorescence) which was restricted 
to sites of MSC invasion (left panel). 1,10-phenanthroline prevented gelatinase activity 
(right panel). DQ-gelantin was used as substrate. Scale bar: 10 µm. 
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3.6 Transmigration is dependent on the endothelial phenotype 
To evaluate differences in the interaction between MSCs and the endothelium which 
depend on the endothelial phenotype, co-cultivation experiments with different 
endothelial monolayers were carried out. Major discrepancies were detected in the 
time course of integration (see Figure 22a) and alteration of MSC morphology 
depending on the endothelial phenotype (see Figure 22b). After 15 minutes, already 
19 ± 4% of MSCs on HCAEC monolayer had completely integrated. In comparison, 
throughout the whole time-series, monolayers consisting of HUVEC enabled the most 
effective integration of MSCs (percentage of integrated MSCs in a HUVEC 
monolayer after 30 minutes: 59 ± 9%; 60 minutes: 93 ± 8%; 120 minutes: 96 ± 7%). 
The flattening of MSCs on HuAoEC monolayer was significantly slowed down 
compared to control experiments without endothelial monolayers (Figure 22a). In 
addition, morphological changes of MSCs quantified by the formation of plasmic 
podia (≥ 25 µm) were also dependent on the type of endothelial monolayer (Figure 
22b). Co-cultivation on HCAEC monolayers resulted in the highest percentage of 
MSCs with long plasmic podia. In general, co-culture with any endothelial monolayers 
significantly increased the formation of plasmic podia compared to control 
experiments without endothelial monolayers.  
 
3.7 Cytokines influence MSC transmigration 
To elucidate the potential influence of cytokines on MSC transmigration, co-
cultivation experiments in the presence of bFGF, VEGF, EPO and IL-6 were carried 
out. After 15 minutes all cytokines resulted in a significant increase of MSC 
integration compared to the control (Figure 23; 15 minutes: control: 5 ± 4%; bFGF: 16 
± 7%; VEGF: 23 ± 10%; EPO: 39 ± 9%; IL-6: 24 ± 14%). After 30 minutes, VEGF and 
EPO enhanced transmigration. After 60 minutes, only EPO showed any effect. After 
120 minutes, VEGF and IL-6 enhanced the transmigration of MSCs, although the 
effect of IL-6 was small. Surprisingly, bFGF significantly decreased the transmigration 
of MSCs at the time point of 60 minutes (control: 66 ± 6%; VEGF: 74 ± 7%; EPO: 79 
± 2%; IL-6: 65 ± 8%; bFGF: 51 ± 10%).  
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Figure 22: Differences in transmigration capacity depend on endothelial phenotype 
a) MSC integration into different endothelial monolayer. The percentage of flattened 
and integrated MSCs was quantified. HCAEC monolayers enabled the fastest 
integration of MSCs. However, throughout the whole time-series, HUVEC monolayers 
were the most effective. The flattening of MSCs on HuAoEC monolayers was 
significantly slowed down compared to control experiments without endothelial 
monolayers (MSC).  
b) Percentage of MSCs forming long plasmic podia (≥ 25 µm) on different endothelial 
monolayers. Co-cultivation on a HCAEC monolayer resulted in the highest amount of 
MSCs with long podia.  
* significant difference compared to control experiments without endothelial monolayer 
(p < 0.05).  
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Figure 23: Cytokines influence the transmigration of MSCs at early time points 
Influence of bFGF, VEGF, EPO and IL-6 on the integration of MSCs co-cultivated with 
MACS monolayer. After 15 minutes, all cytokines accelerated the integration of MSCs. 
VEGF significantly increased integration for up 120 minutes and EPO for up to 60 
minutes. However, bFGF did not affect the integration of MSCs.  
* significant difference compared to control (p < 0.05). 
 
3.8 Role of nitric oxide for the transmigration of MSCs 
To substantiate the role of nitric oxide synthase (NOS) and nitric oxide (NO) on the 
interaction of MSCs and endothelial cells, co-cultivations with the NO-donor DETA 
NONOate and the NOS-inhibitor L-NAME were conducted. Figure 24 summarizes the 
results of the co-cultures. DETA NONOate significantly increased the integration of 
MSCs into endothelial monolayers at the time points 15 and 30 minutes. Throughout 
the whole time series the addition of L-NAME slowed down the process of integration 
(Percentage of integrated MSCs after 15 minutes: control: 5 ± 3%; DETA NONOate: 
38 ± 10%; L-NAME: 0 ± 0%; after 30 minutes: control: 21 ± 6%; DETA NONOate: 59 
± 11%; L-NAME: 1 ± 2%; after 60 minutes: control: 65 ± 5%; DETA NONOate: 64 ± 
7%; L-NAME: 24 ± 9%).  
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Figure 24: Co-cultivation under the influence of NO-donor and NOS-inhibitor 
Influence of DETA NONOate and L-NAME on the integration of MSCs co-cultivated 
with a MACS monolayer. After 15 and 30 minutes, the NO-donor DETA NONOate 
accelerated the integration of MSCs. Throughout the whole time series the NO-
inhibitor L-NAME reduced the integration.  
* significant difference compared to control (p < 0.05). 
 
Changes of NO-release were investigated by measurements using the fluorescent 
NO-indicator DAF. Therefore, red-labeled MSCs (PKH26) were cultivated solitarily or 
co-cultivated with MACS endothelial cells. NO-release was measured in MSCs 
cultivated solitarily, in MSCs which were in contact with endothelial cells, in 
endothelial cells cultivated solitarily and in endothelial cells which were in contact with 
MSCs. Experiments with the NO-inhibitor L-NAME served as controls. Figure 25 
summarizes the results and Figure 26 shows representative pictures of the DAF-
measurements. On the one hand, MSCs in contact with endothelial cells produced a 
significantly higher amount of NO as compared to MSCs cultivated solitarily. On the 
other hand, the NO-release of endothelial cells was not affected by co-cultivation with 
MSCs. In general, the NO-release of endothelial cells was higher than the NO-
production of MSCs.  
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Figure 25: Changes in intracellular NO-levels caused by the co-culture of MSCs 
and endothelial cells 
MSCs and endothelial cells (EC) were either cultured solitarily or in co-culture. The 
relative intensity of green fluorescence of intracellular DAF was measured over time. 
Experiments in the presence of L-NAME served as negative controls.  
a) The relative intensity of DAF signal revealed a significant increase of the NO-
release when MSCs were in contact with ECs as compared to experiments without 
ECs.  
MSCs (▲), MSCs in contact with ECs (■), MSCs + L-NAME (□).  
b) No significant difference in the NO-levels of ECs was measured when cells were in 
contact to MSCs or cultured solitarily.  
ECs (▲), ECs in contact with MSCs (■), ECs + L-NAME (□).  
* significant difference (p < 0.05), n. s.: no significant difference.  
Results 
 
63 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Representative pictures of DAF measurements 
a) Pictures of red-labeled MSCs (PKH26) in contact with endothelial cells. High levels 
of NO-production indicated by green DAF signals were observed over time in MSCs 
contacting endothelial cells.  
b) Pictures of red-labeled MSCs (PKH26) cultivated solitarily. The intensity of green 
DAF signal was significantly lower.  
Magnification: 63x.  
 
3.9 Influence of reactive oxygen species on transmigration of MSCs 
To evaluate the role of reactive oxygen species (ROS) on the interaction of MSCs 
and endothelial cells, co-cultivations in presence of H2O2 and the ROS-scavenger N-
acetylcysteine were conducted. Figure 27 summarizes the results of the co-cultures. 
Exposure to H2O2 tended to result in a decrease of integration whereas N-
acetylcysteine tended to increase the integration of MSCs into endothelial monolayer 
(Percentage of integrated MSCs after 60 minutes: control: 60 ± 16%; H2O2: 41 ± 2%; 
N-acetylcyteine: 85 ± 10%).  
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500 sec 900 sec
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Figure 27: Co-cultivation under the influence of H2O2 and a radical scavenger 
Influence of H2O2 and N-acetylcysteine on the integration of MSCs co-cultivated with 
MACS endothelial monolayer. After 15, 60, 120 and 240 minutes H2O2 reduced the 
integration of MSCs. N-acetylcysteine accelerated the integration after 60 and 180 
minutes.  
* significant difference compared to control (p < 0.05). 
 
Changes of ROS-release, such as peroxynitrite, were investigated by measuring 
fluorescence of the ROS-indicator APF. Therefore, red-labeled MSCs (PKH26) were 
cultivated solitarily or co-cultivated with endothelial cells. ROS-release was measured 
in MSCs cultivated solitarily, in MSCs which were in contact with endothelial cells, in 
endothelial cells cultivated solitarily and in endothelial cells which were in contact with 
MSCs. Experiments with the ROS-scavenger N-acetylcysteine served as controls. 
Figure 28 summarizes the results and Figure 29 shows representative pictures of the 
APF-measurements. After a delay of 50 seconds, MSCs in contact with endothelial 
cells produced a significantly higher amount of ROS as compared to MSCs cultivated 
solitarily. The ROS-release of endothelial cells was also increased by co-cultivation 
with MSCs. In general, the production of ROS in MSCs was up to 4-times greater 
than in endothelial cells.  
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Figure 28: Changes in intracellular ROS-levels caused by co-culture of MSCs and 
endothelial cells 
MSCs and endothelial cells (EC) were either cultured solitarily or in co-culture. The 
relative intensity of fluorescence of intracellular APF was measured over time. 
Experiments in the presence of N-acetylcysteine (N-Ac) served as negative controls.  
a) The relative intensity of APF signal revealed a significant increase of ROS-release 
after a delay of 50 seconds when MSCs were in contact with ECs as compared to 
experiments without ECs.  
MSCs (▲), MSCs in contact with ECs (■), MSCs + N-Ac (□).  
b) A significant difference in ROS-levels of ECs was measured when cells were in 
contact to MSCs compared to ECs cultured solitarily. Note that ECs produce less 
ROS than MSCs.  
ECs (▲), ECs in contact with MSCs (■), ECs + N-Ac (□).  
* significant difference (p < 0.05), n. s.: no significant difference. 
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Figure 29: Representative pictures of APF measurements 
a) Pictures of red-labeled MSCs (PKH26) in contact with endothelial cells (EC, arrow). 
A fast increase in ROS levels indicated by green APF signal was observed.  
b) Pictures of red-labeled MSCs (PKH26) cultivated solitarily. The intensity of green 
APF signal was significantly lower.  
Magnification: 63x.  
 
3.10 Influence of adenoviral infection on the transmigration of MSCs 
To study whether CXCR4 overexpression influences the transmigratory activity of 
MSCs an adenoviral gene transfer using the Ad.CXCR4.GFP adenovirus was 
performed. 
 
3.10.1 Efficiency of MSC infection 
To evaluate the efficacy of adenoviral infection on MSCs, MSCs were assessed by 
fluorescence microscopy 48 hours after infection. Figure 30 illustrates that with 
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increasing concentrations (MOI) of Ad.CXCR4.GFP significantly more infected MSCs 
were detected as indicated by their green fluorescence (Percentage of infected 
MSCs: MOI 0: 0%; MOI 20: 9 ± 3%; MOI 40: 27 ± 1%; MOI 60: 40 ± 1%; MOI 80: 55 
± 8%). Western blot analysis revealed that the expression of the CXCR4-protein was 
increased in a virus-concentration dependent manner.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Efficiency of adenoviral infection of MSCs 
a) Adenoviral infection significantly increased the expression of CXCR4 on MSCs. 
GFP and DAPI fluorescence was visualized by fluorescence microscopy. The co-
expression of GFP demonstrated visually that CXCR4 gene was expressed in the 
cells. Use of variable virus doses revealed significant increase in CXCR4-expressing 
MSCs with increased MOI. Magnification: 63x.  
[continued on next page] 
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Legend to Figure 30, continued: 
b) The percentage of infected MSCs was determined as the number of GFP positive 
cells against the total number of cells counted by DAPI staining. The graph 
summarizes that there was a significant increase in CXCR4-infected MSCs even at 
the lowest MOI.  
* significant difference compared to MOI 0 (p < 0.05)  
c) Protein expression of CXCR4 in MSCs after adenoviral gene transfer with 
Ad.CXCR4.GFP demonstrated by western immunoblot analysis. Expression of 
CXCR4 in uninfected MSCs (control) versus MSCs infected with increasing virus 
doses (MOI 40, 60 and 80). The characteristic CXCR4 band of 45 kDa showed 
increasing intensities. The density of actin band (42 kDa) served as internal standard.  
 
3.10.2 Decrease of migratory and transmigratory activity of MSCs by CXCR4-
infection 
The migratory activity of Ad.CXCR4.GFP infected MSCs was assessed in a migration 
Boyden Chamber assay in the presence of SDF-1β. Figure 31 summarizes the 
results. Interestingly, infection with Ad.CXCR4.GFP significantly decreased the 
migratory activity compared to control experiments using GFP-infected MSCs 
(number of migrated cells: CXCR4: 156.7 ± 25.6; GFP: 344.5 ± 92.0). SDF-1β 
significantly increased migration of GFP-MSCs (273.0 ± 71.0), but not of CXCR4-
infected MSCs (204.3 ± 13.7). 
 
 
 
 
 
 
 
 
 
 
Figure 31: Migratory activity of infected MSCs in the Boyden Chamber 
The number of migrated MSCs infected with Ad.CXCR4.GFP and as a control with 
Ad.GFP under the influence of SDF-1β. Infection with Ad.CXCR4.GFP significantly 
decreased the migratory activity compared to control experiments using GFP-infected 
MSCs. [continued on next page] 
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Legend to Figure 31, continued: 
SDF-1β significantly increased migration of GFP-MSCs, but not of CXCR4-infected 
MSCs.  
* significant difference (p < 0.05), n. s.: no significant difference.  
 
To rule out the effect of CXCR4-overexpression on the transmigratory activity of 
MSCs isolated mouse heart perfusions were performed in the presence or absence 
of SDF-1β. Figure 32 illustrates that the rate of transmigration of MSCs infected with 
Ad.CXCR4.GFP was not increased by the addition of SDF-1β (Percentage of 
transmigrating MSCs: CXCR4: 33 ± 9%; CXCR4 + SDF-1β: 43 ± 4%; p>0.05). Also, 
the transmigratory activity of MSCs infected with the control adenovirus Ad.GFP was 
not significantly influenced by the addition of SDF-1β, but there was a higher 
tendency of enhancement (GFP: 31 ± 11%; GFP + SDF-1β: 47 ± 14%; p>0.05). 
Under standard conditions infection of MSCs either with Ad.GFP or with 
Ad.CXCR4.GFP did not significantly change the rate of transmigration as compared 
to uninfected wild-type MSCs (38 ± 11%).  
 
 
 
 
 
 
 
 
 
 
Figure 32: Transmigration of infected MSCs in isolated mouse heart perfusions 
Transmigration of infected MSCs with Ad.CXCR4.GFP and as a control with Ad.GFP 
under the influence of SDF-1β. Perfusion of isolated mouse hearts in the presence of 
SDF-1β did not increase the transmigration of GFP-infected nor of CXCR4-infected 
MSCs.  
n. s.: no significant difference.  
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3.11 Manipulation of MSC transmigration and attraction via focussed 
ultrasound-mediated microbubble stimulation (UMS) 
To evaluate the impact of focussed ultrasound-mediated microbubble oscillation and 
destruction on the transmigratory activity of MSCs a series of in vivo experiments 
were conducted.  
 
3.11.1 Placement of catheter 
To characterize cell interactions with myocardial endothelium fluorescently labeled 
MSCs were transplanted into native and ischemic rat hearts via percutaneous 
delivery using an aortic root catheter. For optimal cell delivery into the left-ventricular 
myocardium the catheter tip was placed with ultrasound-guidance into the aortic root. 
Before cell transfusion the functionality of the catheter concerning coronary and 
microcirculatory delivery was confirmed with contrast echocardiography (see Figure 
33). 
 
3.11.2 Efficiency of focussed UMS 
The efficiency of focussed ultrasound-mediated microbubble stimulation (UMS) was 
tested via ultrasound imaging. Figure 34 shows representative m-mode images which 
revealed complete left-ventricular contrast destruction and consecutive replenishment 
of contrast microbubbles.  
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Figure 33: Percutaneous myocardial delivery via aortic root catheter 
a) Scheme of echocardiographic parasternal long-axis view. AW - anterior wall, PW - 
posterior wall, Ap - apex, LV - left-ventricular cavity, * - catheter tip. For ultrasound-
picture of the framed area see b).  
b) For in vivo experiments the catheter tip (*) was placed with ultrasound-guidance 
into the aortic root.  
c) Before cell transfusion the functionality of the catheter concerning coronary and 
microcirculatory delivery was confirmed with contrast echocardiography. 
Representative parasternal long axis view before (left panel) and after (right panel) 
application of a SonoVue-microbolus revealed good opacification of the left-ventricular 
myocardium.  
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Figure 34: Focussed ultrasound-mediated microbubble stimulation (UMS) 
a) and b) Target tissue was visualized in m- (right panel) and b-mode (left panel) 
before (a) and during (b) i.v. contrast enhancement. UMS-pulses were applied at 
contrast-opacified myocardium. 
c) Arrows indicate UMS-induced sound-interference during high-resolution imaging, 
complete left-ventricular contrast destruction and consecutive replenishment of 
contrast microbubbles could be obtained during m-mode imaging. 
 
3.11.3 Impact of UMS on MSC cell attraction 
To evaluate the effect of UMS on the attraction of MSCs to myocardium the total 
number of MSCs per heart slide was quantified. Non-ischemic, native myocardium 
revealed the lowest cell infiltration (3.0 ± 1.1 MSCs/slide). UMS nearly doubled the 
total MSC cell count in non-ischemic myocardium (5.4 ± 2.2 MSCs/slide).  
Moreover, regional analysis of the anterior wall in non-ischemic myocardium revealed 
an increase of MSC cell count in the anterior wall (focus of UMS) after UMS as 
compared to non-insonicated hearts reaching the level of significance (4.0 ± 1.2 vs. 
2.2 ± 0.6 MSCs/slide, p<0.05). MSC cell count within the anteroseptal myocardial 
borderzone was significantly higher after myocardial ischemia as compared to non-
ischemic myocardium (9.5 ± 3.7 MSCs/slide, p<0.05). Similar to native myocardium 
UMS induced a significant increase of MSC infiltration in the anteroseptal myocardial 
borderzone (focus of UMS) in ischemic tissue (13.1 ± 4.6 MSCs/slide, p<0.05). 
Furthermore, the anteroseptal myocardial borderzone (focus of UMS) revealed 
significantly higher absolute MSC count as compared to the posterolateral 
borderzone of insonicated rat hearts. Figure 35 and Figure 36 summarize the results. 
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For approximation of myocardial transplantation efficacy the absolute MSC amount 
per rat heart can be estimated as follows: the average length of a rat’s left ventricle is 
12 mm, in conclusion approximately 480-times wider than an average MSC 
(approximately 25 µm). To calculate correct volumetric measurements the area-
length method is validated for estimation of left-ventricular volumes (Ghanem et al., 
2006). Therefore, multiplication of area and length of the cylindrical shape of the left 
ventricle needs to be multiplied by 5/6. For example, 9.5±3.7 MSCs were counted per 
representative slide in ischemic, non-insonicated myocardium (group C), resulting in 
approximately 5/6 * 9.5 * 480 = 3.800 MSCs counted per left-ventricle normalized to 
100.000 transplanted MSCs. The corresponding results for the other groups are: for 
non-ischemic, non-insonicated myocardium (group A) 880 MSCs, for non-ischemic, 
insonicated myocardium (group B) 1.600 MSCs and for ischemic, insonicated 
myocardium (group D) 5.240 MSCs.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: Focussed UMS enhanced cell attraction 
The graph summarizes the regional (anterior wall) analyses of MSC cell counts per 
heart slide. Compared to native tissue, baseline cell attraction was higher in the 
anteroseptal myocardial borderzone of ischemic myocardium. Myocardial MSC count 
of the target tissue was significantly increased after UMS in non-ischemic and 
ischemic myocardium (I/R). Significant differences: * p < 0.05, ** p < 0.01, *** p < 
0.001 
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Figure 36: UMS preconditioning increased MSC cell attraction 
Representative collages of high-resolution fluorescence micrographs demonstrated 
significantly higher myocardial MSC count in the anterior wall after preconditioning 
with UMS (upper panel) in comparison to control tissue without UMS (lower panel). 
Arrows highlight green labeled MSCs. Original magnification: 20x. Scale bar: 100 µm 
 
3.11.4 Transmigration 
As second part of the engraftment cascade transendothelial migration was quantified 
in vivo in native as well as in ischemic rat hearts with and without UMS insonication. 
Initial results revealed endothelial adhesion of MSCs, but no signs of transmigration 
after 30 and 60 minutes (0% each). Therefore, the perfusion time was extended to 
120 minutes. Figure 37 illustrates that after 120 minutes transendothelial migration of 
MSCs was significantly enhanced by UMS in native and ischemic myocardium. 41 ± 
3% of the MSCs demonstrated migration across the endothelial barrier of native 
myocardium. Ischemic myocardium revealed a significantly higher level of 
transendothelial migration (53 ± 6%, p<0.01). The rate of transmigrating MSCs was 
facilitated significantly after focussed preconditioning with UMS in non-ischemic 
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myocardium (50 ± 6%, p<0.05). UMS revealed significant enhancement of 
transmigration of MSCs in ischemic myocardium as well (64 ± 9%, p<0.01; see 
Figure 37). 
 
 
 
 
 
 
 
 
 
 
 
Figure 37: Focussed UMS enhanced transendothelial migration 
The graph summarizes the percentage of transmigrated MSCs after 120 minutes. 
Transmigration of MSCs was significantly enhanced by UMS in native as well as in 
ischemic myocardium (I/R). Significant differences: * p < 0.05, ** p < 0.01 
 
3.11.5 Influence of UMS on endothelial structure, basal lamina, cytokines and 
apoptosis 
The impact of UMS on the basement membrane was further assessed, due to the 
fact that its invasion represents the final step of cell engraftment. Laminin distribution 
demonstrated an inhomogeneous pattern in insonicated myocardium (see Figure 
38b). Moreover, the total content of laminin in non-ischemic myocardium receiving 
UMS was decreased in immunofluorescent stainings. This finding was confirmed by 
western blot (Figure 38c). Here, tissue lysates of anterior walls after UMS treatment 
contained less immunoreactive laminin than untreated probes. However, myocardial 
endothelium of insonicated regions remained intact. Interestingly, in some cases its 
surface looked increased in fluorescence microscopy (see Figure 39b). 
Ultrastructural analysis, however, revealed no alteration of endothelial cell-to-cell 
contacts and no destruction with respect to the basement membrane (see Figure 
39c-k).  
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Figure 38: Alteration of the basal lamina 
a) and b) Confocal images of immunohistochemical laminin staining revealed 
inhomogeneous distribution pattern and absolute reduction of the basal lamina 2 
hours after UMS (b) compared to untreated controls (a). Note the undamaged 
endothelium. Green: myocardial autofluorescence, Red: endothelium (Rhodamine-
Griffonia simplicifolia Lectin I), White: laminin (Cy5). Scale bar: 10 µm  
[continued on next page] 
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d)                                               g)             j)
e)                                               h) k)
c)  f)                                 i)
a) b)
Legend to Figure 38, continued: 
c) Protein expression of laminin in anterior and posterior walls of untreated or UMS 
treated hearts demonstrated by western immunoblot analysis. After application of 
UMS to anteroseptal myocardium myocardial laminin content (shown is the 
characteristic laminin band of 200 kDa) was decreased. The density of the actin band 
(42 kDa) served as internal standard. Densitometric ratios of laminin/actin values 
validated the reduction of laminin content in the anterior wall induced by UMS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: Morphology of the myocardial endothelium 
a) Fluorescence microscopy of myocardial endothelium not pre-exposed to 
ultrasound-mediated destruction of microbubbles (UMS). Note the smooth and even 
surface of the endothelial wall.  
b) After UMS the endothelium appeared more rough (bubbly, distended, swollen, 
bloated) and increased in its surface (arrow), but showed no signs of damage in its 
integrity. [continued on next page] 
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Legend to Figure 39, continued: 
Red: endothelium Rhodamine-Griffonia Simplicifolia Lectin I. Bar: 10 µm.  
c)-k) Electron micrographs of myocardium of the anterior left-ventricular wall treated 
with focussed ultrasound-mediated microbubble stimulation (UMS) (c,f,i) and 
untreated myocardium from posterior ventricular wall of the same heart (d,g,j) as well 
as from an untreated control heart (e,h,k). Hearts were harvested 2 hours after UMS 
application. Physiological vessel shape and structural integrity were obtained in 
treated (c) and untreated myocardium (d,e). No endothelial damage was visible at 
higher magnification; cell-cell-contacts (arrows) looked unchanged. Moreover, the 
morphological integrity of the basement membrane (arrowheads) remained intact after 
UMS.  
Scale bars: c-e: 2 µm; f-h: 250 nm; i-k: 100 nm.  
 
Moreover, regional cytokine array analyses revealed a significant gradient of several 
cytokine levels between anterior myocardial tissue after focussed insonication in non-
ischemic myocardium as compared to non-insonicated myocardial tissue. The 
amount of IL-1α in the anterior wall standardized on the amount in the posterior wall 
increased 2.2-fold after UMS compared to untreated tissue. In addition, the amount of 
IL-1β increased 3.8-fold, TNF-α 1.6-fold and GM-CSF 1.7-fold. IL-4, IL-6 and IL-10 
were not detected in non-insonicated tissue, while insonicated myocardium contained 
these cytokines.  
Eosinophily of cardiomyocytes, capillary rupture and erythrocyte extravasation could 
not be observed histologically as signs of UMS-induced mechanical bioeffects. 
Increased rate of apoptotic cardiomyocytes and myocardial endothelium could be 
ruled out with TUNEL assays. No increase in TUNEL+ cells was detected within 
regions of the myocardium pre-treated with UMS as compared to control myocardium 
and tissue outside the UMS focus (see Figure 40).  
Results 
 
79 
- UMS + UMS
Negative control Positive control
 
Figure 40: TUNEL assay of myocardium under the influence of UMS 
No increase in TUNEL+ cells (pink staining) was detected within regions of the 
myocardium pre-treated with UMS as compared to control myocardium and tissue 
outside the UMS focus. Negative controls were incubated in the absence of terminal 
desoxynucleotidyl-transferase. Positive controls were treated with DNAse. 
Magnification 20x.  
 
Additionally, after UMS – focussed on anteroseptal myocardium – gelatinase activity 
was regionally increased in vessels within the anteroseptal, but not in vessels within 
the posterolateral myocardium (see Figure 41).  
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Figure 41: Induction of gelatinase activity by UMS 
In situ zymography of non-ischemic murine cardiac tissue clearly showed the 
presence of active gelatinases (green fluorescence) in vessels within the anteroseptal 
wall after focussed UMS insonication. No gelatinase activity was detected in the 
untreated posterior myocardium. In control experiments 1,10-phenanthroline (inhibitor) 
prevented gelatinase activity. Small pictures illustrate one vessel at higher 
magnification.  
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4. Discussion 
The use of mesenchymal stem cells (MSCs) for cellular replacement therapy has 
emerged as a novel strategy for the treatment of a variety of diseases. The systemic 
delivery by intravenous or intracoronary injection facilitates a minimal-invasive 
administration of MSCs. However, the prerequisite for a successful systemic stem 
cell therapy is that MSCs exit the blood circulation and home into the target tissue. 
This vascular recruitment of MSCs comprises (1) the cell attraction, (2) the rolling of 
MSCs along the endothelium, (3) the firm adhesion, (4) the transmigration of MSCs 
across the endothelial barrier and finally (5) their invasion into the target tissue. To 
date, the mechanisms underlying the two final steps – transmigration and invasion – 
of the homing of MSCs from the vasculature to the desired tissue are poorly 
understood. However, elevating our knowledge on these core processes might help 
to optimize stem cell based therapies. Therefore, the first part of the present study 
focussed on characterizing some of the key mechanisms involved in transmigration 
and invasion of MSCs. The second part of the study investigated two possible 
options for enhancing the efficiency of MSC-based therapy. First, the genetic 
manipulation of MSCs by infection with a CXCR4 overexpressing adenovirus and 
second, the selected pretreatment of endothelium by a novel technique using 
ultrasound-mediated microbubble stimulation.  
 
4.1 Characterization of MSCs 
Prior to the experiments MSCs were routinely subjected to defined quality controls. 
By microscopic assessments cultured MSCs appeared fibroblastic-like and 
homogenous in size and morphology by the second passage. It was, however, 
important to prove with different approaches that the plastic-adherent expanded 
human cells possessed the described characteristics of MSCs. Therefore, flow 
cytometry, colony-forming unit assays as well as three differentiation assays were 
performed.  
Flow cytometry was used to determine the surface molecules in the expanded cell 
population. Hematopoietic cells were discriminated by at least one of the following 
markers: CD14 (expressed on monocytes and macrophages), CD34 (expressed on 
hematopoietic progenitor cells) or CD45 (leukocyte-common antigen). The most 
frequently used set of markers to detect MSCs are SH2 and SH3 (Pittenger et al., 
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1999). Theses antibodies recognize CD105 (endoglin) (Barry et al., 1999) and CD73 
(ecto-5´-nucleotidase) (Klinz et al., 2005). Both antigens are constitutively expressed 
on MSCs, but also on endothelial cells (Gougos et al., 1988; Airas et al., 1995). In 
light of this fact, for the present study a combination of CD105 and CD106 (VCAM-1) 
was preferred as markers (Klinz et al., 2005; Schmidt et al., 2006a; Schmidt et al., 
2006b). CD106 is constitutively expressed on MSCs (Pittenger et al., 1999), whereas 
endothelial cells are negative for CD106 and only become positive by cytokine 
induction during inflammation (Osborn et al., 1989).  
For example a representative flow cytometric analysis demonstrated that in the 
second passage 64.5% of all cells were double positive for CD105 and CD106 and 
additionally triple negative for CD14, CD34 and CD45 (section 3.1). This indicated 
that most of the cultured cells expressed surface markers of mesenchymal lineages, 
but not the selected hematopoietic markers and therefore could be referred to as 
MSCs. However, in the above example about one third of the cultivated cells did not 
comprise the predicted surface characteristics. One possible reason is a 
contamination of the culture with hematopoietic cells. Although, the ability of MSCs to 
adhere to plastic surfaces is an accepted defining feature of these cells (Docheva et 
al., 2007), it should be kept in mind that pre-B-cell progenitor cells and 
granulocytic/monocytic precursor cells also show plastic adherence (Phinney et al., 
1999). Furthermore, MSCs do not possess a unique marker that can be reliably used 
for their identification (Docheva et al., 2007). Also, controversy about the surface 
characteristics of MSCs still exists (Docheva et al., 2007). Therefore, one cannot 
strictly exclude that in the above example the remaining percentage (35.5%) of the 
cultured cells still represented MSCs even though they expressed a different set of 
surface markers. These remaining cells might form a stem cell subpopulation which 
does not comprise the whole predicted surface characteristics of MSCs. Therefore, 
multiple research groups refer their expanded cells to as bone marrow mononuclear 
stem cells (Strauer et al., 2001; Strauer et al., 2002; Perin et al., 2003; Tse et al., 
2003a; Imada et al., 2005; Li et al., 2005a; Sasaki et al., 2006; Kaminski et al., 2007). 
However, all of the cells which were microscopically evaluated in the present study 
held the typical MSC morphology and size and could therefore reliably be termed 
MSCs. Furthermore, the observed amount of MSCs in culture was comparable to 
results of previous flow cytometric reports (Pittenger et al., 1999; Klinz et al., 2005; 
Schmidt et al., 2006a; Schmidt et al., 2006b). 
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Although, most of the isolated MSCs expressed characteristic surface markers and 
showed fibroblastic morphology the functionality of the stem cells needed to be 
confirmed. Therefore, the abilities of the MSCs to produce daughter cells as well as 
to differentiate into multiple phenotypes had to be assayed (Pittenger and Martin, 
2004). First, to evaluate their expansion capacity, colony-forming unit assays were 
performed. Here, single cells continued to divide and thereby formed clonal cell 
colonies which determined the proliferation potential of the MSCs. However, 
differences in the expansion potential of MSCs derived from different donors existed. 
With increasing age the growth capacity of MSCs seemed to decrease. This is 
consistent with the findings of other research groups. For example, Majors et al. 
demonstrated that although MSCs are present throughout lifetime, their total number 
is inversely correlated to the age of the donor and depends upon the site of 
extraction and the systemic disease state of the patient (Majors et al., 1997).  
Second, the multi-lineage differentiation potential of isolated and cultured MSCs was 
assayed by culturing the cells under conditions favourable for adipogenic, osteogenic 
and chondrogenic differentiation. In vitro adipogenic induction of MSCs required 
specific supplementations, including dexamethasone and indomethacin (Tuan et al., 
2002). Indomethacin, a non-steroidal anti-inflammatory drug, binds to and activates 
the transcription factor peroxisome proliferator-activated receptor gamma (PPAR-γ), 
which is crucial for adipogenesis (Lehmann et al., 1997). During osteogenesis 
treatment with the synthetic glucocorticoid dexamethasone stimulated the 
proliferation of MSCs and supported their osteogenic lineage differentiation (Liu et 
al., 2002). Organic phosphates, such as β-glycerophosphate, also supported 
osteogenesis by playing a role in the mineralization and modulation of osteoblast 
activities (Chung et al., 1992). The induction of chondrogenesis in MSCs depends on 
the coordinated activities of many parameters, including the cell density and various 
growth factors (Tuan et al., 2002). Therefore, culture conditions conductive for 
chondrogenic induction of MSCs required high-density pelleting of the cells and 
growth in serum-free medium containing regulatory factors such as TGF-β which 
increased the amount of matrix proteoglycan produced (Sekiya et al., 2001; Tuan et 
al., 2002). In the present study, the three differentiation assays revealed that the 
cultured MSCs easily differentiated into adipocytes, osteocytes and chondrocytes, 
which served as representative mesenchymal cell lineages.  
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Of particular importance for the growth and differentiation potential of MSCs was the 
lot of fetal calf serum (FCS) selected for the MSC growth medium (Martin et al., 
1997). It became obvious that different charges of FCS had a strong impact on MSCs 
in culture. Alas, since the growth requirements of MSCs are not fully understood, a 
serum-free medium with defined growth factor composition has not been developed 
yet (Pittenger and Martin, 2004).  
To summarize, the isolation technique used for the present study resulted in a 
population of MSCs with required surface characteristics, high expansion as well as 
differentiation potential. These reproducible characteristics which are obtained in 
many different research laboratories qualify MSCs as good candidates for a 
therapeutic usage (Pittenger and Martin, 2004).  
 
4.2 Discussion of the morphological aspects and time course of MSC 
transmigration 
The endothelium forms the main barrier for the passage of macromolecules and cells 
from the blood to the surrounding tissues. A prerequisite for a successful systemic 
therapeutic usage of MSCs is that the cells exit the blood circulation via 
transmigration across the endothelium and subsequently invade their target tissue. 
To understand the underlying mechanisms and to describe the morphology of 
transmigration and invasion in detail co-culture experiments, three different three-
dimensional model systems as well as in vivo experiments were established.  
 
4.2.1 Co-culture experiments 
The co-culture experiments demonstrated that MSCs quickly flattened and integrated 
into a confluent endothelial monolayer. The integration was accompanied by 
morphological changes of the MSCs, especially the formation of long plasmic podia. 
Endothelial cells even started to grow on top of the MSCs to seal their confluent 
monolayer (see Figure 11).  
In a previous work of our laboratory, different staining methods were used for the co-
culture experiments of MSCs and endothelial cells (Schmidt et al., 2006b). Here, 
MSCs were stained using PKH67 whereas endothelial cells either remained 
unstained or were stained via immunohistochemical detection of platelet-endothelial 
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cell adhesion molecule (PECAM)-1. On the one hand, working with unstained 
endothelial monolayer did not allow an analysis of the status of MSC integration. On 
the other hand, the staining of endothelial cells by the antibody PECAM-1 prior to co-
cultivation may have affected the natural interaction of surface molecules. Thus, for 
the present study another technique for visualizing MSCs and endothelial cells was 
established. Staining the cells with CellTracker Green and Red respectively fulfilled 
all requirements (section 2.3.2). The CellTracker staining technique was easy to 
handle and facilitated a more stable and durable staining of the cells; PKH67 was 
emitted into the media and the surrounding cells at the latest after three hours in co-
cultivation experiments. Furthermore, as described by the manufacturer PKH67 
anchors into the cell membrane thereby causing a dotted staining. In contrast, by 
using the CellTracker labeling the cell margins and even very thin plasmic podia were 
clearly definable. As described by the manufacturer CellTracker reagents are 
fluorescent chloromethyl derivatives which freely diffuse through the membranes of 
living cells. Once inside the cell, these mildly thiol-reactive probes undergo a 
glutathione S-transferase-mediated reaction to produce membrane impermeable 
glutathione-fluorescent dye adducts. Moreover, the peptide-fluorescent dye adducts 
contain amino groups and can therefore be covalently linked to surrounding 
biomolecules by fixation. This property permitted long-term storage of the labeled co-
cultures.  
Numerous studies have used co-cultivation experiments to investigate the interaction 
of two cell types (Pawlowski et al., 1988; Maschio et al., 1996; Alter et al., 2003; 
Schmidt et al., 2006b; Bauer et al., 2007). Advantages of co-cultivation experiments 
are that they are feasible to handle, easy to reproduce and that the experiments can 
be accomplished in large numbers. Therefore, in the present study co-culture 
experiments allowed to examine the effects of different conditions or substances on 
the interaction of MSCs and endothelial cells. Nevertheless, a major limitation of co-
culture experiments is that MSCs and endothelial cell are more or less only able to 
interact with each other in a two-dimensional fashion, because MSCs are arrested by 
the coverslips underneath the endothelial monolayer. Thus, more complex model 
systems which mimicked the in vivo situation more closely than monolayer cultures 
were established to analyze the interaction of MSCs and endothelial cells three-
dimensionally.  
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4.2.2 Three-dimensional model systems 
First, to investigate the process of transmigration in a three-dimensional fashion, 
experiments with endothelial cell spheroids were designed. It is known that 
endothelial spheroids establish a two-compartment system consisting of a surface 
monolayer of differentiated endothelial cells and a center of unorganized cells (Korff 
and Augustin, 1998). The surface layer consists of a continuous monolayer with well-
differentiated cell-cell contacts (Korff and Augustin, 1998). The co-culture 
experiments of MSCs with endothelial spheroids demonstrated that MSC came into 
contact with the spheroids after two hours, but MSCs still remained in a spherical 
shape. After four hours MSCs invaded into the inner mass of the spheroids by the 
extension of plasmic podia. However, these experiments were conducted in the 
presence of carboxymethyl cellulose. The cellulose facilitated the preservation of the 
spheroids, but also could affect the transmigratory activity of the MSCs. Therefore, 
additional three-dimensional models were established.  
Second, to evaluate morphological aspects of the transendothelial migration of MSCs 
in the presence of extracellular matrix proteins, collagen invasion assays were 
performed. Collagen invasion assays are well established for the analysis of invasive 
tumor cells (Bauer et al., 2007). Moreover, growth of HUVECs on a collagen gel 
matrix is known to promote the development of intercellular junctions (Pawlowski et 
al., 1988), thus mimicking an intact endothelium. In our study, the collagen gel not 
only enabled the MSCs to integrate into the endothelial monolayer, but also to invade 
the matrix below the monolayer. Again after two hours, MSCs came into contact with 
the endothelial monolayer still retaining a spherical shape. Later, MSCs integrated 
into the monolayer, transmigrated and invaded the collagen gel. These processes 
were accompanied by the formation of plasmic podia. From ultrastructural analysis 
co-culture experiments of monocytes and endothelial monolayers on collagen gels it 
is known that monocytes first establish an extensive membrane contact with the 
surface of the endothelial cells (Pawlowski et al., 1988). Here, the penetration of the 
monolayer also begins with the insertion of a pseudopod between two endothelial 
cells (Pawlowski et al., 1988). Therefore, monocyte and MSC transmigration appear 
to hold similar morphological characteristics.  
However, both model systems – co-cultivation experiments using endothelial 
spheroids as well as collagen invasion assays – did not reflect the complexity present 
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in a complete target organ. Therefore, ex vivo mouse heart perfusions were 
conducted to analyze the transmigration of MSCs in an isolated organ. The observed 
morphology of transmigrating MSCs was comparable to the other more simplified 
models. MSCs also penetrated the endothelial barrier via the insertion of plasmic 
podia. After 90 minutes of perfusion, more than one third of the MSCs started to 
transmigrate across the endothelium. However, no event of completed transmigration 
was noted. Thus, after 90 minutes parts of the cell bodies of the MSCs still resided 
inside the vessels, indicating that transmigration of MSCs is no rapid event. However, 
after longer perfusion times one would expect the MSCs to completely transmigrate. 
In contrast, for the transmigration of leukocytes it is known that this process can be 
accomplished within minutes (Marchesi et al., 1960).  
As already indicated by the two-dimensional co-culture experiments, the three 
different three-dimensional models revealed that the processes of penetration of the 
endothelial barrier and invasion of MSCs into the surrounding tissue were guided by 
the formation of plasmic podia. All model systems showed a time delay compared to 
the two-dimensional monolayer co-culture, emphasizing that the time course of 
interaction of MSCs and endothelial cells is depending on the complexity of the 
model system. In summary, microscopic assessment of different systems revealed 
that MSCs quickly came into contact with the endothelium, but still possessed a 
spherical shape. Subsequently, the MSCs penetrated the endothelial barrier and 
finally invaded the surrounding tissue. Transmigration and invasion of MSCs were 
accompanied by the insertion of plasmic podia. Recently, Ruster and co-workers 
characterized the rolling and adherence of MSCs on endothelial cells (Ruster et al., 
2006). They showed that both processes are accompanied by a rapid extension of 
plasmic podia. In accordance, the present study observed that the final step of 
penetrating the endothelial barrier was also guided by the insertion of plasmic podia. 
Furthermore, as it has been described for leukocytes (Wang et al., 2006), the results 
presented here imply that MSCs use endothelial tri- or bicellular corners to 
transmigrate across the endothelial barrier.  
 
4.2.3 Transmigration of MSCs in vivo 
The reports of successful clinical trials especially for the infarcted heart indicate the 
transmigratory activity of MSCs. As described in section 3.2.2.3 the process of 
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transmigration of MSCs could be monitored ex vivo by performing isolated mouse 
heart perfusions. Thus far, no direct in vivo evidence for the transmigration of MSCs 
in the heart existed. The present study validated that MSCs indeed transmigrate in 
vivo under physiological conditions. This transmigration phenomenon was observed 
in native as well as in infarcted myocardium and possessed the same morphological 
characteristics as described for the other model systems. However, in vivo 
experiments demonstrated a slower process of transmigration kinetics as compared 
to the ex vivo and in vitro situation. In vivo, after 60 minutes no signs of beginning 
transmigration were monitored. Therefore, for in vivo cardiomyoplasty the hearts 
were harvested after 120 minutes. The deceleration of the transmigration process 
may partly be attributed to the blood flow and blood pressure as well as to the 
complexity of emerging events in vivo. Additionally, the experiments demonstrated 
that the number and concentration of MSCs can play a major role in coronary cell 
delivery. Experiments using different numbers of MSCs revealed that application of 
500.000 MSCs into the aortic root – as used for ex vivo experiments – resulted in wall 
motion abnormalities and decrease in systolic function. These complications after the 
delivery of high MSC amounts were most likely due to ischemic events which could 
be explained best with intravascular cell aggregation and consecutive 
microembolisms. Therefore, the amount of MSCs applied during clinical trials should 
be evaluated carefully. For all in vivo cardiomyoplasty experiments of the present 
study the number of MSCs was reduced to 150.000. More results obtained under in 
vivo conditions will be discussed in section 4.9.  
 
4.3 Integrins and their role in transendothelial migration 
Integrins are known to play a key role in cell adhesion, migration and chemotaxis 
(Gao et al., 1997; Werr et al., 1998; Imhof et al., 2004). An individual integrin receptor 
consist of two non-covalently bound subunits – α and β. Therefore, integrins are 
categorized as heterodimeric receptors (Docheva et al., 2007). For example, the 
localization of leukocytes to extravascular sites of inflammation is accompanied by 
repeated adhesive and de-adhesive events along the endothelium (Lauffenburger et 
al., 1996). The surface molecules very late antigen-4 (VLA-4, α4β1 integrin) and its 
most important ligand vascular cell adhesion molecule-1 (VCAM-1) are involved in 
leukocyte transendothelial migration (Ridger et al., 2001). The VLA-4 antigen is 
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expressed by MSCs (Ip et al., 2007). Recently, Ruster et al. verified that human 
MSCs bind to endothelial cells in a P-selectin dependent manner and that rolling of 
MSCs engage VLA-4/VCAM-1 to mediate their firm adhesion on the endothelial cells 
(Ruster et al., 2006). In the present study, blocking experiments additionally identified 
VCAM-1 and VLA-4 as key receptors for the transendothelial migration of human 
MSCs (section 3.4). Taking these findings together MSCs not only require VCAM-1 
and VLA-4 to firmly adhere to the endothelium, but also to transmigrate across the 
barrier.  
Since the interaction of MSCs and endothelial cells was not completely blocked by 
anti-VCAM-1 and antibodies specific for the integrin α4-chain, it is possible that other 
integrin α-chains might be involved in the transmigration. Lately, it was confirmed that 
MSCs not only express integrin α4β1, but also other combinations of integrin 
subunits such as integrin α6β1, α8β1 and α9β1 (Ip et al., 2007). Future studies 
should focus on identifying which additional integrins facilitate the process of MSC 
transmigration.  
Moreover, immunohistochemistry confirmed that co-cultivation of MSCs with 
endothelial cells triggered a massive and distinct clustering of β1 integrins. Because 
integrins function as transmembrane linkers between the extracellular matrix and the 
actin cytoskeleton the integrin-mediated signaling regulates a variety of cellular 
events including migration and invasiveness (Ellerbroek et al., 1999). For example, 
aggregation of integrin receptors is sufficient to induce a prompt transmembrane 
accumulation of a large class of at least 20 signal transduction molecules, including 
c-Src, c-Fyn, RhoA, Racl, Ras, GAP, MEK1, ERK1, ERK2 and JNK1. Furthermore, 
integrin occupancy and aggregation are required for integrin-induced accumulation of 
the cytoskeletal components F-actin, paxillin and filamin (Miyamoto et al., 1995). In 
addition, aggregation of β1 integrins stimulates the activation of matrix 
metalloproteinase-2 (Ellerbroek et al., 1999). Results about the key role of matrix 
metalloproteinase-2 for the invasion of MSCs will be discussed in section 4.4. To 
further evaluate this aspect future studies should focus on downstream effects of β1 
integrin in the signal transduction and cytoskeleton organization of MSCs during 
transmigration. However, one could reasonably speculate that the massive clustering 
of β1 integrins in MSCs triggered by their co-cultivation with endothelial cells might 
effect the signal transduction and cytoskeleton organization of MSCs and thereby 
modulate their transmigratory activity.  
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Recent data suggested that MSCs may be mobilized from the bone marrow, migrate 
to the infarcted myocardium and differentiate into cardiac myocytes (Kawada et al., 
2004). Lately, it has been demonstrated that for intramyocardial trafficking of MSCs 
integrin β1 is crucial, but not integrin α4 (Ip et al., 2007). Ip and co-workers 
demonstrated that injection of MSCs pretreated with blocking antibodies against 
integrin β1 (CD29) into the ischemic myocardium of mice reduced the intramyocardial 
migration of stem cells in the ischemic myocardium by 45% compared with control 
experiments. When using blocking antibodies against CD49d (integrin α4) no 
significant difference in the quantity of MSCs in the infracted myocardium was 
observed. These data suggest a crucial role of CD29 (integrin β1) in stem cell cardiac 
trafficking (Ip et al., 2007). Consistent with these finding, a recent study showed that 
blockade of CD49d in endothelial progenitor cells did not affect their homing into 
ischemic sites in hearts or limbs (Qin et al., 2006). However, as demonstrated in the 
present study, for the vascular transmigration of MSCs integrin α4 does plays a key 
role, thus pointing out that intravascular migration and vascular transmigration are 
two distinct processes which have to be distinguished.  
 
4.4 Role of matrix metalloproteinases for the invasion of MSCs 
A successful and efficient invasion of MSCs into a target tissue not only requires their 
transmigration across the endothelial barrier, but also across the basement 
membrane. The basement membrane is the first barrier encountered by all 
emigrating cells subsequent to the penetration of the vascular endothelial monolayer 
(Agrawal et al., 2006). For transmigration of leukocytes it has been validated that 
integrin α4β1 on the surface of the leukocytes binds to VCAM-1 on the endothelial 
surface of inflamed vessels and subsequently induces matrix metalloproteinase 
(MMP)-2 expression in T cells (Graesser et al., 2000). This mechanism is proposed 
to facilitate the invasion of leukocytes into the subendothelial matrix. The gelatinases 
MMP-2 and MMP-9 were identified as the major proteases active at sites of leukocyte 
infiltration into the brain parenchyma (Agrawal et al., 2006).  
Results of the present study obtained by ELISA validated on protein level that MSCs 
secreted active MMP-2, but not MMP-9. Therefore, in contrast to infiltrating 
leukocytes (Agrawal et al., 2006) MSCs do not express MMP-9. Moreover, in the 
present study in situ zymography was used as technique to detect gelatinases in 
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tissue slides. Alternative methods such as immunohistochemistry and western blot do 
not provide information on the activity of proteases in the tissue because many of 
these enzymes are synthesized in an inactive or proenzyme form. Moreover, in situ 
zymography is a technique to specifically localize proteolytic activity in tissue sections 
(Yan et al., 2003). Here, active gelatinases were located in the heart at sites of 
transmigrating and invading MSCs. This indicated that during invasion into cardiac 
tissue, MSCs secrete active proteinases – for instance MMP-2 –, which might be 
crucial for penetrating the basement membrane and invading the surrounding 
extracellular matrix. Indeed, MMP-2 has the capacity to degrade for example 
collagen IV, laminin and gelatine, major constituents of the basement membrane (De 
Becker et al., 2007). 
In accordance, a recent study demonstrated in vitro that bone marrow and cord blood 
derived mesenchymal stem cells from early up to late passages express MMP-2 and 
membrane type 1 MMP (MT1-MMP) mRNA (Son et al., 2006). However, MMP-9 
mRNA was not detected. Ries and co-workers analyzed bone marrow-derived human 
MSCs and detected strong expression and synthesis of MMP-2 and MT1-MMP as 
well, and, additionally, that of tissue inhibitor of metalloproteinase 1 (TIMP-1) and 
TIMP-2 (Ries et al., 2007). The ability of MSCs to traverse reconstituted human 
basement membranes was effectively blocked in the presence of synthetic MMP 
inhibitors. RNA interference revealed that gene knock-down of MMP-2, MT1-MMP or 
TIMP-2 substantially impaired MSC invasion (Ries et al., 2007). Furthermore, De 
Becker et al. showed in invasion assays that MSCs have the potential to migrate 
through bone marrow endothelium and that this process involves MMP-2 (De Becker 
et al., 2007). By RT-PCR they demonstrated that MSCs express MMP-2 mRNA while 
no transcripts for MMP-9 were detected (De Becker et al., 2007). Neutralizing MMP-2 
with a blocking antibody or MMP-2 siRNA impaired the migration capacity of MSCs in 
vitro. A rewarding future task might be to discover whether MSC invasion into 
myocardium can be completely blocked by MMP inhibitors. One novel possibility to 
facilitate a regional activation of MMPs in the heart will be discussed in section 4.9.4.  
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4.5 Importance of the endothelial phenotype for transmigration 
The endothelium, once viewed as homogenous mass of passive cells, is now 
appreciated to possess regionally specific phenotypic responses (Isenberg et al., 
2005). Therefore, in various regions of the vascular tree, the endothelium is 
functionally different and its barrier function varies accordingly (Dejana et al., 1995). 
Recent advantages have been made in localizing specific endothelial cell 
subpopulations via surface expression mapping techniques (Demeule et al., 2004; 
Schluesener et al., 2004). Thus, different endothelial phenotypes hold functional 
differences (Dejana et al., 1995). For example, variances in the amount of 
intercellular tight junctions exist at different points along the vascular tree and cause 
differences in the endothelial permeability. Human brain-derived endothelial cells 
have reduced levels of adhesion molecules under basal culture conditions and 
therefore represent a less permissive barrier to cell migration than human umbilical 
vein endothelial cells (Wong et al., 1999). Furthermore, it has been reported that 
different phenotypes of endothelial cells produce different amounts of nitric oxide 
(Altland et al., 2004). The results of the present study indicated not only that 
differences exist in the MSC transmigration capacity within the vasculature, but also 
that the morphology of MSCs during transmigration is strongly influenced by the 
endothelial phenotype. Coronary artery endothelium enabled the fastest MSC 
integration in vitro and resulted in the highest percentage of plasmic podia. In 
contrast, over time the transmigration of MSCs across venous endothelium was most 
efficient. Aortic endothelium facilitated the slowest transmigration of MSCs. 
Consequently, MSCs preferably transmigrated across venous and avoided 
transmigrating across the aortic endothelium. Thus, the results indicate that the 
transmigration and invasion efficiency of MSCs into different organs can vary in 
accordance with the surrounding type of vessels.  
Contrary to our results obtained with human MSCs it has been reported that the 
adherence of rat MSCs to aortic endothelial cells and cardiac microvascular 
endothelial cells does not differ significantly (Segers et al., 2006). This suggests that 
rat-derived MSCs – in contrast to human MSCs – do not discriminate between 
different endothelial phenotypes. Consistent with our results for MSC transmigration, 
it has been discussed for leukocytes that endothelial cells not only play an important 
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role in regulating the leukocyte attachment, but also actively modulate their 
diapedesis (Dejana et al., 1996).  
The observations presented in this study were obtained in vitro under static 
conditions without applying shear stress. Therefore, the observed differences of the 
time course of MSC interaction with different endothelial monolayers did not depend 
on variances of the shear rate, but were only influenced by the phenotype of the 
endothelial cells. In vivo different flow conditions within the blood circulation should 
also influence the transmigration efficiency. For example, the rolling of leukocytes is 
reduced by increasing shear rates (Bienvenu et al., 1993) as is the adhesion of rat-
derived MSCs to cardiac microvascular endothelium (Segers et al., 2006). Future 
studies should try to elucidate the role of the endothelial phenotype for MSC 
transmigration in vivo.  
 
4.6 Role of cytokines 
Cytokines are known to increase the expression of adhesion molecules in endothelial 
cells (Mantovani et al., 1992) and play a key role in the homing of hematopoietic stem 
cells (Yong et al., 1998). Moreover, cytokines such as interleukin (IL)-6 and vascular 
endothelial growth factor (VEGF) are up-regulated after myocardial infarction (Ip et 
al., 2007). A previous study of our laboratory validated that the migratory activity of 
MSCs is increased by cytokines, in particular basic fibroblast growth factor (bFGF), 
but also IL-6 and VEGF (Schmidt et al., 2006a). Therefore, the present study 
focussed on the effect of cytokines on the transmigration of MSCs. It was 
demonstrated that in contrast to migration, transmigration was only marginally 
influenced by bFGF. After 15 minutes, bFGF, VEGF, erythropoietin (EPO) and IL-6 
accelerated transmigration, whereas in the remaining experiments the process was 
mostly slowed down by bFGF. EPO and VEGF improved the transmigration capacity 
for up to 120 minutes. Therefore, transmigration might only be influenced by 
cytokines at early time points. Comparing the current findings with the previous 
migration study (Schmidt et al., 2006a) again provides evidence that migration and 
transmigration are processes with unique characteristics that are differentially 
regulated and diversely influenced by cytokines.  
The effect of the angiogenic cytokine EPO during skeletal myoblast transplantation 
was evaluated by Chanseaume and colleagues (Chanseaume et al., 2007). In this 
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study, EPO failed to improve myoblast engraftment and postinfarction leftventricular 
function. Lately, MSCs were shown to express the cognate EPO receptor (Zwezdaryk 
et al., 2007). Here, EPO increased the chemotaxis, migration and activation of matrix 
metalloprotease-2 of MSCs. These findings are in accordance with the present study 
which demonstrated an increase of transmigration induced by EPO. Recently, Chen 
et al. investigated that cord blood plasma induces transendothelial and trans-Matrigel 
migration of stem cells in vitro (Chen et al., 2007). This migration was inhibited by a 
VEGF-neutralizing antibody and antibodies against the VEGF-receptor-1. For bFGF it 
is known that after spinal cord injury a transplantation of MSCs in combination with 
bFGF infusion improved the functional outcome (Kim et al., 2006). Whether this might 
be an effect of the number of MSCs homed to the neural tissue has not been 
investigated. A recent study demonstrated that IL-6 is released into the systemic 
circulation in response to exercise which might result in increased stem cell 
recruitment after exercises (Schmidt et al., 2007).  
Taken together, for the therapeutic usage a local increase of cytokines for example 
induced by a myocardial infarction might not only improve the cell attraction to the 
tissue, but also influence the transmigration and invasion efficiency of MSCs at early 
time points. The local increase of cytokines via ultrasound and its effect on MSC 
attraction will be discussed in section 4.9.3.  
 
4.7 Involvement of nitric oxide and free oxygen radicals 
4.7.1 Nitric oxide 
The blood-endothelial cell interface is a region of significant importance for many 
physiological and pathological processes. Macromolecules and cells gain access to 
the subendothelial space and the extravascular tissues by traversing the endothelium 
(Isenberg et al., 2005). Yet the various factors responsible for modulation of this 
process remain only partially elucidated. Several agents were found to be involved in 
this process, including nitric oxide (NO) (Isenberg et al., 2005).  
In the present study co-cultivation experiments validated that the integration of MSCs 
into endothelial monolayers was accelerated by the NO-donor DETA NONOate 
especially at early points in time. NOS-inhibition via L-NAME decreased the 
integration. Furthermore, NO-measurements by DAF fluorometry revealed that the 
NO-release by MSCs was increased upon contact with endothelial cells while 
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endothelial cells obviously did not change their NO-production upon contact with 
MSCs. Therefore, one could speculate that not only NO produced by the vasculature, 
but also the release of NO by MSCs might influence their transmigration. Potentially, 
MSCs regionally manipulate the endothelial permeability by their endogenous NO-
release. Isenberg and co-workers reported that stimulated endothelial layers alter 
their permeability to low-density mononuclear cells in the presence of exogenous NO 
(Isenberg, 2003). Furthermore, they demonstrated that NO can modify the 
endothelial permeability to macromolecules and low-density mononuclear cells in the 
absence of an inflammatory prestimulation (Isenberg et al., 2005). By using Transwell 
chamber experiments they demonstrated that confluent monolayers of HUVECs 
increase their permeability to low-density mononuclear cells in the presence of 
spermine-NO. This response was dose-dependent, with low doses promoting and 
high doses inhibiting transendothelial cellular migration. Nonselective NOS-inhibition 
with L-NAME had no effect upon permeability to low-density mononuclear cells 
(Isenberg et al., 2005). Moreover, it has been reported that NO alters the expression 
of the adhesion protein VE-cadherin, leading to a decrease of the same (Gonzalez et 
al., 2003). This decrease of VE-cadherin at the adherent junctions between 
endothelial cells was correlated with an increased vascular permeability in vivo to the 
Evans blue dye in mice. Gonzalez and colleagues demonstrated that NO decreases 
β- and γ-catenin, known to make up – along with VE-cadherin – the adherent junction 
complexes between endothelial cells (Gonzalez et al., 2003). Catenin proteins anchor 
the adherens junctional proteins to the actin cytoskeleton (Aberle et al., 1996). Such 
a loss of inter- and intracellular junctional proteins – induced by NO – could allow for 
cellular retraction along the actin cytoskeleton and result in increased paracellular 
space for cellular transmigration (Isenberg et al., 2005). Moreover, Sasaki and co-
workers showed the crucial specific involvement of NO-producing enzymes in the 
migratory activity of bone marrow mononuclear cells in vivo (Sasaki et al., 2006).  
Recently, Kaminski et al. investigated the adhesion of c-kit+ bone marrow stem cells 
to endothelial cells in vivo by intravital fluorescence microscopy of murine cremaster 
muscles (Kaminski et al., 2007). They showed that firm endothelial adhesion of c-kit+ 
cells was entirely abrogated in wildtype mice treated with the arginine analog and 
nonselective NOS-inhibitor L-NAME as well as in eNOS-knockout mice. The fact that 
MSCs also express the endothelial nitric oxide synthase eNOS has recently been 
validated (Klinz et al., 2005). Klinz et al. demonstrated that proliferating MSCs 
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accumulate eNOS phosphorylated at Serin-114 in the nuclear compartment, whereas 
eNOS phosphorylated at Serin-1177 was localized at filamentous structures in the 
perinuclear region of MSCs (Klinz et al., 2005). Indeed, it has been confirmed that 
MSCs produce NO as an immunomodulatory mediator and to suppress T-cell 
proliferation (Oh et al., 2007; Sato et al., 2007). Furthermore, Ladage et al. showed 
that MSCs produce soluble factors which increased endothelial NO synthase (eNOS) 
activity by translocation and by phosphorylation in human umbilical vein endothelial 
cells (Ladage et al., 2007). Thus, MSCs seem to emit soluble factors which alter the 
endothelial barrier mediated by the regulation of endothelial NO-release (Ladage et 
al., 2007). Additionally, as it was confirmed in the present study MSCs increase their 
own NO-release upon contacting endothelial cells. Concluding, NO might be one 
important factor produced by MSCs which could regulate their transmigratory 
capacity by influencing the permeability of the endothelial barrier.  
 
4.7.2 Reactive oxygen species 
Reactive oxygen species (ROS) are a class of molecules that are derived from the 
metabolism of oxygen and include free radical and nonradical species that are 
generally capable of oxidizing molecular targets (Ardanaz et al., 2006). Numerous 
studies have demonstrated the ability of a variety of vascular cells, including 
endothelial cells, to produce reactive oxygen species (ROS) (Ardanaz and Pagano, 
2006). Herein, we present that MSCs are also capable of producing ROS. Fischer 
and colleagues demonstrated that H2O2 is able to induce an increased endothelial 
permeability (Fischer et al., 2005). H2O2 as it was used by Fischer and in the present 
study to induce an oxidative stress situation under co-culture conditions is a cell-
permeable and highly stable ROS (Ardanaz and Pagano, 2006). Although H2O2 is 
classified as a ROS, unlike O2- it is not a free radical, in that it does not possess an 
unpaired electron in its outer shell (Ardanaz and Pagano, 2006). This renders H2O2 
more stable and less reactive with other tissue radicals and, thus, a more likely 
paracrine ROS (Ardanaz and Pagano, 2006). Steady-state H2O2 levels in vascular 
tissue are tightly regulated by the endogenous scavengers catalase and glutathione 
peroxidase (Suttorp et al., 1986). It is known that in patients suffering from 
hypertension, plasma levels of H2O2 do rise (Lacy et al., 1998). Since the superoxide 
anion O2- has the ability to directly attenuate the biological activity of nitric oxide by 
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the formation of peroxynitrite (Ardanaz and Pagano, 2006), ROS have been shown to 
contribute to vascular dysfunction partly by reducing the bioavailability of NO (Yung 
et al., 2006). 
In the present study, it was validated that the integration of MSCs into endothelial 
monolayers was impaired by H2O2, but enhanced by the radical scavenger N-
acetylcysteine. This is in accordance with a study from Montoya and colleagues 
(Montoya et al., 1997). They showed that under flow conditions treatment with 
antioxidants enhanced the adhesion of polymorphonuclear leukocytes to human 
umbilical vein endothelial cells activated with tumor necrosis factor-alpha. This 
adhesion was mediated by β2 integrins (Montoya et al., 1997). Hung et al. found 
evidence that short-term exposure of MSCs to low oxygen conditions of 1% 
augmented expression of certain chemokine receptors thus increasing in vitro 
migration (Hung et al., 2007). 
Moreover, in the present study APF fluorometry demonstrated that MSCs themselves 
produce a large quantity of ROS. Their ROS-levels were about four-fold greater than 
the release by the endothelial cells and increased upon contact with endothelial cells. 
Parts of this production might be peroxynitrite – which is detected by the APF 
fuorometry – produced from the reaction with NO. To summarize, one could 
speculate that ROS decrease the transmigratory activity of MSCs by reducing the 
bioavailability of NO which itself positively influences transmigration. The 
simultaneous production of NO and ROS by MSCs could represent a negative feed-
back mechanism as only a certain range of NO might be adequate to optimally 
influence the endothelial permeability for MSC transmigration. However, 
cardiomyoplasty in the presence of free radical scavengers and NO-donors could 
help to elevate the therapeutic efficiency.  
 
4.8 Genetic manipulation of MSCs via adenoviral infection 
Myocardial infarction is a leading cause of heart failure and death in developed 
countries (Ip et al., 2007). In several trials the application of cell-based therapies for 
the treatment of heart disease has shown promising results (Strauer et al., 2001; 
Assmus et al., 2002; Britten et al., 2003; Perin et al., 2003; Stamm et al., 2003; Tse 
et al., 2003a). However, enhancing the efficiency of stem cell therapy is a major goal 
of current research.  
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Genetic modification of stem cells may represent one important strategic 
advancement in regenerative medicine (Dzau et al., 2005). In future, by combining 
gene with stem cell therapy, one may be able to enhance the stem cell function. 
Indeed, genetic modification can improve the survival, the metabolic characteristics, 
the proliferative capacity and the differentiation of stem cells (Dzau et al., 2005). 
Therefore, genetic modification of MSCs could elevate their therapeutic efficacy 
(Dzau et al., 2005). For example, Mangi and co-workers demonstrated that the 
genetic modification of MSCs with the anti-apoptotic gene Akt1 (Akt-MSCs) increased 
their post-transplantation viability (Mangi et al., 2003). Intramyocardial injection of 
Akt-MSCs led to the prevention of ventricular remodeling and to the restoration of 
cardiac function. Following studies demonstrated that the functional improvement of 
Akt-MSC transplantation occurred within 72 hours, which raised the hypothesis that 
paracrine actions instead of differentiation into cardiomyocytes might be important for 
tissue repair (Gnecchi et al., 2006). Recently, secreted frizzled related protein 2 has 
been identified as the key paracrine factor released by Akt-modified MSCs mediating 
myocardial survival and repair (Mirotsou et al., 2007).  
Given its essential role in the hematopoietic system including bone marrow homing 
and recruitment (Jo et al., 2000), stromal-derived factor (SDF)-1 (also known as 
CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) are candidates to 
promote stem cells recruitment to the heart (Pyo et al., 2006). The SDF-1/CXCR4 
system, which is implicated in migration, proliferation, differentiation and survival of 
hematopoietic stem and progenitor cells (Lapidot et al., 2002), probably plays a 
significant role in stem cell homing after myocardial infarction (Barbash et al., 2006).  
Son and co-workers demonstrated that the CXCR4 transcript is strongly expressed in 
both bone marrow- and cord blood-derived MSCs (Son et al., 2006). Additionally, it 
was reported that SDF-1 increases the migratory activity of MSCs (Schmidt et al., 
2006a). A recent study demonstrated that a small subpopulation of bone marrow-
adherent cells that are small in size, seen in the colonies of earliest passages, 
express high levels of CXCR4 and exhibit greater engraftment into the hippocampal 
region after systemic infusion (Lee et al., 2006). In a rat model it has been shown that 
SDF-1-CXCR4 interactions mediate the homing of bone marrow-derived MSCs to 
impaired sites in the brain (Ji et al., 2004). Taken together, utilization of the SDF-
1/CXCR4 system might be a potential target to improve the homing efficacy of MSCs 
(Barbash and Leor, 2006). Therefore, in the present study MSCs were adenovirally 
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infected to study the impact of overexpression of the SDF-1 receptor CXCR4 on the 
transmigration of MSCs in the murine heart.  
Successful adenoviral infection of MSCs has been described in different studies 
(Barbash et al., 2003; Mangi et al., 2003; Gnecchi et al., 2005; Gnecchi et al., 2006; 
Mirotsou et al., 2007). For example, an adenoviral infection efficiency of MSCs of 
>95% was achieved using a recombinant adenovirus enconding the reporter gene 
LacZ (Barbash et al., 2003). However, in the present study the efficiency of 
adenoviral infection of MSCs with Ad.CXCR4.GFP was worse than it has been 
described for adult rat cardiac myocytes (Pyo et al., 2006). The present study and 
Pyo et al. used the same adenovirus. However, Pyo and colleagues reported that 
after 48 hours even at the lowest virus concentration (MOI 1) almost 100% of the 
adult rat cardiac myocytes were infected as visualized by GFP fluorescence. The 
infection efficiency of MSCs using the Ad.CXCR4.GFP adenovirus was significantly 
inferior compared to the adult rat cardiac myocytes. Even by using high virus 
concentrations (MOI 80) only about 60% of the MSCs were infected. Nonetheless, 
the amount of CXCR4 protein in infected MSC lysates was strongly increased. 
Contrary to the expectation, the migratory activity of MSCs infected with 
Ad.CXCR4.GFP was significantly reduced as compared to MSCs infected with the 
control virus Ad.GFP. Addition of SDF-1 could not abrogate this discrepancy.  
A study from Bhakta and co-workers also describes the transduction of MSCs using 
either CXCR4 and GFP or GFP alone (Bhakta et al., 2006). Here, in contrast to the 
present study MSCs were retrovirally transduced. By performing flow cytometry they 
showed that on average 83% of the transduced MSCs expressed CXCR4. In contrast 
to the present work, MSCs transduced with CXCR4 exhibited significantly more 
migration toward SDF-1, threefold greater after 3 hours and more than fivefold 
greater after 6 hours compared with control MSCs (Bhakta et al., 2006). Son and co-
workers demonstrated that the surface expression of the CXCR4 antigen both on 
bone marrow- and cord blood derived MSCs was quite low, suggesting that this 
protein can be expressed intracellularly rather than on the cell surface (Son et al., 
2006). They assume that CXCR4 sequestered intracellularly in MSCs is mobilized to 
the cell surface, for example, during cytokine stimulation (Wynn et al., 2004). 
Therefore, in the present study the overexpressed CXCR4 receptor might not have 
been transported sufficiently to the cell surface. However, this fact would still not 
explain why the migratory activity of MSCs infected with Ad.CXCR4.GFP was 
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significantly reduced as compared to MSCs infected with the control virus Ad.GFP. 
The presented data rather imply that adenoviral infection of MSCs using the 
Ad.CXCR4.GFP virus disturbed the physiological behavior of the cells. To 
summarize, on the one hand as demonstrated in the present study infection of MSCs 
using the Ad.CXCR4.GFP adenovirus impaired their migratory motility. On the other 
hand, infection with a CXCR4 expressing retrovirus is able to augment MSC motility 
(Bhakta et al., 2006). Thus, a retroviral mediated CXCR4 transduction of MSCs might 
be the better alternative to increase their therapeutic potential.  
In addition, the transmigratory activity of Ad.CXCR4.GFP infected MSCs with or 
without SDF-1 was not significantly altered as compared to the GFP-control cells. 
However, transmigration of MSCs infected with Ad.GFP tended to be increased in the 
presence of SDF-1. Thus, a genetic manipulation of MSCs by overexpressing 
CXCR4 was not beneficial for the transmigration of MSCs. Experiments of the 
present study were conducted in the presence of 50 ng/ml SDF-1 as described for 
transendothelial migration assays of human breast cancer cells across human brain 
microvascular endothelial cell monolayers (Lee et al., 2004a). However, a recent 
study validated that high concentrations of SDF-1 between 100 and 600 ng/ml might 
be more efficient to increase the migratory activity of c-kit+ bone marrow stem cells 
(Kaminski et al., 2007). Nonetheless, Bhakta and colleagues observed a significant 
increase of the migration of CXCR4-expressing MSCs even in the presence of 30 
ng/ml (Bhakta et al., 2006).  
Kaminski et al. recently demonstrated that for the firm adhesion of c-kit+ bone marrow 
stem cells to endothelial cells the presence of both SDF-1 chemoattractant activity 
and inflammatory endothelial activation by TNF-α were required (Kaminski et al., 
2007). SDF-1 alone induced a transient c-kit+ cell-endothelium interaction (rolling), 
but not their firm adhesion. This might explain why in the present study SDF-1 alone 
was not sufficient to increase the transmigration of MSCs in the isolated mouse heart. 
Furthermore, Kaminski and co-workers validated that ICAM-1 and CXCR4 on the 
vascular endothelium were crucial for the firm adhesion of the c-kit+ cells. In 
accordance with the present study, Ip and co-workers demonstrated that injection of 
MSCs pretreated with blocking antibodies against CXCR4 into the ischemic 
myocardium of mice did not affect the amount of stem cells in the ischemic 
myocardium compared with control experiments (Ip et al., 2007). Furthermore, Abbott 
and co-workers confirmed that SDF-1 plays a critical role in stem cell recruitment to 
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the heart after myocardial infarction, but that it is not sufficient to induce homing in 
the absence of injury. In this context, it would be interesting to investigate the 
efficiency of CXCR4 overexpressing MSCs in ischemic myocardium.  
It is known that SDF-1 becomes up-regulated at sites of tissue damage (Ponomaryov 
et al., 2000). For instance, levels of the chemokine SDF-1 and its receptor CXCR4 
were elevated in patients with heart failure (Shioi et al., 1997; Aukrust et al., 1998; 
Aukrust et al., 2001). This up-regulation of SDF-1 – also in the ischemic myocardium 
– mediates the homing of hematopoietic stem cells via its direct interaction with 
CXCR4 on the stem cells (Askari et al., 2003; Abbott et al., 2004). Furthermore, local 
manipulations to increase levels of SDF-1 in the myocardium have been shown to 
increase stem cells homing following myocardial infarction (Askari et al., 2003). In 
addition, SDF-1 has been shown to not only regulate the adhesion of hematopoietic 
stem and progenitor cells to the endothelium (Grabovsky et al., 2000), but also to 
control the expression of basement membrane degrading matrix metalloproteinases 
(Kijowski et al., 2001). A recent study indicated that up-regulation of SDF-1 by 
hypoxic endothelial cells was required for the attachment and transendothelial 
migration of circulating CXCR4-positive endothelial progenitor cells (Ceradini et al., 
2004).  
To conclude, the amount of CXCR4 receptor expressed on MSCs might not be the 
limiting factor for an efficient homing to the heart, while the concentration of SDF-1 
could be important for the intravascular trafficking of MSCs. Furthermore, an 
adenoviral overexpression of CXCR4 in MSCs does not increase their myocardial 
homing potential. However, future studies should further examine the role of SDF-1 
for the recruitment of MSCs into the heart.  
 
4.9 Preconditioning of the endothelium by ultrasound-mediated 
microbubble stimulation triggers attraction, transmigration and 
invasion of MSCs 
4.9.1 Systemic delivery of MSCs 
A critical step for the clinical success of a stem cell-based therapy for myocardial 
repair is an efficient method for cell delivery (Barbash et al., 2003). Intramyocardial 
transplantation of MSCs has been shown to promote cardiac repair with resulting 
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functional improvement and reduced infarct size (Kocher et al., 2001; Mangi et al., 
2003; Amado et al., 2005). Different groups reported good results after direct 
intracardiac injection of autologous bone marrow or skeletal myoblast cells during 
coronary artery bypass surgery. However, in contrast to skeletal myoblasts 
differentiated MSCs may have the capacity for electromechanical coupling (Nagaya 
et al., 2004). Of note is that, although the patients had improved myocardial 
performance after stem cell therapy, increased arrhythmogenic potential has been 
reported, necessitating the implantation of internal defibrillators (Assmus et al., 2002; 
Strauer et al., 2002; Chen et al., 2004). Moreover, this way of administration holds a 
considerable the risk for calcifications in the heart (Breitbach et al., 2007). Instead of 
a direct transplantation, the mobilization of MSCs with cytokines such as granulocyte 
stimulating factor (G-CSF) and SDF-1 has been reported to enhance myocardial 
repair and improve cardiac function (Anversa and Nadal-Ginard, 2002; Askari et al., 
2003). Stem and progenitor cells have been shown to circulate in the peripheral 
blood and home to ischemic tissue (Asahara et al., 1997). These results raise the 
possibility that intravenously administrated MSCs could participate in the repair of 
ischemic myocardium. Saito et al. were the first to demonstrate that MSCs 
administered intravenously engraft within regions of myocardial infarction (Saito et 
al., 2002). Therefore, intravenous delivery of bone marrow-derived stem cells, as 
performed during bone marrow transplantation, to patients recovering from 
myocardial infarction is an alternative and attractive non-invasive strategy that allows 
repeated administrations of large numbers of cells (Barbash et al., 2003). This 
systemic cellular transplantation could be achieved by the injection of cells either 
intracoronary during coronary interventions or intravenously (Barbash and Leor, 
2006). Furthermore, it may be applicable to patients with diffuse myocardial disease, 
such as the idiopathic dilated cardiomyopathy (Barbash et al., 2003). Once delivered, 
the cells would migrate through the systemic circulation, resettle in the infarcted 
myocardium and receive local signals that would direct myogenic differentiation (Orlic 
et al., 2002; Toma et al., 2002). Strauer and colleagues were the first to show the 
feasibility of intracoronary injection of enriched autologous mononuclear bone 
marrow cells in patients with acute myocardial infarction (Strauer et al., 2002).  
A positive effect of intravenously administrated MSCs on rats subjected to traumatic 
brain injury has been observed (Lu et al., 2001). Here, MSCs preferentially entered 
and migrated into the parenchyma of the injured brain and significantly reduced 
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motor and neurological deficits. Another study performing a systemic MSC 
transplantation in a pig model of chronic ischemia showed significant functional 
improvements in the postinfarcted heart (Krause et al., 2007). Here, systemic 
administration of MSCs reduced the infarct size and improved the hemodynamics. 
The authors speculate whether increased myocardial thickness, due to local 
infiltration of transplanted cells in the area of scarring, may have decreased the wall 
stress, resulting in a more compliant, less stiff ventricle with improved diastolic filling 
(Krause et al., 2007).  
However, Dai and colleagues reported for a postinfarcted rat model that although 
MSCs were detected 4 weeks after transplantation in the infarct scar, differentiation 
of MSCs to cardiomyocytes was incomplete because only immature myofibrillar 
organization was developed (Dai et al., 2005). Therefore, mechanisms apart from cell 
differentiation contribute to the early functional effects of MSC transplantation 
(Krause et al., 2007). Paracrine effects seem to be a plausible explanation because it 
has been shown that MSCs secrete a great number of growth factors and cytokines 
(Kinnaird et al., 2004). Paracrine factors released from MSCs were recently been 
shown to promote antiapoptotic effects in cardiomyocytes subjected to hypoxia 
(Gnecchi et al., 2005).  
Barbash and co-workers investigated the engraftment of MSCs in the ischemic 
myocardium after systemic delivery (Barbash et al., 2003). For gamma camera in 
vivo imaging and organ counting MSCs were labeled with the radioactive tracer 
isotope technetium-99m. Furthermore, they tested the feasibility of different systemic 
application routes: systemic intravenous delivery, infusion into the left ventricular 
cavity and infusion into the right ventricular cavity. However, shortly after infusion into 
the right ventricular cavity, Barbash and colleagues report that all animals died of 
massive pulmonary embolisms. Relative specific activity of labeled MSCs revealed 
that intravenous infusion of MSCs resulted predominately in lung uptake and lower 
uptake in liver, heart and spleen. In contrast, infusion into the left ventricular cavity 
was significantly more effective with lower lung uptake and increased uptake in the 
heart. However, gamma camera imaging indicated that even after intracoronary 
cardiomyoplasty within the first hours less than 1% of the infused cells resided in the 
infarcted heart (Barbash et al., 2003). Furthermore, they identified clusters of infused 
cells at the boderzone. Thus, the main findings of Barbash and colleagues were that 
systemic intravenous delivery of MSCs is limited by the entrapment of donor cells 
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mainly in the lungs and that MSCs delivered by left ventricular cavity infusion migrate 
to and colonize the infracted heart in significantly higher amounts (Barbash et al., 
2003). Furthermore, a study which assessed the homing capabilities of bone marrow-
derived stem cells in humans using  three-dimensional positron-emitted tomography 
discovered that 1.3-2.6% of injected cells homed into the myocardium after 
intracoronary injection and no cells were found following intravenous injection 
(Hofmann et al., 2005). Nagaya and co-workers investigated whether intravenously 
transplanted MSCs induce angiogenesis and myogenesis and improve cardiac 
function in rats with acute myocardial infarction (Nagaya et al., 2004). Here, 
transplanted MSCs were preferentially attracted to the infarcted, but not the non-
infarcted myocardium. The engrafted MSCs were positive for some cardiac markers. 
Capillary density was markedly increased and cardiac infarct size was significantly 
decreased after MSC transplantation. The fraction of left ventricular ejection was also 
higher in the MSC than in the control group. Semiquantitative analysis of the hearts 
demonstrated that about 3% of the transplanted MSCs were incorporated into the 
heart 24 hours after transplantation. At 4 weeks after transplantation, MSCs were 
incorporated predominantely into the borderzone of infarcts. These results suggested 
that intravenously administrated MSCs are capable of engraftment in the ischemic 
myocardium and that transplantation improves cardiac function after acute 
myocardial infarction through enhancement of angiogenesis and myogenesis in 
ischemic myocardium (Nagaya et al., 2004). However, only a low percentage of 
transplanted MSCs incorporated into the heart (Nagaya et al., 2004), which could be 
explained by MSC apoptosis (Mangi et al., 2003) or tacking in the lung (Barbash et 
al., 2003). To summarize, only a small percentage of MSCs home to the desired 
tissue after a systemic delivery. Thus, the development of a method to increase the 
cell engraftment by modulating the process of transmigration of MSCs in a site-
specific manner would be of great clinical benefit.  
 
4.9.2 Ultrasound-mediated microbubble stimulation 
One possible technique to influence the interaction of MSCs and the endothelium 
could be ultrasound-mediated microbubble stimulation (UMS). Ultrasound is 
commonly used for diagnostic imaging and physiotherapy (Altland et al., 2004). 
Contrast agent microbubbles have been currently used for therapeutic purposes (Zen 
Discussion 
 
105 
et al., 2006). UMS in the capillary lumen elicited arteriogenesis and enhanced the 
hyperaemic blood flow in normal and ischemic rat skeletal muscle (Skyba et al., 
1998; Song et al., 2004). However, UMS is also used as a novel gene- and cell-
delivery system which depends on intravenous application of gas-filled microbubbles 
and their cardiopulmonary circulation through intravascular space until ultrasound-
induced bubble-tissue interaction in the target organ (Shohet et al., 2000). UMS was 
used for cell-delivery in skeletal muscle and myocardium (Imada et al., 2005; Zen et 
al., 2006). The study of Imada and co-workers demonstrated that the release of pro-
inflammatory factors activated by UMS plays a key role in the attachment of 
transplanted bone marrow-derived mononuclear cells onto the endothelial layer 
(Imada et al., 2005). Zen and co-workers obtained increased cardiac function via an 
angiogenic response 12 weeks after application of UMS and intravenous infusion of 
endothelial progenitor cells in a cardiomyopathy model. Both, gene- and cell-
therapeutic approaches revealed no significant delivery in the controls using 
ultrasound or microbubbles alone (Bekeredjian et al., 2003; Imada et al., 2005). 
Therefore, exposure of defined regions of the heart to UMS prior to systemic 
administration of MSCs may be well suited to non-invasively augment MSC 
recruitment to non-ischemic and ischemic myocardium. 
UMS is known to administrate a mechanical action on endothelial and vascular 
smooth muscle cells via a so called sonoporation resulting in the formation of 
transient pores which revert to normal appearance within 24 hours (Taniyama et al., 
2002a). However, this technique can also cause fatal bioeffects, such as capillary 
rupture and extravasation of erythrocytes as well as eosinophily and cardiomyocyte 
necrosis which are positively associated with ultrasound emission power (Chen et al., 
2002; Chen et al., 2003; Miller et al., 2007). However, the ultrasound emission power 
used in the present study was well defined and did not result in obvious vasculature 
and tissue damage. For the treatment of non-ischemic myocardium the anterior wall 
was selected as the target tissue. In ischemic myocardium the borderzone of infarcts 
served as UMS target. It has been described previously that transplanted MSCs were 
preferentially attracted to and retained in the borderzone of infarcts (Barbash et al., 
2003; Nagaya et al., 2004). Therefore, the borderzone of infracted myocardium 
should be a sufficient target tissue for stem cell therapy.  
In the present study, the effect of UMS applied shortly before cardiomyoplasty was 
evaluated by calculating the cell attraction (section 3.11.3) and the transmigration of 
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MSCs (section 3.11.4). Furthermore, the impact of UMS on cytokine levels, 
apoptosis, protease activity as well as endothelium and basement membrane 
morphology was studied (section 3.11.5).  
 
4.9.3 Effect of UMS on cell attraction and cytokine levels 
The number of MSCs attracted into the ischemic myocardium was significantly higher 
than the number of cells in non-ischemic myocardium. However, focussed pre-
treatment of the anterior wall resulted in a significant increase in the absolute number 
of MSCs per heart slide in ischemic as well as in non-ischemic myocardium. It has 
been previously described that MSCs are preferentially attracted to ischemic 
myocardium (Nagaya et al., 2004). Earlier studies showed that endothelial progenitor 
cells are mobilized from the bone marrow into the peripheral blood in response to 
tissue ischemia and home to and incorporate into sites of neovascularization 
(Asahara et al., 1997). Although, the underlying mechanisms remain unclear, 
ischemic tissue may express specific receptors or ligands to facilitate trafficking, 
adhesion and infiltration of MSCs in ischemic sites (Nagaya et al., 2004). In the 
present study investigations of MSC cell therapy in non-ischemic myocardium were 
performed since its cytokine and chemokine activity and therefore intrinsic attraction 
of MSCs is the lowest and might therefore resemble the chronic state of an idiopathic 
cardiomyopathy.  
To approximate the myocardial transplantation efficacy, the absolute amount of 
MSCs per rat heart was estimated and related to the left-ventricular volume (Ghanem 
et al., 2006). For example, in ischemic, non-insonicated myocardium 3.800 MSCs 
retained in the left-ventricle, normalized to 100.000 transplanted MSCs. The 
corresponding transplantation efficacy of 3.8% is comparable to previous 
observations in experimental (Barbash et al., 2003) and clinical studies (Hofmann et 
al., 2005). However, UMS preconditioning significantly increased the transplantation 
efficacy to 5.2%. This UMS-induced improvement of cell attraction in ischemic as well 
as in non-ischemic myocardium could be explained with the transient endothelial 
alteration and with well known shear forces generated through the transient 
ultrasound-induced pressure pulse (Hsu et al., 2004). Ruster and co-workers showed 
that P-selectin is involved in the rolling of MSCs on endothelial cells (Ruster et al., 
2006). However, Imada et al. demonstrated that UMS quickly induced the expression 
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of adhesive molecules such as P-selectin in treated endothelial cells (Imada et al., 
2005). Therefore, the increased cell attraction of MSCs induced by UMS could also 
be explained by an alteration of the P-selectin expression on the endothelial cells, 
which might result in an increase of the rolling and adhesion behavior of MSCs.  
Furthermore, ultrasound exposure was reported to cause a rapid response in nitric 
oxide synthesis by endothelial cells (Altland et al., 2004). This increase of nitric oxide 
release within the first minutes after insonication (Altland et al., 2004) might allow an 
additional mechanistic explanation of the increased attraction and adhesion of MSCs 
after UMS. Kaminski and co-workers showed for eNOS-knockout mice that the firm 
adhesion of c-kit+ bone marrow stem cells was entirely abrogated (Kaminski et al., 
2007). Moreover, the present study implies that nitric oxide also plays a key role 
during the transmigration of MSCs (section 3.8 and 4.7.1).  
On the other hand, in the present study regional analyses of non-ischemic anterior 
and posterior myocardial segments of the same rat hearts by cytokine arrays, done 
immediately after UMS, revealed that UMS acutely induced a local pro-inflammatory 
response resulting in an anterior-to-posterior gradient of cytokines as compared to 
control tissue. Interleukin (IL)-1α, IL-1β, tumor necrosis factor (TNF)-α and 
granulocyte macrophage stimulating factor (GM-CSF) were significantly increased by 
UMS. IL-4, IL-6 and IL-10 were not detected in non-insonicated tissue, while 
insonicated myocardium contained these cytokines. Previous studies already 
described the induction of cytokine expression after UMS (Imada et al., 2005; Zen et 
al., 2006). These experiments studied cytokine levels a minimum of 3 days after 
insonication; to our knowledge the present study is the first investigation of acute 
UMS effects on cytokine levels. The study of Imada and co-workers demonstrated 
that the release of pro-inflammatory factors activated by UMS plays a key role in the 
attachment of transplanted bone marrow-derived mononuclear cells onto the 
endothelial layer (Imada et al., 2005). Moreover, UMS markedly elevated the 
expression of inflammatory chemokines and cytokines (IL-1β, TNF-α, monocyte 
chemoattractant protein (MCP)-1, VEGF and bFGF) three days after insonication 
(Zen et al., 2006). In accordance with the present study, cytokines were mainly 
expressed in UMS-treated myocardium.  
In this study hearts were harvested within 10 minutes after UMS application. Thus, 
up-regulation of protein expression cannot explain the observed differences in 
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cytokine levels. The cytokines could rather be released from extracellular matrix 
storages or secreted by activated cells. Ultrasound has been shown to increase the 
production of IL-1β and VEGF by monocytes (Reher et al., 1999). To speculate, UMS 
could also have induced a loosening of matrix-bound cytokines (Park et al., 1993); 
and these free cytokines might be detected more sufficiently by the cytokine array as 
compared to matrix-bound cytokines (oral information provided by the manufacturer). 
This hypothesis is supported by the observation that UMS regionally activated 
proteases which will be discussed in the following section. Indeed, previous studies 
obtained for example fibronectin-bound TNF-α which allowed stimulation of cellular 
MMP-9 expression and consecutively regulated the chemotaxis of monocytes (Vaday 
et al., 2000; Vaday et al., 2001). One of the most interesting characteristics of MSCs 
is their ability to home to sites of tissue damage or inflammation (Devine et al., 2001). 
Therefore, by regionally increasing the cytokine level UMS might imitate an 
inflammatory situation and thereby increase MSC attraction to insonicated regions. 
Recently, Segers and co-workers demonstrated an increase of cardiac infiltration of 
MSCs after activation with TNF-α or IL-1β before cell interaction (Segers et al., 
2006). In addition, rolling and adhesion of MSCs was found to be increased after pre-
stimulation of endothelial cells with TNF-α (Ruster et al., 2006). Furthermore, 
Kaminski and colleagues validated that activation of the endothelium by TNF-α and 
SDF-1 led to a relevant attraction of c-kit+ bone marrow stem cells (Kaminski et al., 
2007). Wang et al. showed a significant increase in the attachment of neutrophils to 
endothelial cells after application of IL-1β (Wang et al., 2006) and IL-1α increases the 
expression of matrix metalloproteinases and thereby mediates matrix degradation 
(Wisithphrom et al., 2006). Cho et al. demonstrated that GM-CSF treatment 
mobilized endothelial progenitor cells, accelerated reendothelialization and reduced 
monocytes infiltration after intravascular radiation therapy (Cho et al., 2003). 
Moreover, MSCs have been mobilized from the bone marrow by G-CSF and SDF-1, 
which has been reported to enhance myocardial repair and improve cardiac function 
(Anversa and Nadal-Ginard, 2002; Askari et al., 2003). 
To summarize, the present findings lead to the hypothesis that UMS – apart from 
other bioeffects – induced a regional cytokine release, which triggered an 
intravascular trafficking of MSCs to the target zone. This increase of cytokines might 
also influence the transendothelial migration of MSCs.  
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4.9.4 Effect of UMS on transmigration, basement membrane and protease 
activity 
To evaluate the effect of UMS on the transmigration of MSCs the percentage of 
transmigrating MSCs in the target tissue in native and ischemic myocardium with and 
without UMS preconditioning was calculated. UMS significantly increased the number 
of transmigrating MSCs in native as well as in ischemic hearts. Therefore, UMS not 
only increased the number of MSCs attracted to the target tissue, but also the 
number of actually transmigrating and invading MSCs. In accordance, UMS has 
previously been reported to induce an opening of cell-cell-contacts in a 
chorioallantoic membrane model and thereby increasing the vascular permeability 
(Stieger et al., 2007). 
UMS was used for cell-delivery in the skeletal muscle and myocardium (Imada et al., 
2005; Zen et al., 2006). Zen and co-workers obtained increased cardiac function via 
an angiogenic response 12 weeks after application of UMS and endothelial 
progenitor cells in a cardiomyopathy model. Those findings were related to an 
approximately 2.5-fold increase in expression of the adhesion molecules VCAM-1 
and ICAM-1 (Zen et al., 2006). In addition, Hsu et al. propose that ultrasound 
activates endothelial integrins (Hsu et al., 2006). Since the present study identified 
VCAM-1 and integrins as key surface molecules for the transmigration of MSCs, the 
activation of surface molecules via ultrasound might be one possible explanation for 
UMS-induced increase of transmigration. However, in contrast to Imada and Zen et 
al., the present study investigated the acute impact of UMS on cell infiltration as well 
as endothelial and basal membrane alterations, since post-ischemic remodeling can 
be positively influenced best at an early stage. 
Altland and co-workers demonstrated that exposure of endothelial cells to low-
frequency ultrasound increased their NO production through up-regulation of eNOS 
activity within minutes (Altland et al., 2004). Hsu and Huang published that the 
enhanced NO release by endothelial cells was maintained up till days after 
ultrasound treatment (Hsu and Huang, 2004). Since in the present study NO has 
been shown to increase transmigration this might be another possible and important 
explanation for the enhanced transmigratory activity of MSCs after UMS.  
Since degradation of the basement membrane is a critical step for the invasion of 
MSCs into the myocardium (section 3.5 and 4.4) the expression of the basement 
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membrane component laminin was investigated after UMS exposure. Thus, heart 
sections were immunostained for laminin. The expression of laminin 2 hours after 
UMS insonication was decreased as demonstrated by reduced fluorescence 
intensity, indicating a reduced level of immunoreactive laminin. This UMS-mediated 
decrease of laminin was confirmed by western blot analysis. Wang and co-workers 
lately identified regions within the venular wall, where the expression of certain 
basement membrane constituents such as laminin and collagen IV was lower than 
the average vascular level (Wang et al., 2006). These regions were highly associated 
with gaps between pericytes and appeared to be preferentially used by 
transmigrating neutrophils. One potential mechanism by which neutrophils may 
increase the size of low expression regions of extracellular matrix proteins is via 
proteolytic cleavage (Wang et al., 2006). 
However, in the present study by performing electron microscopy no visual 
alterations of the basement membrane and the endothelium on an ultrastructural 
level were observed. Studies investigating the emigration of leukocytes also did not 
note visible damage of the basement membrane at sites of leukocyte transmigration 
(Marchesi and Florey, 1960; Hurley, 1963). Therefore, it is possible that 
ultrastructural analysis did not enable us to visualize those transient changes in 
extracellular matrix protein expression caused by UMS. Perhaps, UMS induced – by 
activating proteases – a transient remodeling of the basement membrane and 
thereby enabled regionally a more efficient transmigration and invasion of MSCs 
without gross and irreversible disruption of the vascular wall structure. Such a 
transient basement membrane remodeling has been observed at sites of emigrating 
neutrophils (Wang et al., 2006). Here, the above mentioned low expression regions 
of extracellular matrix proteins do not lack the basement membrane, but are regions 
in which there is less expression of selective basement membrane constituents 
(Wang et al., 2006). Neutrophils traverse the vessel wall preferentially at those 
regions (Wang et al., 2006).  
To investigate whether the observed changes in the extracellular matrix protein 
expression might be caused by the activation of proteases, in situ zymographies 
were conducted. They allowed localizing gelatinase activity in heart slides after UMS 
treatment. Localized protease activity in the targeted myocardium within the 
anteroseptal wall was observed after focussed insonication, while no gelatinase 
activity was detected in the untreated posterior myocardium. Thus, UMS locally 
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induced the activation of proteases, which might explain the observed transient 
reduction of basement membrane components. The activity of proteases was shown 
to be crucial for invasion of MSCs into the basement membrane of bone marrow (De 
Becker et al., 2007; Ries et al., 2007) and as demonstrated in the present study for 
the invasion into myocardial tissue (section 3.5 and 4.4). Therefore, the described 
finding of MMP-activation via UMS might contribute substantially to the improved 
myocardial engraftment of MSCs after exposition to UMS. 
However, UMS is known to cause bioeffects on endothelial cells, such as capillary 
rupture and extravasation of erythrocytes, and cardiomyocytes, for example 
eosinophily and cardiomyocyte necrosis, which are positively associated with the 
used ultrasound emission power (Chen et al., 2002). Recently, Miller and colleagues 
demonstrated an early onset of apoptosis within hours after UMS at high emission 
power and histological signs of myocardial necrosis days after insonication (Miller et 
al., 2007).  However, extensive endothelial damage was not observed in the present 
study as supported by the observations of lack of early apoptosis by TUNEL staining 
and microscopic as well as ultrastructural assessments. These discrepancies are 
likely due to the differences in the insonication protocol as well as microbubble 
properties and concentration. In this study, UMS was performed for 60 pulses at a 
duty cycle of >1%. It is also worth to mention that this is the first study using 
SonoVue microbubbles. As described by the manufacturer, even at higher emission 
power its microbubble shell did not increase in size and thereby did not cause 
potential capillary disruption. Therefore, UMS with the described insonication protocol 
and microbubble properties did not produce an intolerable level of side effects in the 
treated myocardium and vasculature.  
In conclusion, the presented study proved that myocardial MSC attraction, 
transmigration and invasion after systemic stem cell therapy can be enhanced locally 
by means of focussed UMS in native and ischemic myocardium. Therefore, exposure 
of hearts to the non-invasive UMS prior to a systemic stem cell therapy may be well 
suited to augment the stem cell recruitment to non-ischemic as well as ischemic 
myocardium. Whether this UMS-mediated MSC recruitment and incorporation leads 
to a functional improvement of impaired heart function needs to be assessed by 
subsequent studies.  
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It will be one of the major future tasks to find the most practical and specific way of 
evolving and targeting the healing potency of stem cells for tissue regeneration 
(Wollert et al., 2005). 
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5. Summary 
Stem cell therapy using human adult mesenchymal stem cells (MSCs) has emerged 
as a novel strategy for the treatment of a variety of damaged tissues. For a 
successful systemic stem cell therapy MSCs have to exit the blood circulation by 
transmigrating across the endothelium and invading into the target tissue. Elevating 
our knowledge on these core processes might help to optimize stem cell based 
therapies. The first part of the present study provides insights into key mechanisms 
involved in the transmigration and invasion of MSCs. Different model systems as well 
as in vivo studies revealed that MSCs quickly come into contact with the endothelium 
and subsequently exit the blood circulation by (1) integrating into the endothelium, (2) 
transmigrating across the endothelial barrier via the insertion of plasmic podia, (3) 
penetrating the basement membrane and subsequently invading the surrounding 
tissue.  
Additionally, it was proven that transmigration of human MSCs not only requires the 
interaction of very late antigen-4 (VLA-4, α4β1 integrin) and its most important ligand 
vascular cell adhesion molecule-1 (VCAM-1), but also triggers a clustering of β1 
integrins. Furthermore, upon invading into cardiac tissue MSCs secrete active matrix 
metalloproteinase (MMP)-2, but not MMP-9.  
This study also demonstrates that both the time course and the morphological 
aspects of MSC transmigration differ depending on the endothelial phenotype, thus 
indicating, that a variable capacity for transendothelial migration exists within the 
vasculature. Furthermore, addition of cytokines, mainly vascular endothelial growth 
factor (VEGF) and erythropoietin (EPO), accelerate the transmigration of MSCs at 
early stages. Moreover, nitric oxide (NO) and reactive oxygen species (ROS) are 
released by MSCs upon contact with endothelial cells; manipulating the NO and ROS 
system by donors and inhibitors resulted in alterations of the transmigratory capacity 
of MSCs.  
The second part of the study deals with two possible strategies to enhance the 
transmigration of MSCs and thereby their therapeutic effectiveness. First, the results 
demonstrate that genetic modification of MSCs using adenoviral overexpression of 
the chemokine receptor CXCR4 does not lead to an increase in the transmigration 
efficiency. Second, focussed pretreatment of the endothelium by a novel and non-
invasive technique using ultrasound-mediated microbubble stimulation (UMS) 
induces a targeted improvement of MSC attraction, transmigration and invasion into 
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non-ischemic as well as into ischemic myocardium. This effect was most likely due to 
the release of nitric oxide, cytokines and the regional activation of proteases. Thus, 
UMS represents a forward-looking possibility to increase the efficiency of MSC 
engraftment by modulating the process of transmigration in a targeted and non-
invasive manner. 
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